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LLC-PK1   porcine kidney cells 
MDCK  Madin Darby canine kidney cells 
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Ox   oxalate 
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TEM   transmission electron microscopy 
TER   transepithelial electrical resistance 
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1.1 NEPHROLITHIASIS 
 
Nephrolithiasis is a common disease in industrialized countries. In 
Europe and North America about 5-10% of the population forms at least 
one stone in the kidney during lifetime and the incidence is rising. It is 
often considered a “disease of affluence” since the prevalence of stone 
formation is related to the economical situation: during war and recession 
it decreases, to increase during times of abundance [1, 2]. The incidence 
in men is two to three times higher than in women. After development of 
an initial stone, recurrence rates vary from 31 to 75% depending on 
duration of follow-up. About 50% of the patients forms a new stone 
within ten years [2-4]. Most stones are passed spontaneously, but about 
25% of stones requires active removal with methods like extracorporeal 
shock wave lithotripsy and percutaneous nephrolithotomy [1, 3, 5].  
 
Risk factors 
During the past decades, a range of risk factors for renal stone formation 
has been identified: positive family history of stones, nutrition, 
nutritional deficiencies, life style and associated diseases [4, 6-9]. 
Excessive intakes of salt, animal protein and oxalate, as well as 
insufficient intake of fluid, vegetable fibres and calcium increase the risk 
of stone formation [8-13]. However, nephrolithiasis is not primarily a 
nutritional disorder, but nutrition should be regarded as an additional 
factor to underlying abnormalities like primary hyperparathyroidism, 
distal renal tubular acidosis and primary or enteric hyperoxaluria. 
Specific dietary advice and/or pharmacological intervention can lower 
the risk of recurrence for some patients   [3, 4, 8, 14].  
 
Hyperoxaluria 
High oxalate concentrations increase the risk of CaOx crystallization [11, 
15]. Dietary intake, endogenous production, intestinal absorption, and 
renal handling determine the amount of oxalate that appears in the urine. 
Most of the urinary oxalate originates from endogenous production in the 
liver [13]. Recent studies have shown that the mean dietary contribution 
is higher (± 45%) than the 10-20% that was reported earlier, but 
interindividual variability is ranging from 10 to 72 % [10]. In the 
intestine, the amount of oxalate available for absorption and subsequent 
urinary excretion can be limited by complex formation with calcium [9, 
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12, 15, 16], as well as by oxalate-degrading bacteria (Oxalobacter 
formigenes) [17].  
 
Dietary oxalate loads increase the oxalate levels in plasma and thereby 
the filtered oxalate load. The oxalate concentrations in all nephron 
segments will increase accordingly. Oxalate-rich foodstuff, like spinach 
and chocolate, can cause transient hyperoxaluria with peak excretion 
rates comparable to those found in primary hyperoxaluria patients. 
Within 2 to 4 hours after ingestion, urinary oxalate excretion can 
duplicate or even triplicate in comparison to fasting values [6, 11, 18]. 
Oxalate load can be reduced by dietary measures as well as by bacterial 
oxalate breakdown in the gut. Reduction of calcium in given segments of 
the nephron is more complicated. Urine normally contains about ten 
times less oxalate than calcium. After an oral calcium load, the body tries 
to keep plasma calcium homeostasis by manipulating the intestinal 
uptake, bone metabolism as well as renal absorption. In persons with 
normal intestinal calcium absorption, little changes will occur in the 
composition of the proximal tubular fluid and the major increase in 
calcium will occur from the distal tubules onwards [19]. Restriction of 
dietary calcium intake will have an adverse effect on crystallization risks. 
Severe reduction of calcium intake causes the urinary oxalate excretion 
to rise, probably because the pool of oxalate available from absorption in 
the gut is increased [19]. Great changes in dietary calcium load will have 
less effect on the risk of CaOx super saturation than small increases in 
urinary oxalate. Hess et al. have studied the effects of increasing dietary 
calcium after 20-fold normal oxalate loading on intestinal oxalate 
absorption, hyperoxaluria and urinary crystallization. Urines of healthy 
subjects were studied after a normal calcium and oxalate-rich diet, 
oxalate and calcium-rich diet, or after a free-choice diet. Dietary 
hyperoxaluria was prevented and CaOx crystallization reduced when 
calcium intake was increased while eating oxalate-rich food [20]. Low 
calcium intake will lower the amount of calcium available for 
complexation of CaOx in the gut, leading to increased gastrointestinal 
absorption of oxalate and subsequent hyperoxaluria [7-11, 20-22]. In 
calcium-stone forming patients, idiopathic hypercalciuria frequently 
occurs, which may be ascribed to increased intestinal calcium absorption, 
increased bone resorption and decreased renal tubular calcium 
reabsorption. Increasing dietary calcium in normocalciuric as well as in 
dietary-independent hypercalciuric patients leads to reduction in mean 
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urinary oxalate levels. In contrast, in dietary-dependent hypercalciuric 
patients urinary oxalate does not decrease with a higher calcium supply, 
probably due to a higher calcium absorption under these conditions, 
leaving less calcium for complexation with oxalate in the intestinal 
lumen. Nevertheless, a reduction in calcium intake is undesirable for all 
stone forming patients, since it can worsen the bone condition [12].In 
primary hyperoxaluria (PH), metabolic overproduction of oxalate occurs 
and the oxalate excretion is strongly increased in comparison to normal 
persons (3-3.5 mmol / 24 h vs. 0.2-0.5 mmol/24 h)[23]. Primary 
hyperoxalurias are rare autosomal recessive disorders resulting from 
deficiency of hepatic alanine:glyoxylate aminotransferase (PH type I) or 
D-glycerate dehydrogenase/ glyoxylate reductase (PH type II). In the 
Netherlands the prevalence and incidence of primary hyperoxaluria type I  
are 2.9 per million and 0.15 per million per year, respectively [24].  
Disease expression is more severe in type I, where systemic oxalate 
deposition occurs, than in type II [13, 16, 25]. Excess oxalate is excreted 
via the urine, resulting in increased calcium oxalate supersaturation and 
calcium oxalate crystalluria. Together with decreased urine inhibition of 
calcium oxalate crystal formation as compared with normal persons, this 
leads to an augmented risk of renal stone formation.  
 
 
1.2 RENAL FUNCTION AND STONE FORMATION 
 
The physiological function of the kidneys is to excrete endogenous (e.g. 
creatinine, ureum and oxalate) as well as exogenous (like drugs) waste 
products and maintaining body homeostasis. Human kidneys are 
composed of 1-2 million nephrons, which are the functional units. The 
nephron is a specialized structure that is involved in concentration and 
dilution of primary urine. Blood flow in the kidneys is 1.2-1.3 l per 
minute. Each day, 180 litres of fluid are filtered and concentrated to form 
about 1.5 l urine. During this process, nutrients and salts are conserved 
and waste products are excreted. 
 
Each nephron consists of different segments that perform specific 
functions. The blood enters the nephron at the glomerulus, where 
ultrafiltrate is formed. Ultrafiltrate has the same composition as blood, 
but without macromolecules larger than 30 kD. From there on, primary 
urine flows through the proximal tubules and Loop of Henle to the distal 
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tubules. In the proximal tubules, glucose, sodium chloride, and water are 
resorbed and return to the blood stream, together with essential nutrients 
such as amino acids, proteins, bicarbonate, calcium, phosphate, and 
potassium. In the Loop of Henle, the urine concentrating process 
proceeds and in the distal tubule the salt- and acid-base balance of blood 
is regulated. The final urine is formed in the collecting ducts, that drain 
the urine into the calyces from where it enters the ureter [26].  
 
 
Figure 1.  Schematic overview of the nephron 
 
 
Crystallization 
Kidney stones are composed of numerous small crystals that accumulate 
to ultimately form a stone. Crystals can precipitate in the urinary tract 
when the urine is supersaturated, i.e. when the concentration of salts is 
higher than what can be kept in solution. Calcium phosphate (CaP) can 
precipitate already in the loop of Henle or distal part of distal tubules, 
while calcium oxalate (CaOx) supersaturation usually occurs later in the 
nephron, in the collecting ducts. CaP that is precipitated in the earlier 
parts of the nephron dissolves as it travels through the tubules to the 
collecting ducts, where the pH is lower. At that site, CaP can act as 
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nucleation site for CaOx crystals [27-29]. On the basis of super-
saturations, CaOx nucleation can first occur in the loops of juxtamedullar 
nephrons. High plasma calcium moves the chance of  CaOx nucleation 
further upstream. Only in the extreme case of a serum oxalate of 50 µM, 
which is about five times higher than peak values reached in stone 
formers, CaOx can form in all loops and even in the proximal tubules 
[19].  
 
Crystal retention 
Before crystals can turn into an actual stone, they have to be retained in 
the kidney. Different opinions exist about this process. On one hand, it is 
believed to be a “free particle disease”, while on the other hand, it could 
be a “fixed particle disease”. In the first opinion, crystals grow and 
aggregate to the point at which they become too large to pass through the 
tubular lumen and become trapped. Alternatively, crystal retention in the 
kidney could be dependent on the interaction between crystals and the 
epithelium lining the renal tubules, even when crystals are small [28-32].  
It is hypothesized that this occurs when the epithelium lining the renal 
tubules becomes susceptible to crystal binding. Under pathological 
conditions, crystal binding molecules that are normally absent from the 
cell surface might be expressed, enabling crystal-cell interaction. It 
remains to be determined what the triggers are that render the epithelium 
adherent to crystals. In addition, the nature of the crystal binding 
molecules has to be elucidated. Evidence has been provided for the 
existence of tubular damage in idiopathic CaOx stone formers. Urinary 
excretion of  γ-glutamyl transpeptidase, beta-galactosidase, N-acetyl-
beta-glucosaminidase and angiotensin I converting enzyme is higher than 
normal in these patients [33].  
Renal stones are preferentially located in the calyces near the papillary 
tip. In kidneys of stone forming patients, crystalline material was found 
attached to the epithelium in collecting ducts near the papillary tip. These 
submucosal structures, consisting mainly of calcium phosphate (CaP or 
apatite), are termed “Randall’s plaques” [34, 35]. It is believed that these 
sites could serve as nidus for the formation of renal stones. Evan et al. 
found that in intrarenal biopsies of idiopathic calcium-stone formers, 
obtained during percutaneous nephrolithotomy, scattered microscopic 
CaP deposits were located in the basement membrane of the thin loop of 
Henle. Larger plaques were extending from there to the papillary 
interstitium. In this study, no plaque was found in kidneys of non-stone 
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formers or  among patients with stones from obesity-related bypass 
procedures [34, 35]. 
 
Inhibitors of stone formation 
So-called “inhibitors of crystallization” can influence crystal-crystal 
interaction. These are compounds that can interfere with nucleation, 
growth, agglomeration, or retention of crystals, thereby diminishing the 
risk of actual stone formation. Small precipitated crystals can be 
harmlessly excreted with the urine. Urinary macromolecules, like 
proteins and glycosaminoglycans, can affect the growth and aggregation 
of these crystals, acting as either promoters or inhibitors [36-42]. Among 
those are prothrombin fragment 1, inter-α-trypsin inhibitor, Tamm 
Horsfall protein, osteopontin, albumin, and α1-microglobulin. Small 
organic or inorganic compounds, like citrate, pyrophosphate, and 
magnesium, can also act as inhibitors of stone formation. These 
molecules all have affinity for calcium oxalate crystals and can be found 
inside the organic matrix that surrounds the crystals [36, 43-46]. Studies 
have been conducted to investigate possible differences in urine 
composition between stone formers and normal subjects, but indisputable 
distinctions are not yet obtained [40, 45, 47-49].   
 
 
1.3 RENAL CELL CULTURE 
 
Crystal-cell interaction is frequently studied using renal tubular epithelial 
cells in tissue culture. Although cell lines are not always a perfect 
representation of cell behaviour in vivo, they form reliable models to 
repeatedly perform experiments under reproducible conditions. In the 
studies that are described here, renal tubule epithelial cell lines were 
cultured on porous supports in a two-compartment system, to mimic the 
in vivo situation. The lower compartment represents the ‘blood-side’ of 
the epithelium, while the upper or apical compartment represents the 
tubular lumen or ‘urine-side’ of the epithelium. In contrast to cells 
cultured on impermeable plastic surfaces, cells cultured on inserts are 
able to take up nutrients from their basal side. Subsequently, they 
develop into functional polarized monolayers with  a higher degree of 
differentiation than cells grown on impermeable surfaces. These 
confluent layers have preserved many of their in vivo characteristics [50].
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In the experiments described here, MDCK-I and RCCD1 cells were used 
as model systems for the distal part of the nephron. MDCK-I is a 
substrain of the original MDCK cell line, that was derived from the 
kidney of a normal Cocker Spaniel in 1958 [51, 52]. When cultured on 
porous supports, MDCK-I cells develop in to well-differentiated 
polarized monolayers, that have retained most characteristics of distal 
tubule/collecting duct cells [50, 53]. MDCK strain I cells develop a high 
transepithelial electrical resistance (>10.000 Ω.cm2), are covered with 
short and stubby microvilli and express low levels of alkaline 
phosphatase (AP) and γ-glutamyltranspeptidase (γ-GT) [50, 54]. These 
cells also exhibit significant carbonic anhydrase activity [55] and their 
inward current can be activated by vasoactive intestinal polypeptide [56]. 
RCCD1 cells are isolated from rat collecting duct and are characterized 
by high transepithelial resistances (>3.000 Ω.cm2) and specific hormonal 
sensitivities. The cell line contains intercalated as well as principal cells. 
Their morphological appearance resembles that of intact CCD, with 
cuboid cells that are connected by tight junctions [57].  
 
LLC-PK1 and MDCK-II cells are used as model for the proximal tubule 
epithelium. Confluent monolayers formed by these cells are leaky (<200 
Ω.cm2), are endowed with a luxurious brush border packed with tall 
microvilli and their membranes express high levels of AP and γ-GT 
activity [50]. LLC-PK1 cells were isolated from porcine kidney [58]. 
These cells actively reabsorb essential nutrients and water across the 
epithelium [59]. MDCK strain II cells are derived from the parental 
MDCK cell line [54]. In contrast to strain I cells, these cells express 
characteristics of proximal as well as distal tubular cells.  
 
It is important to confirm if findings obtained with cell lines represent the 
actual situation in the kidney. Therefore, primary cultures of renal tubular 
cells can be used. Since experiments with these cells are performed 
directly after their isolation from the kidney, they have retained most of 
their in vivo characteristics. Proximal and distal tubular cells are isolated 
from normal human kidney tissue, which became available thorough 
nephrectomies. Fluorescence-activated cell sorting (FACS) in 
combination with specific monoclonal antibodies is used to identify the 
segmental origin of the cells. When passage 1 cells reached confluence, 
hormonal stimulation and antigen expression were used to verify that 
these cells retained their in vivo behaviour as close as possible [60]. 
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1.4  CRYSTAL-CELL INTERACTION IN CELL CULTURE 
 
To unravel the mechanisms that might be involved in the development of 
renal stones, we studied crystal-cell interactions in cell culture. It was 
previously shown that the affinity of MDCK-I, MDCK-II, and LLC-PK1 
cells for COM crystals was high during subconfluence, when they were 
proliferating. Confluent proximal as well as distal tubule epithelial cells 
cultured on impermeable surfaces for the most part retained their crystal 
binding capacities. When cultured on permeable supports in a two-
compartment model, differences in crystal retention between distal- and 
proximal tubule epithelial cells occurred. Cells derived from the proximal 
part of the nephron retained their high affinity for COM crystals during 
their growth to confluence [50, 61], while distal tubule/collecting duct 
cells on the other hand became non-adherent to crystals at confluence. 
An explanation for this might be that, in vivo, the proximal tubular cells 
normally do not encounter crystals and therefore do not require defence 
mechanisms against their retention. In distal tubule/ collecting duct cells 
the transition from adherence to non-adherence occurred at the time 
when the tight junctions became functional [50, 61-63], indicating that 
intact monolayers that are likely to encounter crystals indeed possess a 
protective mechanism against crystal retention.  
 
Renal tubular injury 
It is hypothesized that, while normal intact epithelium in the distal part of 
the nephron is non-adherent or ‘protected’ against crystal binding, cell 
stress or injury can turn the tubular lining into a crystal-binding state [29, 
62, 64, 65]. Indeed, cell culture studies have shown that cells derived 
from distal parts of the nephron, when grown into intact confluent mono-
layers, are non-adherent to COM crystals. At times when the epithelial 
integrity is lost due to mechanical damage (scrape wounding) of the 
monolayer, crystal binding temporarily occurs until the cell layer is 
recovered. After closure of the wound and restoration of tight junctions, 
the epithelium becomes non-adherent again [62].  
 
Oxalate toxicity 
Recent investigations by our group focussed on the identification of 
potential stressors, capable of inducing injury to confluent tubular 
epithelial cells, which could in turn lead to enhanced affinity for crystals. 
About 80% of all renal stones are composed of calcium oxalate (CaOx) 
9 
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and oxalate is considered one of the most harmful endogenous agents in 
this field of investigation. Cell culture studies have provided evidence 
that oxalate and/or calcium oxalate crystals are damaging to the renal 
tissue [66-68]. CaOx crystals are internalized by proximal tubular cells 
[69-72], which might lead to cell stress and activation [72-74]. In a 
calcium-containing environment, oxalate ions precipitate as CaOx 
crystals. This mechanism complicates the results from most cell culture 
studies, in which oxalate was added to the cells in calcium-containing 
cell  culture medium. According to a study by Belliveau et al., addition of 
as little as 50 µM oxalate to DMEM (containing 1.8 mM CaCl2) results 
in precipitation of about  45%  of the oxalate with calcium from the 
medium. When 1 mM oxalate is added, 94% of the oxalate precipitates as 
CaOx [75]. To study the effects of oxalate ions alone, thus in absence of 
CaOx crystals, a calcium free buffer has to be used. Despite the fact that 
in vivo a calcium free environment does not occur in the kidney, these 
conditions can be created in cell culture to distinguish between effects 
caused by oxalate or crystals. In the two-compartment model, detachment 
of cells due to calcium deprivation can be prevented by addition of 
calcium-containing medium to the basal compartment (blood-side), while 
the apical (urine-) side of the cells receives calcium free medium. 
 
Oxalate concentrations in the tubular fluid vary considerably per nephron 
segment. In ultrafiltrate, the concentration is similar to that in plasma (± 
2 µmol/l). In the proximal tubules, this rises to approximately 17 µmol/l. 
During passage of the urine through the distal parts of the nephron, 
oxalate concentration can increase up to about 120 µmol/l.  The maximal 
concentration of oxalate reported in final urine is 1 mmol/l [27, 28]. 
When the 24-hour excretion exceeds 450 µmol, this is usually considered 
as hyperoxaluria [23]. It has been reported that cells from proximal 
tubular origin (LLC-PK1) and distal tubular origin (MDCK) respond 
differently to oxalate exposure, proximal tubular cells appearing to be the 
most sensitive to oxalate toxicity [74]. In studies presented in Chapters 5 
and 6 of this thesis, we used the two-compartment cell culture model to 
investigate whether CaOx crystals and/or oxalate ions are indeed toxic to 
renal tubule epithelial cells. 
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1.5 IDENTIFICATION OF CRYSTAL BINDING MOLECULES 
 
To obtain more insight into the mechanisms of crystal-cell interaction in 
vivo, identification of crystal binding molecules in vitro can provide 
important information. Certain criteria have to be met before a molecule 
can be identified as crystal binding molecule. First of all, the molecule in 
question must have affinity for crystals; second, it must be present at the 
cell surface at moments when crystal binding occurs and third, at 
moments when the epithelium is non-adherent, the potential crystal 
binding molecule has to be absent from the epithelium. Fourth, the 
removal of the molecule in question should result in lower levels of 
binding. It is however conceivable that other crystal binding molecules 
can compensate for the removal of a single type of crystal binding 
molecule. Molecules that meet these four criteria in cell culture studies 
can only serve as true crystal binding molecules when their expression in 
vivo is rationalized by existing physiological mechanisms. 
  
Various potential crystal-binding molecules have been proposed during 
the past years. These molecules may play distinct roles in crystal-cell 
interaction, depending on the cell line used or the type of damage that is 
inflicted to the cells. It is conceivable that more than one crystal-binding 
molecule is involved in the pathogenesis of kidney stone disease. In a 
review by Asselman and Verkoelen, the candidate crystal binding 
molecules that have been proposed during the past decade and the way 
these might be connected to each other are discussed [76].  
 
Hyaluronan (HA), a large polysaccharide was first identified as a major 
crystal binding molecule during proliferation and injury repair in studies 
with MDCK-I cells [77]. Furthermore, it was shown to function as crystal 
binding molecule in primary cultures of human renal epithelial cells [63]. 
HA at the cell surface attracts water and forms a thick viscous ‘coat’ or 
pericellular matrix (PCM) at the cell surface, that is stabilized by proteins 
and proteoglycans that form bridges between the HA chains. Due to the 
unique water-absorbing properties of the networks and the negative-
charge repulsion between the various macromolecules, the whole 
construction straightens to extend several microns outward from the 
surface. PCMs play an important role in cell migration, proliferation and 
injury repair. The hydrated matrix facilitates movement of  cells during 
tissue remodelling [78-83].  
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Recent data from a study with rats given ethylene glycol in drinking 
water to induce crystal formation and retention have provided more 
evidence for the concept that HA is involved in stone disease. 
Injured/regenerating tubule epithelial cells express HA on their apical 
surface, and at these sites calcium oxalate crystals are found attached to 
the tubule wall [84]. 
 
Other investigators studied the role of phospholipids, like 
phosphatidylserine (PS), in crystal attachment. PS is normally confined 
to the inner leaflet of the cell membrane and is expressed at the outer 
leaflet as a classic response to toxic stimuli. Cao et al. have shown that 
exposure of MDCK cells to oxalate (0.25-0.50 mM) induced re-
distribution of phosphatidylserine to the cell-surface and crystal binding 
[85]. Crystal binding was also enhanced when PS expression in the outer 
leaflet of the membrane was stimulated by exogenous addition of PS or 
by membrane lipid scrambling agents [86].  
 
Preincubation with positively charged compounds reduced crystal 
binding to BSC-1 cells, suggesting that crystals are attracted by 
negatively charged cell surface molecules [87]. Since terminal sialic acid 
residues account for most of the negative charge of the cell-surface, sialic 
acid was proposed as crystal binding molecule.  Lieske et al. have shown 
that sialidase (neuraminidase) treatment of BSC-1 cells reduced crystal 
binding to these cells. These authors concluded that sialic acid-containing 
cell surface glycoconjugates are critical determinants of face-specific 
crystal nucleation upon the renal cell surface. The spatial three-
dimensional organization of the sialic acid-containing glycoconjugates at 
the cell surface, rather than the amount of sialic acid, may enable their 
interaction with the crystal surface [87, 88]. However, investigations by 
our group showed that in MDCK-I cells sialic acid does not seem to act 
directly as crystal binding molecule, as it is more heavily expressed on 
non-adherent confluent cells than on subconfluent cells with affinity for 
crystals. Nevertheless, neuraminidase treatment significantly reduced 
COM crystal binding  to subconfluent MDCK-I cells [89]. Sialic acid 
could be of importance in COM crystal binding, by stabilizing the HA-
rich pericellular matrix or by regulating the CD44-mediated binding of 
HA to the cell surface [90, 91]. Other candidate crystal-binding 
molecules under investigation are annexin II  [92] and nucleolin-like 
protein [93]. 
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Extracellular matrix (ECM) molecules are also suggested to act as crystal 
binding molecules under certain conditions. After denudating injury, for 
example, molecules like collagen IV, fibronectin and laminin could be 
exposed. Urine sediments from stone-forming patients were shown to 
contain collagen IV-positive mucous threads with affinity for crystals 
[94]. Fibronectin was strongly expressed on crystal-containing tubules in 
a stone-forming rat model [95]. A study by Kramer et al. using CAKI-1 
cells also suggested a role for collagen I and -IV and fibronectin as 
potential crystal binding molecules [96]. 
 
It has been demonstrated that the cell surface properties of the crystal 
binding phenotype differ considerably from that of cells that are non-
adherent to crystals. The binding phenotype is characterized by the 
luminal expression of HA, OPN and CD44. We do not exclude the 
possibility that one or more of the aforementioned molecules also belong 
to the crystal binding phenotype. The relative contribution of these 
molecules to crystal retention remains to be resolved. 
 
 
1.6  SCOPE OF THIS THESIS 
 
The studies in the present thesis were performed to obtain more insight in 
the response of different renal tubular cell types to calcium oxalate 
crystals and oxalate ions. There are many conflicting data in the literature 
that for a large part may result from the use of renal tubular cells derived 
from different segments of the nephron and by the cell culture methods 
used. In this thesis attempts were made to clarify some of the existing 
indistinctness and contradiction. In Chapter 2, we investigated if urinary 
crystallization inhibitors were also capable of inhibiting the binding of 
calcium oxalate crystals to renal tubular epithelial cells. In Chapter 3, we 
studied the ability of renal tubular cells in culture to form hyaluronan-
rich pericellular matrices with affinity for crystals. In Chapter 4,  we 
addressed the potential significance of crystal binding and endocytosis in 
the pathophysiology of renal stone disease. In Chapter 5, we studied the 
possible damaging effect  of the interaction of renal tubular cells with 
crystals and Chapter 6 is devoted to the proposed nephrotoxic effect of 
free (soluble) oxalate. Finally, the results are discussed in  Chapter 7. 
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ABSTRACT 
 
Purpose. Renal stone formation requires the persistent retention of 
crystals in the kidney. Calcium oxalate monohydrate (COM) crystal 
binding to Madin Darby canine kidney strain I (MDCK-I), a cell line that 
resembles the epithelium in the renal distal tubule/collecting duct, is 
developmentally regulated, while LLC-PK1 cells (American Type Tissue 
Collection), which are widely used as model for the renal proximal 
tubule, bind crystals irrespective of their stage of epithelial development. 
Whereas to our knowledge the binding molecules for COM at the surface 
of LLC-PK1 cells are still unknown, crystals adhere to the hyaluronan 
(HA) rich pericellular matrix transiently expressed by mobile MDCK-I 
cells. In the current study we investigated whether crystal binding to 
either cell type is influenced by urinary substances, including 
glycoprotein inhibitors of crystallization.  
Materials and Methods. We studied crystal binding to MDCK-I cells 
during wound repair, to confluent LLC-PK1 cells and to HA immobilized 
on a solid surface using [14C]COM pretreated or not pretreated with urine 
obtained from healthy male volunteers. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and Western blot analysis were 
performed to assess whether the crystals became coated with urine 
derived proteins.  
Results. Western blot analysis demonstrated that pretreated COM 
crystals were covered with protein inhibitors of crystallization. However, 
this protein coat had no significant effect on the level of crystal binding 
to either cell type. In contrast, the adherence of urine treated crystals to 
immobilized hyaluronan was significantly reduced.  
Conclusions.  The adherence of crystals to pericellular matrixes may 
encompass more than their simple fixation to the polysaccharide HA. 
Calcium oxalate crystal retention is not prevented by coating crystals 
with urinary constituents such as glycoproteins and, therefore,  may 
predominantly depend on the surface properties of the renal tubular 
epithelium. 
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INTRODUCTION 
 
The production of concentrated urine frequently initiates crystal formation 
in the kidney. Persistent inadequate elimination of crystal material with 
urine eventually can lead to the formation of a stone in the urinary tract. 
Retention of crystals may be caused by their attachment to epithelial cells 
lining the renal tubules. We [1] and others [2-4] developed cell culture 
models to investigate the mechanisms involved in crystal-cell interaction. 
Most of our studies are performed with Madin Darby canine kidney 
(MDCK) strain I cells=?, which exhibit morphological and functional 
characteristics of the epithelium found in the renal distal tubule/collecting 
duct [6]. At confluence MDCK-I cells form highly polarized functional 
monolayers with transepithelial resistances over 5000 Ω x cm2. Calcium 
oxalate monohydrate (COM), the most common crystalline component of 
kidney stones, abundantly adheres to the surface of developing MDCK-I 
cultures but not to confluent monolayers. Since the renal epithelium in vivo 
occurs in continuous cell layers, it suggests that a healthy epithelium is non 
adherent. However, the resistance to crystal binding is temporarily lost at 
the time of intact monolayer wounding and during the subsequent healing 
process. During repair COM crystals bind to the hyaluronan (HA)rich 
pericellular matrix surrounding wounded areas. Soon after wounds are 
healed HA disappears from the surface and the epithelium regains its 
nonadherent properties. From these observations it was speculated that 
tissue injury may initiate the stone forming process[1, 7, 8]. 
Developmentally regulated COM binding is not the only form of crystal-
cell interaction. Crystals avidly adhere to mobile LLC-PK1 cells in 
subconfluent cultures as well as to growth-inhibited cells during 
confluence[6].  
Crystallization in the tubular fluid is under the control of various high and 
low molecular weight urinary constituents. A considerable part of this 
inhibitory activity is provided by glycoproteins, such as members of the 
inter-α-trypsin inhibitor and prothrombin families of proteins, osteopontin, 
Tamm-Horsfall protein (THP) and α1-microglobulin. The appreciation of 
these urinary inhibitors has led to the hypothesis that pathological 
calcification in the urinary tract is caused by alterations in the amount or 
the structure of these compounds[9]. It has been suggested that crystal-cell 
interaction can also be prevented by urine constituents[9]. Although this 
idea seems to be supported by results obtained with purified inhibitors of 
crystallization [10, 11], there is no solid evidence that crystal-cell 
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interaction indeed is modulated in the presence of physiological 
concentrations of naturally occurring urinary constituents. In the current 
study we investigated the effect of urine pretreatment on crystal-cell 
interaction. 
  
 
MATERIALS AND METHODS 
 
Cell culture.  
Cells were seeded on 24 mm. polycarbonate porous filter inserts 
(Corning Costar, Badhoevedorp, The Netherlands) at a concentration of 
1x106 cells/insert [7]. As described previously [7], strips of cells were 
scraped off from confluent MDCK-I monolayers. Crystal binding was 
studied 2 days after injury to MDCK-I and 7 days after seeding to LLC-
PK1 (ATCC). 
 
Pretreatment of COM with human urine.  
Fresh morning midstream urine samples were obtained from 10 healthy 
male volunteers between 30 and 50 years old who were selected from the 
laboratory staff. Urine specimens did not receive any additives and were 
not centrifuged. They were maintained at room temperature and used for 
the various experiments the same morning. COM crystals were prepared 
as described previously [7]. Radiolabeled crystals (1.45 mg) were 
centrifuged for 5 minutes at 1000 x gravity. The supernatant was 
discarded and the crystal pellet was incubated in 1 ml. urine for 1 hour 
under end-over-end rotation at room temperature, centrifuged, washed 
and re-suspended in calcium oxalate saturated distilled water. To assess 
whether sufficient amounts of protein were available to cover the crystals 
an experiment was performed. Nonradiolabeled COM crystals (3.6, 7.25 
or 14.5 mg.) were added to 5 ml. urine (0.72, 1.45 and 2.9 mg./ml., 
respectively). After 2-hour end-over-end incubation the crystal were 
centrifuged, washed and dissolved in 1 ml. 0.25 M. ethylene diamine 
tetraacetic acid. The amount of protein adsorped was determined by 
spectrophotometry using a protein assay (Roche Diagnostics GmbH, 
Mannheim, Germany). The method of studying crystal binding has been 
previously described in detail [7]. 
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Sodium dodecyl sulfate (SDS- polyacrylamide gel elctrophoresis 
(PAGE) and Western blot analysis. 
Urinary constituents were allowed to cover the crystal surface by the 
addition of 22 mg. non-radiolabeled COM to 50 ml. freshly voided urine. 
The crystals were incubated for 2 hours at room temperature under end-
over-end rotation. After centrifugation at low speed the pellet was 
washed, demineralized in 0.25 M ethylene diamine tetraacetic acid, pH 8 
for 2 days at 40 C, dialyzed and freeze-dried. SDS-PAGE was performed 
with a 1.0 mm 10% mini-slab gel using a mini-Protean II apparatus 
(BioRad Laboratories, Hercules, California). Samples of 20 µg. protein 
and molecular weight standards were electrophoresed under nonreducing 
conditions. Proteins were visualized using a silver staining kit 
(Amersham Pharmacia Biotech, Roosendaal, The Netherlands) or blotted 
onto nitrocellulose. After electrophoresis gels and nitrocellulose 
membranes were equilibrated in the blotting buffer containing 16.5 mM. 
TRIS, 150 mM. glycine and 10% volume/volume methanol. Proteins 
were transferred for 1 hour at 40C. Immunochemical staining was 
performed using different polyclonal antibodies, including sheep-α-
human inter-α-trypsin-inhibitor, sheep-α-human prothrombin, sheep-α-
human α1-microglobulin (The Binding Site,Birmingham, United 
Kingdom) and mouse-α-human THP (Cedarlane Laboratories Ltd., 
Hornby, Canada).  Nonspecific protein binding sites were blocked by 
incubating  for 60 minutes in phosphate buffered saline-0.1% Tween-5% 
nonfat dry milk. The membranes were incubated overnight with the 
primary antibody, diluted 1:1000, at 40C  followed by 60 minutesd of 
incubation with the secondary antibody, diluted 1:2,500, using rabbit-α-
sheep or mouse-α-sheep horseradish peroxidase (DAKO, Glostrup, 
Denmark). The membranes were then developed for 1 minute using a 
chemiluminescence substrate kit (Roche Diagnostics GmbH, Mannheim, 
Germany). 
 
Enzyme treatment and HA staining. 
After rinsing with a physiological saline solution cells were treated at 
37°C, pH 5.3 for 1 hour with 5 units per ml Streptomyces hyaluronidase 
(EC 4.2.2.1, Sigma-Aldrich, Zwijndrecht, The Netherlands) in serum-free 
Dulbecco’s modified Eagle’s medium. The method of staining HA as 
well as the procedure for coating plastic wells with this polysaccharide 
have been previously described [1].  
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RESULTS 
 
To study the effect of urine constituents on crystal-cell interaction we 
measured crystal adherence after pretreatment with urine derived from 
healthy males. Crystal adherence was studied to confluent LLC-PK1 
cultures 7 days after seeding and during the recovery of the MDCK-I 
cultures from scrape damage 2 days after injury. Although binding was 
slightly decreased in some experiments, this treatment did not prevent 
crystal adherence of urine treated crystals. Compared with the adherence 
of untreated crystals preincubation with 10 different urines reduced mean 
COM binding plus or minus standard deviation to LLC-PK1 and MDCK-
I cells to 92% ± 8% and 89% ± 12%, respectively, which was not 
statistically significant (table 1). To coat COM crystals with urinary 
constituents a standard amount of 1.45 mg. crystals was pre-incubated in 
1 ml. undiluted urine. This ratio was chosen, such that urinary proteins 
were in excess compared with the amount of crystals. Figure 1 shows the 
linear relationship of protein adsorption and increasing amounts of 
crystals. An average of 1 ml. urine contained 0.1 mg. protein, of which 
approximately 10% became adsorbed to the the standard amount of COM 
crystals. [14C]COM binding was not different using crystals generated in 
urine instead of pre-incubated in urine (data not shown). 
 
 
Figure 1. Adsorption of urinary proteins to COM crystals. To coat COM crystals with 
urinary constituents 1.45 mg. crystals were pre-incubated in 1 ml. undiluted urine at 
room temperature for 2 hours. There was linear relationship op protein adsorption and 
increasing amounts of crystals. 
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6CDNG   $KPFKPI QH =%? %1/ ET[UVCNU RTGVTGCVGF YKVJ WTKPG CU RGTEGPV QH
WPVTGCVGFET[UVCNUKPKPUGTVU
 
Urine 
Sample No. 
Mean % MDCK-I ± SD 
2 Days After Injury 
Mean % LLC-PK1  ± SD 
7 Days After Seeding 
1   78 ± 10 111 ± 19 
2   78 ± 9*   88 ± 3* 
3 118 ± 17   75 ± 1* 
4     80 ± 10*   51 ± 8* 
5 93 ± 4 20 ± 1 
6   71 ± 6* 111 ± 10 
7   73 ± 22    74 ± 6 * 
8 89 ± 4 97 ± 3 
9 102 ± 16 94 ± 3 
10 90 ± 9 96 ± 8 
Av.   89 ± 12 92 ± 8 
*Significantly decreased compared to the binding of untreated COM crystals (Student’s 
t-test p < 0.05) 
 
To assess whether urinary inhibitors of crystallization became adsorbed 
onto the crystal surface COM crystals incubated with urine were 
demineralized and analyzed by silver staining. This technique revealed 4 
major bands in the gel at approximately 80, 60, 36 and 20 kDa (Fig.2, A). 
Corresponding Western blots were stained with antibodies against a 
number of known urinary inhibitors of crystallization (Fig.2, B). Using 
anti-α1-microglobulin we detected 2 major bands at a molecular weight 
of 80 and 35 kDa. in lane 1. ITI related proteins were present as 1 major 
band at 55 kDa. in lane 2. We found 2 main bands for the prothrombin  
family of proteins at 40 and at 30 kDa. in lane 3, while a large spot of 
THP was found at 98 kDa. in lane 4.   
Previously we have identified HA as crystal binding molecule at the 
surface of migrating and proliferating MDCK-I cells. Since mobile as 
well as growth-arrested LLC-PK1 cells are susceptible to crystal 
attachment, it is possible that these cells constitutively express HA. 
Therefore, we studied the presence or absence of HA at the cell surface 
using biotinylated HA binding protein coupled to avidin-fluorescein 
isothiocyanate and visualized by confocal microscopy. Scans done  
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perpendicular to the cell layer (xz scan) showed HA at the surface of 
mobile MDCK-I cells covering the whole apical cell surface (Fig. 3A). 
6TGCVKPI /&%-+ EGNNU YKVJ 5VTGRVQO[EGU J[CNWTQPKFCUG EQORNGVGN[
CDQNKUJGFVJG*#DKPFKPIRTQVGKPUVCKPKPI
PQVUJQYP+TTGURGEVKXGQH
VJGKT UVCIG QH GRKVJGNKCN FGXGNQROGPV ..%2- EGNNU PGXGT GZRTGUUGF
UWTHCEG CUUQEKCVGF *# 
(KI $ 6TGCVOGPV QH OQDKNG EGNNU YKVJ
5VTGRVQO[EGUJ[CNWTQPKFCUGECWUGFCUKIPKHKECPVOGCPTGFWEVKQPXGTUWU
EQPVTQNUKPET[UVCNDKPFKPIVQ/&%-+EGNNU
vXGTUWU
vRDWVPQV VQ..%2-EGNNU 
vCPFv
TGURGEVKXGN[
Previously we have demonstrated that crystals adhere to the surface of 
plastic wells pre-coated with HA =?. This method was used in the 
current series to study selectively the effect of urinary constituents with 
affinity for COM on crystal binding to HA. Pre-coating wells with HA 
resulted in higher levels of binding, which was reduced to background 
levels by Streptomyces hyaluronidase. Although the magnitude of the 
effect varied, coating the crystals with urine significantly reduced their 
binding to HA coated wells (p<0.05, table 2). 
 
 
 
Table 2.  Binding of [14C] COM crystals pretreated with urine as percentage of 
untreated crystals. Average ± SD of three wells, p-values according to Student’s t-
test.  
Before treatment Mean % COM binding 
Control 100 
Streptomyces Hyaluronidase   3 ± 1 
Urine 11   4 ± 1 
Urine 12 20 ± 1 
Urine 13 18 ± 2 
Urine 14 35 ± 7 
Urine 15 22 ± 2 
 *Versus controls all pretreatment values were significantly decreased (Student’s t-test 
p < 0.05)  
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
(KIWTGAnalysis of COM-associated urinary proteins. (A) Silver staining revealed 4 
major bands in the gel at approximately 80, 60, 36 and 20 kDa as well as a number of 
minor bands. (B) Corresponding Western blots show 2 major bands for α1-
microglobulin (α1MG) at 80 and 35 kDa, inter-α-trypsin inhibitor (ITI)-related proteins 
as one major band  at 55 kDa, prothrombin (PT) proteins in 2 bands at 40 and 30 kDa. 
and broad band of THP at 98 kDa. 
 
 
Figure 3. Presence or absence of HA at the surface of subconfluent MDCK-I and LLC-
PK1 cells on confocal microscopy after staining with HA binding protein, coupled to 
fluorescein isothiocyanate. Cell nuclei were counterstained with propidium iodide. 
Scans were done perpendicular to cell surface as xz-scan. A. HA staining appears as a 
bright layer covering MDCK-I cells. B, no bright layer appears on LLC-PK1 cells. 
A 
B 
α1MG ITI PT THP 
98
64
50
36
30
250
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DISCUSSION 
 
This study shows that pretreatment of COM crystals with urine derived 
from healthy men does not prevent crystal binding to renal tubular cells 
in culture. Nevertheless, SDS-PAGE and Western blot analysis 
nevertheless revealed that many known urinary protein inhibitors of 
crystallization adsorbed onto the crystal surface, including α1-micro-
globulin, THP, and inter-α-trypsin-inhibitor- and prothrombin-related 
proteins. To study the potential effect of urinary constituents on crystal-
cell interaction we selected 2 cell types, namely LLC-PK1 cells, which 
constitutively express crystal binding molecules, and MDCK-I cells, which 
are susceptible to crystal binding only during locomotion. MDCK-I and 
LLC-PK1 cells are representative of the distal tubule/collecting duct and 
proximal convoluted tubule, respectively. When considering the levels of 
stone salt supersaturation, in contrast to that in the proximal convoluted 
tubule, the epithelium in the distal tubule/collecting duct requires protection 
against encountering crystals. In line with their suspected origin LLC-PK1 
cells are endowed with a well developed brush-border specialized for 
binding and endocytosing molecules that escaped the glomerular barrier, 
whereas MDCK-I cells are covered with a smaller amount of short and 
stubby microvilli[6]. The current study shows that urinary constituents 
cannot prevent the possible early as well as late nephron mode of crystal 
attachment. Since the effects of urinary inhibitors on crystal growth, 
aggregation and retention are often bracketed together [9, 11], our 
observations could make a distinction between the role of these substances 
in renal stone disease.  
It has been reported  that crystal attachment can be inhibited by pre-
incubating COM with negatively charged low- and high molecular 
urinary constituents[10, 11]. In those studies glycoproteins, such as 
nephrocalcin and uropontin, were isolated and purified from biological 
fluids[11], whereas purified citrate and polysaccharides were commer-
cially obtained[10, 11]. It is questionable whether these substances 
inhibited crystal adherence at concentrations within the physiological 
range. For example, citrate inhibited crystal binding at concentrations 
greater than 50 µM [11], whereas normocitraturia is approximately 2 
µM. Heparan sulfate and chondroitin sulfate only marginally inhibited 
crystal attachment, whereas the level of crystal binding was increased in 
the presence of HA [10]. Most inhibitory capacity was obtained with 
anionic compounds that are not normally present in the urine, such as 
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synthetic polysaccharides[10], poly-aspartate[11] and heparin[10, 11]. In 
the current study we selected the urine of healthy males because the 
highest levels of inhibitory activity are most likely  expected in the urine 
of men that do not form kidney stones. On the other hand, it is 
conceivable that the kidneys of stone formers are triggered to the overall 
or local excretion of protective compounds to prevent crystal-cell 
interaction. Ebusino et al. reported that the presence of 10% urine during 
the incubations inhibited the adherence of calcium oxalate crystals to 
MDCK cells by approximately 50% [12]. In that series the inhibitory 
effect of stone former derived urine was not significantly different from 
that of healthy controls, which seems to contradict the possibility that 
stone formers excrete higher levels of protective substances. The idea 
that stoneformers excrete higher levels of urinary crystallization 
inhibitory proteins was recently disproved [13]. To verify the results of 
Ebusino et. al [12], we also performed part of our experiments in the 
presence of 10% urine. When compared with pre-treated crystals, the 
inhibition levels inclined to be somewhat higher in the presence of urine 
(data not shown). Considering the amount of inhibitors available in 10% 
versus whole urine, it was most likely caused by other factors. Renal 
medullary cells are routinely under osmotic stress. MDCK cells are 
capable of regulating their cell volume under anisotonic conditions. 
When suddenly exposed to anisotonic extracellular fluid, they initially 
swell or shrink to return subsequently to the original cell volume [14]. 
Our crystal binding studies were performed under isosmotic conditions 
(310-320 mOsmol/ kg. water). It is possible that the inhibitory effect in 
the presence of urine is mediated by an acute adaptive response of the 
plasma membrane to osmotic stress. The effect of osmotic variations on 
crystal binding clearly merits investigations that are more detailed. 
Finally in contrast to the results of cell culture, urinary constituents signi-
ficantly reduced the level of [14C] COM binding to immobilized HA, 
suggesting that crystal binding to synthesized plasma membrane 
associated HA differs from binding to purified HA. It may have been 
caused by differences in the spatial structure, state of hydration, 
molecular mass of MDCK-I synthesized HA or by the presence of stabi-
lizing proteins in the pericellular matrix. More detailed studies are 
required to investigate whether HA immobilized on a solid surface is 
representative for the structural organization of HA in organic cell coats. 
In conclusion, together the results of this study show that urinary protein 
inhibitors of crystallization have only a minor role in the attachment of 
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COM crystals to renal tubular cells, suggesting that crystal retention 
primarily depends on the composition of the cell surface. 
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ABSTRACT 
 
Background/Aim. Retention of crystals in the kidney ultimately leads to 
renal stone formation. Hyaluronan (HA) has been identified as binding 
molecule for calcium oxalate monohydrate crystals. The association of 
high molecular mass (Mr) HA with cell surface receptors such as CD44 
gives rise to pericellular matrix (PCM) formation by many eukaryotic 
cells in culture. Here, we study the ability of several renal tubular cell 
lines to assemble PCMs and to synthesize high-Mr HA during proli-
feration in relation to crystal retention.  
Methods. PCM assembly by MDCK-I, MDCK-II and LLC-PK1 cells was 
visualized by particle exclusion assay. Metabolic labeling studies were 
performed to estimate the cellular production of HA. The expression of 
CD44 and HA was studied using fluorescent probes, and crystal binding 
was quantified with radiolabeled calcium oxalate monohydrate.  
Results. PCMs were formed, and HA was expressed by most MDCK-I 
and some MDCK-II, but not by LLC-PK1 EGNNU. All cell types expressed 
CD44 at their apical surface. MDCK-I, MDCK-II secreted, respectively, 
14.7 ± 1.6 and 0.5 ± 0.2 pmol [3H]glucosamine incorporated in high-Mr 
HA, whereas LLC-PK1 did not secrete HA. Streptomyces hyaluronidase 
treatment significantly decreased crystal binding (µg/cm2) to MDCK-I  
cells (from 8.6 ± 0.4 to 3.9 ± 0.9), but hardly to MDCK-II cells (from 
10.2 ± 0.2 to 9.6 ± 0.1) or LLC-PK1 cells(from 10.2 ± 0.8 to 9.9 ± 0.3). 
Conclusions. There are various forms of crystal binding to renal tubular 
cells in culture. Crystal attachment to MDCK-I cells and some MDCK-II 
cells involves PCM assembly that requires high-Mr HA synthesis. HA 
production and PCM formation do not play a role in crystal binding to 
LLC-PK1 and the majority of MDCK-II cells. It remains to be 
determined which form of binding is involved in renal stone disease. 
 
 
INTRODUCTION 
 
Calcium oxalate kidney stones are composed of innumerable crystals 
formed by calcium and oxalate ions in the tubular fluid. Although the 
solubility product of calcium oxalate is exceeded already shortly after 
glomerular filtration, crystal nucleation is postponed to later nephron 
segments by tubular fluid constituents collectively indicated as 
“crystallization inhibitors”. Despite the presence of these substances in 
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the primary urine, crystals are formed occasionally in the kidneys of 
stone formers as well as of subjects not forming stones. Crystal formation 
is harmless as long as the crystals are efficiently eliminated with the 
urine. The epithelial lining in the late nephron and also in more distal 
parts of the urinary tract is provided with a nonadherent surface. People 
are at risk of urinary tract stone formation when these antiadherent 
properties somehow are compromised [1-3].  
Confluent monolayers formed in culture by renal distal tubule/collecting 
duct-like MDCK-I cells [4] and by primary cultures of human distal renal 
tubular cells [5] are nonadherent to calcium oxalate monohydrate (COM) 
crystals, the most common crystalline phase in kidney stones. In contrast, 
subconfluent cultures and monolayers recovering from mechanical injury 
are quite susceptible to crystal binding. From these observations, it was 
speculated that crystal retention in the kidney is caused by some form of 
tissue damage [6]. The polysaccharide hyaluronan (HA) was 
subsequently identified as major crystal-binding molecule (CBM) at the 
surface of renal tubular cells in locomotion [5, 7]. 
HA is a high molecular mass (Mr) polysaccharide (up to 104 kD) 
consisting of repeating units of disaccharides formed by glucuronic acid 
and N-acetylglucosamine (GlcNAc). HA is known for its ability to form 
“cell coats” or pericellular matrices (PCMs) surrounding eukaryotic cells, 
including fibroblasts [8], chondrocytes [9], keratinocytes [10], arterial 
smooth muscle cells [11] and tumor cells [12]. Linear polysaccharide 
chains synthesized by specific HA synthases (HAS-1, HAS-2 and HAS-
3) at the inner surface of the plasma membrane are extruded into the 
extracellular space. Once outside the cell, the HA forms complexes with 
HA-binding proteins (HABPs) [13]. Due to the unique water-absorbing 
properties of these networks and the negative-charge repulsion between 
the various macromolecules, the whole construction straightens to extend 
up to several microns outward from the surface. These swollen coats 
remain associated with the cell surface by their HA synthases [13, 14] or 
via transmembrane HABPs, such as CD44 [15-17]. During embryonic 
development, tissue repair, and inflammation, these coats provide the 
microenvironment for many cellular activities such as proliferation, 
migration, and cell division [18-21]. 
In the kidney, large amounts of HA are found in the inner medullary 
portion and in the papilla, where it plays a role in renal water 
homeostasis [22]. Although the renal cortex usually contains only small 
amounts of HA, a pronounced accumulation is observed during 
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interstitial nephritis, ischemic injury and allograft rejection [23-26]. 
These inflammatory disease states in the kidney are frequently accom-
panied by an upregulated expression of CD44 by renal tubular cells [5, 
27-29]. The identification of HA as CBM at the surface of activated renal 
tubule epithelial cells prompted us to study HA biology related processes, 
including PCM formation, HA synthesis, and CD44 expression by 
various renal tubular cell types in culture. 
 
 
MATERIALS AND METHODS  
 
Cell culture 
MDCK-I and MDCK-II cells [30] were kindly provided by Prof. G. van 
Meer (Laboratory for Cell Biology and Histology, Academic Medical 
Centre, Amsterdam, The Netherlands). These strains are isolated from 
the wild-type American Type Culture Collection (ATCC) MDCK cell 
line. Although it is not possible to assign MDCK-I cells to a specific 
nephron segment, these cells exhibit many characteristics of the renal 
distal tubule/collecting ducts [30, 31], whereas MDCK strain II cells 
consists of cells with characteristics of the renal proximal and distal 
tubule [4]. LLC-PK1 cells obtained from the Americam Type Culture 
Collection have widely been used as a model for the renal proximal 
tubule [32, 33]. Routinely, the cells are grown in Dulbecco’s modified 
Eagle’s medium (DMEM; GIBCO, Grand Island, N.Y., USA) 
supplemented with 10% fetal calf serum (PAA Laboratories, Linz, 
Austria) and weekly trypsinized and replated. To obtain subconfluent 
cultures, the cells were seeded at a plating density of 1 x 106 cells/24-mm 
polycarbonate porous filter insert (Transwell; Corning Costar, 
Badhoevedorp, The Netherlands). Two days after seeding, the inserts 
contain on average 1-2 x 106 cells. Although at this point the growth 
substrate is already entirely covered with cells, the maximal amount of 
cells per insert has not yet been reached, and tight junctions are not yet 
formed. Tests were routinely performed to assure that the cells used in 
this study were not contaminated with mycoplasma. 
 
Particle exclusion assay 
The presence of cell-associated coats was visualized by a particle 
exclusion assay, as first described by Clarris and Fraser [34]. This assay 
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blood cells, to penetrate HA-rich cell coats. Because conventional 
fixation/staining methods lead to the collapse of these hydrated coats, the 
particle exclusion assay is a useful technique to visualize their true size. 
Cells were seeded at 1x104/well in DMEM + 10% fetal calf serum in 24-
well plates (15 mm in diameter; Corning Costar). The next day, 50 µl of 
a suspension of formalin-fixed mouse red blood cells (109/ml) was added 
in serum-free DMEM. After settling for 15 min., the cells were inspected 
by phase-contrast microscopy for the presence of cell coats. The 
dependence of cell coats on HA was tested by treating coat-bearing cells 
with 5 U/ml Streptomyces hyaluronidase (E.C. 3.2.1.35; Sigma–Aldrich 
Chemie, Zwijndrecht, The Netherlands) which specifically digests HA. 
To determine the number of coat-bearing cells and the size of the coats, 
digital micrographs were taken from 100 randomly selected cells per cell 
line. These images were analyzed by KS-400 V2.0 image analysis 
software. Morphometric analysis was limited to single cells, and the size 
of the PCM was expressed as the ratio between the surface areas of the 
coat and the cell (coat/cell ratio) calculated from their diameters. Since 
the cell border is not clearly visualized by phase-contrast microscopy, we 
considered a coat to be present, if this ratio was equal to or larger than 
1.50.  
 
HA synthesis 
Metabolic labeling studies were performed to explore the capability of 
the cells to synthesize HA. Proliferating cells seeded at a density of 
1x106/insert were starved overnight in low- glucose DMEM (1 g/l). One 
day after seeding, they were labeled in low-glucose medium with 74 
kBq/ml [3H]glucosamine _ D-1-[3H]GlcNAc hydrochloride (Amersham 
Pharmacia Biotech, Roosendaal, The Netherlands). Two days after 
seeding, the apical fluid was collected. To distinguish between HA and 
other secreted glycoconjugates, we subjected portions of the apical fluid 
to differential enzyme digestion. One portion was left untreated (control) 
to measure the total glycoconjugate secretion. The second portion was 
incubated with papain overnight to digest proteins in the sample, but not 
the papain-resistant polysaccharide HA. Papain (E.C. 3.4.22.2; Sigma-
Aldrich Chemie) was used at a final concentration of 5 U/ml at 60 °C and 
pH 6.0.  To check whether the papain-resistant fraction indeed consisted 
of HA, the third portion was treated with papain as described above, 
followed by additional treatment with 5 U/ml Streptomyces 
hyaluronidase for 1 h at 37 °C. The macromolecules in the various 
Chapter 3 
 38 
portions were assayed by Sephacryl S-1000 gel filtration, using 55 x 15-
mm columns, that were equilibrated with the elution buffer (0.05 M Tris, 
0.15 M NaCl, pH 8.0). Fifty-microliter samples were applied to each 
column and eluted in 250-µl fractions with the Tris-NaCl buffer. The 
elution pattern showed two major peaks, the first consisting of high-Mr 
[3H]GlcNAc-labeled molecules (>103 kD) and the second with molecules 
<103 kD (including excess radiolabel). Synthesis was expressed as 
picomoles of [3H]GlcNAc incorporated into glycoconjugates. This was 
calculated from the total amount of label added per insert (2.1 nmol) and 
the specific activity (107 GBq/mmol) of the precursor. The presence of 
cell surface-associated [3H]GlcNAc-labeled HA was determined by 
measuring the release of radiolabel during 1 h incubation of the cells with 
serum-free DMEM with or without Streptomyces hyaluronidase. 
Additional release of [3H]GlcNAc by the enzyme-treated cells, as 
compared with the spontaneous release by cells incubated without 
enzyme, was considered to represent cell surface-associated HA. 
[3H]GlcNAc incorporation into the cells was determined by solubilizing 
the cells in 500 µl 4 M guanidine/2% Triton X-100/0.05 M sodium 
acetate buffer, pH 6.0. It was expressed as percentage of the total amount 
of precursor added per insert. 
 
Hyaluronan and CD44 expression 
Subconfluent cells grown on inserts were fixed for 10 min. in 3.7% 
formaldehyde/0.1% glutaraldehyde (v/v). Blocking of nonspecific 
binding as well as dilution of antibodies was done using 3% nonfat dry 
milk in phosphate-buffered saline/Tween 20 (w/v). HA was visualized 
using 5 µg/ml biotinylated hyaluronic acid binding protein (Seikagaku, 
Tokyo, Japan) coupled to 1:250 fluorescent avidin (avidin-FITC; Vector 
Laboratories, Burlingame, Calif., USA). CD44 was visualized using rat 
antimouse CD44 (IM7; PharMingen International, Woerden, The 
Netherlands), diluted 1:50, after coupling to FITC-conjugated rabbit 
antirat IgG (Southern Biotechnology Associates Inc, Birmingham, Ala., 
USA), diluted 1:100. The cells were incubated with primary antibodies 
overnight at 4°C, while incubation with secondary antibodies was 
performed for 1 h in the dark at room temperature. In some pictures, 
nuclei were counterstained with 1.0 µg/ml propidium iodide in 
phosphate-buffered saline. Confocal images were made using an LSM 
410 laser-scanning microscope (Zeiss, Oberkochen, Germany). A 488-
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nm argon laser was used to excite the FITC and a 543-nm laser to 
visualize propidium iodide. 
 
Generation of COM crystals 
A solution of sodium oxalate was prepared by adding 1 ml 0.37 MBq/ml 
[14C]oxalic acid (Amersham International, Little Chalfont, UK) to 0.25 
ml 200 mM sodium oxalate. A calcium chloride solution was prepared by 
adding 0.25 ml 200 mM calcium chloride to 9.5 ml distilled water. 
Mixing the two solutions at room temperature (final concentration of 5 
mM for both oxalate and calcium) immediately resulted in the nucleation 
of radiolabeled COM. After settling for 3 days, crystals were washed 
three times with and resuspended in CaOx-saturated H2O in a final 
volume of 5 ml (1.46 mg CaOx crystals/ml). The same procedure, but 
without [14C]oxalic acid was used for the generation of nonradiolabeled 
COM.  This procedure results in crystals with an average size of 1-2 µm 
=? Larger (5 µm) crystals for particle exclusion and confocal 
microscopy (CLSM) studies were prepared by using a final concentration 
of 1 mM for both calcium and oxalate =?. 
 
Crystal binding 
Subconfluent cells on inserts were pretreated or not with Streptomyces 
hyaluronidase in serum-free DMEM at a concentration of 5 U/ml, pH 5.3 
at 37°C for 60 min, after which [14C]COM crystal binding was performed 
as described earlier [7]. Briefly, radiolabeled crystals were added to the 
cultures and allowed to adhere for 1 h, after which the inserts were 
extensively rinsed to remove all nonassociated crystals, cut out, and 
counted in a liquid scintillation counter (Packard, Meriden, Conn., USA). 
The number of associated crystals was calculated from the disintegrations 
per minute per filter and usually expressed as micrograms per square 
centimeter.   
 
Statistical analysis 
Data were summarized as mean ± SD. The release of HA from the cell 
surface and the coat/cell ratios were analyzed by the unpaired Student t 
test. ANOVA was used to analyze the amount of [3H]GlcNAc-labeled 
glycoconjugates secreted into the apical fluid. Differences were 
considered significant at p < 0.05. 
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RESULTS 
 
Particle exclusion assay 
To investigate whether renal tubular cells are able to form HA-rich 
pericellular coats, we applied a particle exclusion assay. Phase-contrast 
microscopy revealed that 24 h after seeding most MDCK-I cells (~91%) 
indeed were surrounded by prominent areas that excluded fixed red blood 
cells. Cell coats were also observed in a minority of the MDCK-II cells 
(~23 %), but LLC-PK1 cells did not form PCMs (Fig. 1). The dependence 
of the cell coats on HA was shown by the disappearance of PCMs 
surrounding MDCK cells, shortly after the addition of hyaluronidase 
(Fig. 1, right corner).  
 
 
Figure 1. Particle exclusion assay. Proliferating MDCK-I cells are surrounded by 
PCMs. The PCMs disappear shortly after the addition of Streptomyces hyaluronidase 
(top, right). PCMs are formed by a minority of the MDCK-II cells, but not by LLC-PK1 
cells. Bar = 10 µm. 
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The size of the PCMs was expressed as coat/cell ratio. Coats surrounding 
MDCK-I and MDCK-II cells cultured in the presence of 10% fetal calf 
serum were similar in size (Table 1). To assess whether coat formation 
depended on the presence of serum components, we studied PCM 
assembly in serum-deprived cells. After a 4-hour plating period in serum-
containing DMEM, the cells were washed and further cultured overnight 
under serum-free conditions. This serum deprivation did not alter the 
percentage of coat-bearing MDCK-I and MDCK-II cells, or the coat/cell 
ratios (Table 1). 
 
 
Table 1. Coat/cell ratios.  
 
 10% serum coat/cell ratio
% cells 
with coat 
serumdeprived 
coat/cell ratio 
% cells 
with coat 
MDCK-I 2.07 ± 0.48 91 1.99 ± 0.39 94 
MDCK-II v 23 1.60 ± 0.10 21 
LLC-PK1  not applicable <1.50 
not 
applicable 
 
Using the particle exclusion assay, coat/cell ratios were measured for 100 cells per cell 
line. Due to the limitations of phase-contrast microscopy, a cell is considered coat-
bearing when the coat/cell ratio is ≥ 1.50. Mean ± SD calculated for coat-bearing cells 
only. Statistical analysis by Student’s t-test.  
 
 
Metabolic labeling studies 
Since most MDCK-I and some MDCK-II cells, but none of the LLC-PK1 
cells, assembled PCMs, we hypothesized that these differences could 
arise from variations in the synthesis of  high-Mr HA between those cell 
types. For that reason, we studied the ability of the various cell types to 
synthesize HA by measuring the incorporation of [3H]-N-acetyl-
glucosamine ([3H]GlcNAc) into high-Mr glycoconjugates. Two days 
after seeding, comparable amounts of [3H]GlcNAc were incorporated in 
MDCK-I, MDCK-II and LLC-PK1 cells (5.3-9.1 % of applied label). 
Representative elution patterns of apical culture medium collected from 
cells after 24-hour metabolic labeling are shown in figure 2. Untreated 
supernatants collected from MDCK-I cells contained two major peaks, 
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the first one between fractions 6 and 13, containing labeled 
macromolecules larger than 103 kD, and a second much larger peak 
between fractions 14 and 30, containing excess precursor molecules and 
radiolabeled glycoconjugates smaller than 103 kD (Fig. 2, top left). The 
high-Mr peak decreased about 50% in size after papain treatment, 
whereas the remaining macromolecular substances were completely 
digestible by bacterial hyaluronidase. Although MDCK-II cells also 
produced high-Mr glyconconjugates, the amounts were much smaller 
than those produced by MDCK-I, whereas LLC-PK1 did not produce 
[3H]-labeled molecules >103 kD (Fig. 2). The amount of [3H]GlcNAc 
incorporated in high-Mr HA was estimated from the amount (pmol) of 
high-Mr molecules remaining after papain treatment (Table 2, Papain) 
minus the calculated  amount (pmol) of high-Mr molecules remaining 
after the papain-treated sample was further digested with hyaluronidase 
(Table 2, Papain + hyaluronidase). The estimated amounts of label 
incorporated in high-Mr HA for MDCK-I, MDCK-II and LLC-PK1 were, 
respectively, 14.7, 0.5 and 0 pmol. 
 
 
 
 
Figure 2 
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Table  2. Hyaluronan synthesis.  
 
 
 [3H]GlcNAc in glycoconjugates >103 kD, pmol 
 papain - papain + hyaluronidase = high-Mr  HA 
MDCK-I 15.5 ± 2.2 - 0.8 ± 0.2* = 14.7 ± 1.6 
MDCK-II   1.2 ± 0.3 - 0.7 ± 0.1* =   0.5 ± 0.2 
LLC-PK1   0.6 ± 0.1 - 0.6 ± 0.1 =      0 
 
 
Aliquots of the apical fluid of [3H]GlcNAc-labeled subconfluent cells were analyzed by 
Sephacryl S-1000 gel filtration for the presence of high-Mr glycoconjugates. Papain 
was added to the samples to digest proteins (papain) after which hyaluronidase was 
added to digest HA (papain + hyaluronidase). The difference between the papain- and 
hyaluronidase-digested fractions represents the amount high-Mr HA in the original 
sample; high-Mr HA = (papain) – (papain + hyaluronidase). Results expressed as 
picomoles [3H]GlcNAc incorporated into high-Mr glycoconjugates in the total apical 
fluid volume. Mean ± SD of three independent samples of a representative experiment. 
Statistical analysis by ANOVA. *Significantly reduced as compared with samples 
treated with papain alone (p< 0.05). 
 
 
 
 
 
Figure 2. High-Mr hyaluronan synthesis. Aliquots of the apical fluid of [3H]GlcNAc-
labeled MDCK-I, MDCK-II and LLC-PK1 cells were analyzed by Sephacryl S-1000 gel 
filtration for papain- and hyaluronidase-sensitive high-Mr glycoconjugates. The whole 
elution pattern derived from MDCK-I cells is depicted in the top left image, whereas the 
other three images are enlargements of fraction 6-13 obtained from by the various cell 
types. The left top image shows a first peak between fractions 6-13 containing molecules 
>103 kD and a second peak between fractions 14 and 30 containing molecules <103 kD 
and excess [3H]GlcNAc precursor. Untreated samples were run to assess total cellular 
production of high-Mr glycoconjugates (open squares). Aliquots were treated with 
papain to digest proteins (closed circles) and subsequently treated with hyaluronidase 
to digest HA (open circles). Mean ± SD of three independent samples of a 
representative experiment.  
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Table 3. Cell surface-associated hyaluronan.  
 
 
[3H]GlcNAc released from the cell surface, pmol 
 
hyaluronidase - spontaneous = HA 
MDCK-I 9.7 ± 0.3* - 6.0 ± 0.6   = 3.7 ± 0.4 
MDCK-II 2.9 ± 0.2* - 2.3 ± 0.5 = 0.6 ± 0.3 
LLC-PK1  1.3 ± 0.3 - 1.1 ± 0.1 = 0.2 ± 0.1 
 
 
The amount of cell surface bound HA was estimated from the spontaneous and 
Streptomyces hyaluronidase-induced release of radioactivity from metabolically 
([3H]GlcNAc) labeled cells (hyaluronidase-induced release - spontaneous release = 
HA). Mean ± SD of three independent inserts derived from a representative experiment. 
Statistical analysis by Student’s t test (one tailed). *Significantly higher than 
spontaneous release (p < 0.05). 
 
 
 
The amount of cell-surface-associated HA was estimated from the 
amounts of label released by Streptomyces hyaluronidase minus that 
released by vehicle alone. Hyaluronidase released significantly more 
label from MDCK-I than from MDCK-II, whereas this treatment did not 
release significant amounts of radioactivity from LLC-PK1 cells (Table 
3).  
 
Cell surface HA and CD44 expression 
Confocal microscopy staining using biotinylated HABPs revealed that 
MDCK-I cells were entirely covered with a thin layer of HA, whereas 
MDCK-II cells expressed a discontinuous layer of HA and LLC-PK1 
cells did not express HA (Fig. 3). Since the transmembrane protein CD44 
plays an important role in the retention of HA-containing coats in many 
eukaryotic cell types, we also studied the expression of CD44 by the 
various proliferating renal tubular cells. Immunohistochemical studies 
revealed that CD44 was expressed by subconfluent cultures of all three 
cell types (Fig. 3).  
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Figure 3. HA and CD44 expression. Confocal images of proliferating cells stained 
with specific probes for HA and CD44 were made perpendicular to the growth 
substrate. MDCK-I cells uniformly expressed HA, whereas the HA staining pattern was 
dispersed at the surface of MDCK-II cells. LLC-PK1 cells were HA negative (top row). 
All three cell types expressed CD44 at their apical surface (bottom row).  x 63 . 
Table 4. Crystal binding. 
 [14C]COM crystal binding (µg/cm2)
 untreated hyaluronidase 
MDCK-I 8.60 ± 0.40 3.88 ± 0.90* 
MDCK-II 10.23 ± 0.18 9.64 ± 0.12* 
LLC-PK1 10.15 ± 0.84 9.94 ± 0.27 
Subconfluent cultures were incubated for 1 h with Streptomyces hyaluronidase or left 
untreated prior to incubating the cells for 1 h with [14C]COM crystals.  
Mean ± SD of three independent inserts. Statistical analysis by Student’s t test. 
*Significantly  different as compared with untreated controls (p < 0.05). 
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COM crystal binding 
To determine whether HA-rich PCMs were involved in the binding of 
COM crystals to proliferating cells, subconfluent cultures of MDCK and 
LLC-PK1 were treated with  Streptomyces hyaluronidase prior to the 
incubation with [14C]COM.  In all cell lines, COM binding to control 
cells was high. Hyaluronidase treatment significantly reduced crystal 
binding to MDCK-I, hardly affected the affinity of MDCK-II for the 
crystals and had no effect on the adherence of crystals to LLC-PK1  
(Table 4). 
 
DISCUSSION 
 
This study shows that practically all MDCK strain I cells and part of the 
MDCK strain II cells assemble PCMs during proliferation, whereas LLC-
PK1 cells are unable to form these “cell coats”. High-Mr HA is 
synthesized by proliferating MDCK cells, but not by LLC-PK1 cells. The 
PCM formation plays an important role in COM crystal binding to 
MDCK-I cells, but is less important in the attachment of crystals to the 
other two cell lines. 
Confocal microscopy studies showed that subconfluent cultures of 
MDCK-I are entirely covered with HA, while MDCK-II cultures are 
partially positive, and LLC-PK1 cells do not express cell surface HA. The 
coats as well as the surface expression of HA disappear shortly after the 
addition of Streptomyces hyaluronidase, an enzyme that specifically 
cleaves β-1,4-glycosidic bonds in HA chains, indicating the crucial role 
of this polysaccharide in PCM formation. 
The question that we subsequently addressed is why some of our cells 
form PCMs whereas others do not. Could it be that cells without PCMs 
do not express cell surface receptors with affinity for HA, or are these 
coat-free cells unable to produce high-Mr HA? Confocal microscopy 
studies showed that during subconfluence all three cell types expressed 
CD44 at their apical membrane (Fig. 3). Although we did not in detail 
study the HA-binding capacity of these membrane receptors, the 
presence of CD44 at the luminal surface suggests that the cells possess 
the required machinery for PCM retention. Furthermore, metabolic 
labeling studies demonstrated that proliferating MDCK-I cells produced 
relatively large amounts of high-Mr HA, whereas only very small 
amounts of HA were synthesized by MDCK-II cells and LLC-PK1 did 
not produce high-Mr HA. These results indicate that only those cells that 
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are able to synthesize macromolecular HA assemble PCMs. Coat-
forming MDCK-I cells not only produced significant amounts of high-Mr 
HA, but also relatively large amounts of high- Mr glycoproteins. Large 
proteoglycans such as aggrecan and versican serve as HABPs in the HA 
networks surrounding other cell types, such as chondrocytes [18]. It is, 
therefore, possible that MDCK-I cells not only produce the required 
amount high-Mr HA for successful PCM formation, but also the HA-
binding glycoconjugates needed for coat stabilization [13].  
Because in some cell types in culture PCM formation is supported by 
fetal calf serum components [36-38], we investigated coat formation by 
MDCK cells during serum deprivation. The number of coats as well as 
their sizes were not different under serum-deprived conditions, indicating 
that the PCMs surrounding renal tubular cells are predominantly 
composed of endogenous components. Coats formed by MDCK-II cells 
exhibited coat/cell ratios similar to those formed by MDCK-I cells. The 
two MDCK strains are both isolated from wild-type MDCK which was 
derived from the whole kidney of a dog. Because MDCK-II cells exhibit 
properties of more than one segment of the nephron, these observation 
suggests that MDCK strain II is not homogeneous and also seems to 
contain some MDCK-I cells.  
The finding that LLC-PK1 cells are unable to synthesize high-Mr HA and 
assemble PCMs seems to suggest that these coats are not formed in the 
renal proximal tubule. However, HA synthesis and PCM assembly are 
basic tools of most eukaryotic cells and there are reports about the 
synthesis of HA by various renal tubular cells, including proximal tubular 
cells. Mouse cortical tubular cells and primary cultures of human renal 
proximal tubular cells secrete HA, especially in response to cytokines 
[23, 39]. Recently, we observed that primary cultures of both human 
proximal and distal tubular cells were covered with HA [5]. It is possible 
that LLC-PK1 and the majority of MDCK-II cells have lost the ability to 
synthesize high-Mr  HA, emphasizing potential shortcomings in cell 
culture studies. Another possibility is that certain cell types are not 
supposed to synthesize and secrete HA or that there are species 
differences. More detailed studies are clearly warranted to answer these 
and other questions. For the time being, the subconfluent proximal-
tubule-like LLC-PK1 cells in Figure 4 are provided with an “imaginary 
PCM” (dotted line).  
Subconfluent cultures formed by all three cell types are highly 
susceptible to COM crystal binding. Treatment with hyaluronidase 
Chapter 3 
 48 
significantly reduced the affinity of the MDCK-I cell surface for crystals, 
whereas it hardly or not affected crystal binding to MDCK-II and LLC-
PK1 cells (Table 4). Thus, this study shows that coats formed by HA at 
the surface of MDCK-I cells serve as major CBMs, but that these coats 
do not play an important role in crystal binding to LLC-PK1 or MDCK-II 
cells. From these observations it can be deduced that HA certainly is not 
the only constituent of the renal tubular cell surface with affinity for 
calcium oxalate crystals. The finding that the enzymatic removal of the 
PCMs from MDCK-I cells only leads to a 50% reduction in crystal 
binding suggests the presence of apical membrane CBMs beneath the 
coats. Previously, we have demonstrated that at confluence not only HA 
disappears from the MDCK-I cell surface, but since these cells 
practically become nonadherent, apparently also the CBMs that were 
located underneath the coat [7]. Most likely the latter group of CBMs 
represents epithelial-polarity-related plasma membrane components 
which are translocated to the basolateral membrane after the development 
of a functional epithelium. COM crystals avidly adhere to coat-free LLC-
PK1 cells, indicating that crystal binding to this cell line is mediated by 
cell surface constituents distinct from HA. Previously, we reported that 
this cell type does not lose its affinity for COM crystals after its 
development to intact polarized monolayers [4]. This suggests that, 
besides possible polarization-dependent CBMs, proximal tubular cells 
also express cell surface CBMs that do not disappear from the apical 
membrane at confluence or that disappearing CBMs are replaced by 
others. The identity of CBMs located beneath HA-rich PCMs expressed 
by late- nephron cells in locomotion or by early-nephron cells without 
PCMs is still unknown. It is possible that under these conditions sialic 
acid residues are exposed in a configuration that permits crystal 
attachment [2, 40] or that the cells express nucleonin-like calcium-
binding proteins [41]. Another possibility is that these CBMs are “sticky” 
extracellular matrix molecules, such as laminin, collagen IV [42], 
fibronectin, or osteopontin [43], molecules that normally are restricted to 
the basolateral membrane. A schematic summary of CBM expression by 
MDCK-I and LLC-PK1 is depicted in figure 4. This presentation does not 
include the results obtained with MDCK-II because this cell line seems to 
be a mixture of the proximal- and distal-tubule-like cell types. 
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MDCK-I
LLC-PKI
confluencesubconfluence
constitutively expressed CBMs
polarization-dependent CBMspericellular matrix (PCM)
missing PCM
 
 
Figure 4. Crystal binding molecules (CBMs). At subconfluence, MDCK-I cells express 
PCMs and polarization-dependent CBMs which all disappear from the luminal side of 
the cultures at confluence. Although LLC-PK1 cells populating subconfluent cultures do 
not express PCMs, these coats presumably will be formed by activated proximal tubular 
cells in the kidney, which is why the missing PCM is depicted as a dotted line. 
Furthermore, it is hypothesized that LLC-PK1 cells in locomotion express polarization-
dependent and -independent CBMs, of which the latter type (constitutive CBM) is still 
present at the apical surface of confluent monolayers. 
 
 
Assuming that the surface properties of MDCK-I cells indeed are 
representative of cells lining the renal distal tubule/collecting duct and 
that those of LLC-PK1 are largely in agreement with cells in the renal 
proximal tubule, then what is the significance of this and earlier reports 
in relation to crystal retention? In the first place, our studies suggest that 
proliferating renal tubular cells are always susceptible to crystal binding. 
However, such massive proliferation by renal tubular cells does not take 
place unless the renal tubular epithelium is significantly injured. In the 
second place, crystals adhere to early-nephron cells in their normal 
quiescent state, but not to late-nephron cells. Considering the stone salt 
concentrations in the tubular fluid, crystallization is a rare event in the 
early nephron and only to be expected when plasma oxalate is 
considerably raised, such as, for example in primary hyperoxalurias or 
after oxalate intoxications. Taken together, these observations suggest 
that proximal tubular cells are constitutively covered with molecules with 
Chapter 3 
 50 
affinity for calcium oxalate crystals, whereas distal tubular/collecting 
duct cells as a rule are protected from crystal binding. 
Collectively, the results from this investigation provide evidence for the 
concept that crystal retention in the renal distal tubule/collecting ducts 
requires PCM formation, whereas the formation of calcium oxalate 
crystals in the renal proximal tubule inevitably leads to crystal binding 
and nephrocalcinosis. The appreciation of these various forms of crystal 
retention may have its repercussion in the management of the various 
forms of nephrolithiasis, including those associated with inborn errors in 
oxalate metabolism and idiopathic recurrent calcium oxalate stone 
disease. 
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ABSTRACT 
 
Background. Crystal retention in the kidney is caused by the interaction 
between crystals and the cells lining the renal tubules. These interactions 
involve crystal attachment, followed by internalization or not. Here, we 
studied the ability of various renal tubular cell lines to internalize calcium 
oxalate monohydrate (COM) crystals. 
Methods. Crystal-cell interactions are studied by light-, electron- and 
confocal microscopy with cells resembling the renal proximal tubule 
[porcine kidney (LLC-PK1)], proximal/distal tubule [Madin-Darby 
Canine Kidney II (MDCK-II)] and distal tubule and/or collecting ducts 
[Madin Darby Canine Kidney I (MDCK-I), rat cortical collecting duct 1 
(RCCD1)]. Crystal-binding strength and internalization are characterized 
and quantified with radiolabeled COM. 
Results. Microscopy studies showed that crystals were firmly embedded 
in the membranes of LLC-PK1 and MDCK-II cells to be subsequently 
internalized. On the other hand, crystals bound only loosely to MDCK-I 
and RCCD1 and were not taken up by these cells. Crystal uptake by LLC-
PK1 and MDCK-II, expressed in µg/106 cells, is temperature-dependent 
and gradually increased from 0.88 and 0.15 in 30 minutes, respectively, 
to 4.70 and 3.85, respectively, after five hours, whereas these values 
never exceeded background levels in MDCK-I and RCCD1 cells. 
Conclusions. The adherence of COM crystals to renal cells with 
properties of the proximal tubule is inevitable and actively followed by 
their uptake, whereas crystals attached to cells resembling the distal 
tubule and/or collecting duct are not internalized. Since crystal formation 
usually occurs in segments beyond the renal proximal tubule, crystal 
uptake may be of less importance in the etiology of idiopathic calcium 
oxalate stone disease. 
 
 
INTRODUCTION 
 
Kidney stones are composed of myriad microliths pasted with organic 
material. Although most stones are found in the renal pelvis, the stone-
forming process actually starts already in the nephrons. Crystals are 
frequently precipitated in the renal tubular fluid of stone-forming as well 
as non-stone-forming individuals [1]. Following their formation in the 
nephron, the crystals are rapidly covered with inhibitors of crystal-
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lization, which facilitates their excretion [2]. This elimination process is 
thwarted, however, when the crystals adhere to the tubular lining [3]. 
Several investigators in the past have proposed the concept that the onset 
of nephrolithiasis lies within the nephron. More than 30 years ago, Malek 
and Boyce [4] collected renal biopsies from idiopathic calcium oxalate 
stone formers who underwent nephrolithotomy, and from patients who 
were operated for other renal disorders. They found microliths lying in 
nephrons of all stone formers, whereas intranephronic calculosis, as this 
phenomenon was called, was observed in only a minority of the non-
stone formers. Later, Hering et al. [5] found microliths inside the renal 
collecting ducts of stone formers who required nephrectomy. More 
recently, Lieske et al. [6] not only found intra-nephronic crystals in renal 
biopsies of a patient with type I primary hyperoxaluria, but strikingly 
they also found crystals inside renal tubular cells. Cell culture studies 
subsequently showed that calcium oxalate monohydrate (COM) crystals 
were taken up by renal tubular cells, and that this process stimulated cell 
proliferation [7, 8]. On the basis of these results, the authors proposed 
that this response of renal cells to crystals could play a role in the 
development of kidney stones. Although we extensively studied the 
adherence of COM crystals to renal tubule epithelial cells in culture, 
crystal uptake received little attention. The polysaccharide hyaluronan 
(HA) was identified as major crystal binding molecule at the surface of 
Madin-Darby canine kidney (MDCK) strain I cells in locomotion, 
whereas HA-negative quiescent cells in confluent cultures are non-
adherent [9]. The level of crystal binding to rat cortical collecting duct 
(RCCD1) cells also significantly decreased during their growth to 
confluence (unpublished observations). Crystal binding to porcine kidney 
(LLC-PK1) and Madin-Darby canine kidney II (MDCK-II) cells is quite 
different because, irrespective of their stage of development, these cells 
constitutively express crystal binding molecules [10]. The present 
investigation was conducted to study the ability of various cell types to 
internalize calcium oxalate crystals. 
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METHODS 
 
Cell culture 
MDCK-I and MDCK-II cells [11] were kindly provided by Prof. G. van 
Meer (Laboratory for Cell Biology and Histology, Amsterdam Medical 
Center, The Netherlands). LLC-PK1 cells were obtained from the 
American Type Culture Collection (ATCC). Routinely, the cells were 
grown in Dulbecco’s modified Eagle's Medium (GIBCO, Grand Island, 
NY, USA) supplemented with 10% fetal calf serum (PAA Labs, Linz, 
Austria) and replated weekly. RCCD1 cells [12] were kindly provided by 
Dr. M. Blot-Chabaud (INSERM U246, Faculté de Médecine Xavier 
Bichat, Paris, France). Routinely, these cells were grown in DMEM/F12 
supplemented with 14 mmol/L NaHCO3, 2 mmol/L glutamine, 5 µg/mL 
transferrin, 5 µg/mL insulin, 1.3 ng/mL sodium selenite, 10 µg/mL EGF, 
5 x 10-8 mmol/L T3, 10 U/mL penicillin-streptomycin and 2% FCS in 
collagen-coated flasks (collagen-G; 100 µg/mL, Biochrom KG, Berlin, 
Germany) and replated weekly. Most studies described in the present 
investigation were obtained using subconfluent cultures. The rationale to 
use subconfluent cultures was that crystals do not adhere to collecting 
duct cells populating confluent cultures, which makes it impossible to 
study crystal binding and uptake at that stage of epithelial development. 
To obtain subconfluent cultures, cells were seeded at a plating density of 
1 x 106 cells on 24 mm polycarbonate porous filter inserts (Corning 
Costar, Badhoevedorp, The Netherlands). RCCD1 cells were grown on 
collagen-coated inserts. Two days post-seeding the inserts contain on 
average 1 to 2 x 106 cells. We considered these cultures subconfluent as 
it takes a few more days before the maximal amount of cells per insert (3 
to 4 x 106 cells) and the maximal transepithelial electrical resistances 
(TER) are reached [11,12]. Routinely, polymerase chain reaction (PCR) 
analyses were performed on DNA isolated from cell culture- conditioned 
medium for the presence of mycoplasma. Cells used in this study were 
not contaminated with mycoplasma. 
 
Crystal formation 
A solution of sodium oxalate was prepared by adding 10 µL 37 MBq/mL 
[14C] oxalic acid (Amersham Int.plc, Buckinghamshire, UK) to 0.25 mL 
200 mmol/L sodium oxalate. A calcium chloride solution was prepared 
by adding 0.25 mL 200 mmol/L calcium chloride to 9.5 mL distilled 
water. Mixing the two solutions at room temperature (final concentration 
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of 5 mmol/L for both oxalate and calcium) immediately resulted in the 
nucleation of radiolabeled COM. After settling for three days, crystals 
were washed three times with, and resuspended in, CaOx-saturated H2O 
in a final volume of 5 mL (1.46 mg COM crystals/mL). The same 
procedure but without [14C] oxalic acid was used for the generation of 
nonradiolabeled COM. The crystals have an average size of 1 to 2 µm 
[13]. For the light (phase-contrast) microscopy studies we used a slightly 
different protocol in which the final concentration of both calcium and 
oxalate was 1 mmol/L, which resulted in larger crystals with an average 
size between 5 to 6 µm [11]. 
 
Phase-contrast microscopy 
Twenty-four hours post-seeding on solid growth substrates, crystals were 
added to proliferating small islands of cells and allowed to adhere for 30 
minutes, after which all nonadhered crystals were removed and the cell 
surface-associated crystals inspected (magnification, x200) under a 
phase-contrast microscope (Axiovert 25) coupled with an AxioCam 
camera scanner (Carl Zeiss Vision GmbH, Munchen-Hallbergmoos, 
Germany). 
 
Scanning electron microscopy 
Cells cultured on porous supports were fixed in 2.5% glutaraldehyde in 
0.15 mol/L cacodylate buffer for 4 hours. After washing in 0.1 mol/L 
cacodylate buffer for 3 hours, the samples were postfixed in OsO4 in 0.1 
mol/L cacodylate buffer for 4 hours, washed again in cacodylatebuffer 
for 3 hours, dehydrated in a graded series of ethanol and finally critical 
point dried. After mounting on stubs, a conductive layer was 
sputtercoated on the samples and examined in a Philips SEM 525 
(Philips, Eindhoven, The Netherlands) (magnification, x 20.000). 
 
Transmission electron microscopy 
Cells were fixed in 1.5% (vol/vol) glutaraldehyde in 0.1 mol/L 
cacodylate/HCl buffer for 1 hour at 37°C. After aldehyde fixation, cells 
were postfixed in 1% (weight/vol) OsO4 in the same buffer system, to 
which K4Fe(CN6).3H2O was added to a final concentration of 0.05 mol/L 
for 1 hour at room temperature. The cells were routinely dehydrated and 
embedded in Epon. Ultrathin sections (30 to 50 nm) were sectioned with 
diamond knives, collected on unfilmed 400 mesh copper grids and 
Chapter 4 
 58 
inspected in a Zeiss EM 902 transmission electron microscope (Zeiss, 
Oberkochen, Germany) operating at 80 kV (magnification, x 2500). 
 
Crystal binding 
Radiolabeled crystals were added to the cultures and allowed to adhere for 
one hour, after which the inserts were extensively rinsed to remove all 
nonassociated crystals, cut out, and counted in a liquid scintillation counter 
(Packard, Meriden, CT, USA). The number of associated crystals was 
calculated from the disintegrations per minute (dpm)/filter [9]. The effect 
of hyaluronan removal on crystal-cell association was studied by treating 
the monolayers with 5 U/mL Streptomyces hyaluronidase (E.C. 3.2.1.35; 
Sigma–Aldrich Chemie, Zwijndrecht, The Netherlands) in serum-free 
DMEM, pH 5.3 at 37°C for 1 hour before the addition of radiolabeled 
crystals. Then crystal-binding measurements were performed as 
described above. Experiments were performed to examine the firmness of 
crystal binding. Cultures were incubated with [14C]COM crystals for 1 
hour. After removal of non-adhered crystals by extensive washings, the 
cells were treated for 10 minutes with either 70% ethanol or with a mixture 
of 3.7% formaldehyde/0.1% glutaraldehyde. Released crystals were 
removed, the inserts cut out and the remaining cell-associated 
radioactivity counted. All [14C]COM binding experiments were repeated 
at least three times, using three independent inserts per group.  
 
Confocal laser scanning microscopy  
A combination of light reflection (to visualize the crystals) and 
fluorescent-labeled phalloidin (to visualize the cells) was used to monitor 
the fate of cell-associated crystals by confocal microscopy. In time-lapse 
studies, nonradiolabeled COM crystals were incubated with subconfluent 
cultures for the indicated periods of time at 37°C and 4°C. All 
nonattached crystals were removed by extensive washings and the cells 
were fixed for 10 minutes with formaldehyde (3.7%), followed by 
membrane permeabilization with 70% ethanol for 10 minutes. The inserts 
were then washed, cut out, and incubated for 15 minutes with 2 µg/mL 
fluorescein isothiocyanate-conjugated (FITC) phalloidin (Sigma-Aldrich 
Chemie), washed two times with phosphate-buffered saline (PBS) and 
mounted in Vectashield (Vector Laboratories, Burlingame, CA, USA). A 
488 nm argon laser was used to excite the FITC-phalloidin. The extra- 
and/or intracellular localization of the crystals was detected by 633 nm 
(red) Kr-laser light reflection. A 560 nm beam splitter separated the FITC 
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emission signal and the 633 nm signal reflected by the crystals. The FITC 
signal was passed through a 510 to 540 nm band-pass filter to block the 
reflection from the 488 nm laser. No blocking filter was used for the light 
reflection signal. The mounted inserts were extensively inspected, images 
(magnification, x63) were made of at least 10 random fields per insert 
with a Zeiss LSM 410 laser scanning confocal microscope (Zeiss) from 
which representative images were selected. Experiments were repeated at 
least three times.   
 
Quantification of crystal internalization 
To assess if cell surface-associated crystals could be internalized, 
[14C]COM crystals were added and incubated for the indicated periods of 
time, after which all nonadhered crystals were washed away. The cells 
were subsequently treated for 5 to 10 min. with 0.25% trypsin to digest 
cell surface glycoconjugates and thereby release most of the crystals 
attached to the cell exterior. TER measurements indicated that this mild 
enzyme treatment did not yet release the cells from each other or from 
the growth substrate. This method does not discriminate between crystals 
that are halfway through the membrane and those that are entirely inside 
the cell. With this restriction in mind, we considered the remaining cell-
associated radiolabeled crystals as internalized. 
 
 
RESULTS 
 
Phase-contrast microscopy 
The adherence of calcium oxalate monohydrate (COM) crystals to 
proliferating cells was viewed using light microscopy. These 
observations showed remarkable differences in the manner by which 
crystals were attached to LLC-PK1 and MDCK-II compared to MDCK-I 
cells. The crystals appeared to be lying flat on the surface of the cell 
islands formed by LLC-PK1 and MDCK-II. On the other hand, crystals 
were predominantly found at the periphery of the cell groups formed by 
MDCK-I (Fig.1). These observations prompted us to inspect the 
attachment of crystals to these cell types more closely.  
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Crystal binding 
Hyaluronan (HA) is one of the major crystal binding molecules at the 
surface of MDCK-I cells [9]. To determine whether HA also plays a role 
in crystal binding to LLC-PK1 and MDCK-II, these cells were treated 
with Streptomyces hyaluronidase prior to incubating subconfluent 
cultures with radiolabeled COM crystals. Hyaluronidase significantly 
reduced the level of binding to MDCK-I cells, whereas this enzyme had 
no or negligible effect on crystal binding to LLC-PK1  and MDCK-II 
cells  (Fig.1). 
Figure 1. Phase-contrast microscopy. Crystals associated with small groups of 
proliferating Madin-Darby canine kidney strain I (MDCK-I),Madin-Darby canine 
kidney strain II (MDCK-II), and porcine kidney (LLC-PK1 ) cells. The crystals cover the 
entire surface of MDCK-II and LLC-PK1, whereas they seem to be restricted to the 
periphery of MDCK-I (magnification, x200). The bar graph in the lower righthand 
corner depicts the effect of hyaluronidase treatment on [14C] calcium oxalate 
monohydrate (COM) binding. Open bars represent control; filled bars represent 
hyaluronidase. *P < 0.05 is statistically significant compared to control. 
 
Figure 2. Scanning electron microscopy (SEM). (A) SEM image of calcium oxalate 
monohydrate (COM) crystals generated by 5 mmol/L of both calcium and oxalate. (B) 
SEM image of the surface of Madin-Darby canine kidney strain II (MDCK-II) cells 
cultured on porous supports, showing numerous microvilli. (C) The same cells, but after 
incubation with COM crystals (magnification, x20,000). (D) Transmission electron 
microscopy (TEM) image of COM crystal ghosts inside MDCK-II (magnification, 
x2500). 
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Electron microscopy 
Electron microscopy (EM) images were made to study the interaction 
between crystals and the different cell types more in detail. Scanning 
electron microscopy (SEM) images showed the attachment of COM 
crystals to the surface of MDCK-II cells (Fig. 2) that is abundantly 
covered with microvilli (Fig. 2). Figure 2 suggests that the crystals 
became embedded in the plasma membrane and even entered the cells. 
Similar results were obtained with LLC-PK1 (not shown). SEM images 
of crystal binding to MDCK-I cells were entirely different, however. 
Although our standard [14C]COM crystal-binding studies indicated that 
relatively large amounts of crystals were able to bind to proliferating 
MDCK-I, these crystals were hardly recovered in the SEM images. This 
suggests that these crystals are lost somewhere during preparation, a 
process that requires extensive washing steps. To assess if crystals 
actually entered certain cell types, the cells were incubated for two hours 
with COM crystals, after which single cell suspensions were prepared 
with trypsin to be inspected by transmission electron microscopy (TEM). 
These images indeed provided evidence for the presence of crystals 
inside MDCK-II cells in the form of so-called ghosts (Fig. 2). Crystal 
ghosts were also seen in LLC-PK1 cells, but never inside MDCK-I cells  
(not shown). 
 
Figure 2 
A
C
B
D
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Effect of fixatives and enzymes on the release of cell surface-associated 
[14C]COM 
 
The presence in the SEM images of crystals at the surface of LLC-PK1 
and MDCK-II cells, and their absence from MDCK-I, as well as the 
adherence of crystals to these cells under phase-contrast microscopy, 
suggest that there are differences in the way by which crystals attach to 
these cell types. To test this concept, radiolabeled COM crystals were 
allowed to adhere to the various cell types, after which the cells were 
treated either with ethanol to dehydrate the cell surface or with 
formaldehyde/ glutaraldehyde to cross-link membrane proteins. These 
treatments released relatively large amounts of crystals from MDCK-I. 
Ethanol had the most profound effect and liberated approximately 60% 
of the cell surface-associated [14C]COM, whereas formaldehyde/ 
glutaraldehyde released about 40% of adhered crystals. Neither fixation 
method, however, significantly liberated crystals from MDCK-II or LLC-
PK1 cells (Table 1). 
 
 
Table 1. Effect of fixatives on the release of pre-bound COM crystals.  
 
 Untreated Ethanol Formaldehyde/ 
glutaraldehyde 
MDCK-I 100 ± 5  39 ± 6* 60 ± 6* 
MDCK-II   100 ± 12 92 ± 4 88 ± 6 
LLC-PK1 100 ± 5 98 ± 7 87 ± 6 
 
Abbreviations are: COM, calcium oxalate monohydrate; LLC-PK1 , porcine kidney; 
MDCK-I, Madin-Darby canine kidney strain I; MDCK-II, Madin-Darby canine kidney 
strain II. Subconfluent cultures formed by LLC-PK1, MDCK-II and MDCK-I cells 
preincubated with [14C]COM crystals for one hour were treated for 10 minutes with 
ethanol or formaldehyde/glutaraldehyde to study the release of radiolabeled crystals. 
Results are expressed as percentage crystals remaining associated with the cells. 
Average ± SD of three independent inserts. Statistical analysis was performed using 
Mann-Whitney U-test. * Significantly different compared to control (P<0.05). 
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Figure 3. Confocal laser scanning microscopy (CLSM). The cells are visualized using 
phalloidin-FITC (green), and COM by light reflection (red). A) Subconfluent cells with 
surface properties of the proximal tubule (MDCK-II and LLC-PK1) internalize crystals, 
unless they are kept at 40C. B) Subconfluent cells with surface properties of the distal 
tubule and/or collecting ducts (MDCK-I and RCCD1) do not internalize crystals. Note 
that although the cultures appear to be confluent we consider them subconfluent 
because the number of cells per insert is still increasing and the tight junctions have not 
yet been fully developed (magnification 63x). 
Confocal microscopy
To assess the fate of cell surface-associated crystals, we performed time-
lapse studies using confocal microscopy. Nonradiolabeled COM crystals 
were added to subconfluent cultures formed by the various cell lines. 
Confocal images made perpendicular to the cell surface showed that after 
half an hour at 37°C, crystals were exclusively located at the surface of 
all cell types. After 90, 180 and 300 minutes, however, crystals were 
found inside LLC-PK1 and MDCK-II cells, unless they were kept in the 
cold (300 minutes, 40C), indicating that crystal uptake is an active 
process. It should be noted that crystals were also taken up by confluent 
LLC-PK1 and MDCK-II cells, indicating that the uptake of crystals is not 
crucially dependent on their stage of development (not shown). In 
contrast, crystals were never found inside MDCK-I cells. Since MDCK-I 
cells form hyaluronan-rich cell coats [3,24], it cannot be excluded that 
these coats make crystal internalization impossible by preventing the 
crystals from directly contacting the cell surface. Confocal images, 
however, revealed that crystals were also not taken up by cells that were 
made coat-free with hyaluronidase prior to the addition of crystals (not 
shown). To examine whether the inability to take up crystals could be an 
intrinsic property of late nephron cell types, crystal uptake was studied in 
Chapter 4 
 64 
RCCD1, another renal collecting duct cell line. The vast majority of the 
RCCD1 cells also did not internalize COM crystals (Fig. 3).  
 
Quantification of crystal internalization 
Experiments were performed to quantify crystal uptake. In time-lapse 
studies, radiolabeled COM crystals were allowed to interact with the 
cells. The cultures were subsequently briefly treated with trypsin to 
trypsin gradually increased from background levels of 0.15 ± 0.03 µg/106 
cells at 30 minutes to 3.85 ± 0.04 µg/106 cells after 300 minutes (Fig. 4), 
indicating crystal internalization. Crystals were also taken up by LLC-
PK1, but with a somewhat different time-course. Uptake showed a steep 
rise from 0.88 ± 0.11 to 3.23 ± 0.21 µg/106 cells between 30 and 90 
minutes, followed by a slower increase to 4.70 ± 0.77 µg COM crystals 
per million LLC-PK1 cells in the next hours. More than 90% of the 
[14C]COM associated with MDCK-I was released by trypsin at all time 
points, and the amount of radiolabeled COM that remained associated 
with the cell surface after enzyme treatment never reached values above 
background (~0.4 µg/106 cells). We speculated that the polymer 
hyaluronan, the major binding substance at the surface of MDCK-I, 
might have prevented the crystals from contacting the membrane. To find 
out if the cell surface expression of hyaluronan is responsible for the 
inability of MDCK-I cells to take up crystals, uptake was measured by 
cells that were pre-treated with hyaluronidase. The uptake assay 
demonstrated that crystals that were able to bind to MDCK-I after 
hyaluronidase treatment also did not enter the cells (not shown). 
[14C]COM uptake studies performed with RCCD1 cells showed that even 
after an incubation period of five hours at 37°C, more than 90% of the 
crystals associated with the cell surface could be removed with trypsin. 
In the time lapse studies the amount of crystals internalized by RCCD1 
never exceeded background levels (Fig. 4). 
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Figure 4. Quantitative crystal uptake assay. Subconfluent cultures were incubated with 
[14C]COM for increasing periods of time, after which all non-adhered crystals were 
removed by extensive washings. The cells were then briefly treated with trypsin to 
liberate crystals associated with the cell surface but not incorporated in the plasma 
membrane. Remaining cell-associated crystals are considered internalized. The uptake 
of crystals by MDCK-II is linear between 30 and 300 minutes (▲), whereas crystal 
internalization by LLC-PK1 cells shows a steep rise in the first 90 minutes, followed by 
a more gradual increase thereafter (■). Crystals are not taken up by MDCK-I (●) or 
RCCD1 (○). Average ± SD of three independent inserts of a representative experiment. 
 
 
DISCUSSION 
 
This study shows that the adherence of calcium oxalate monohydrate 
(COM) crystals to renal tubular cells is not necessarily followed by 
crystal uptake. Although crystals avidly bind to subconfluent LLC-PK1, 
MDCK-II, MDCK-I and RCCD1 cells, they are eagerly internalized by 
LLC-PK1 and MDCK-II, but not by MDCK-I and RCCD1.  
Light microscopy images showed that crystals entirely covered the 
surface of LLC-PK1 and MDCK-II cells, whereas their adherence to 
MDCK-I cells seemed to be restricted to the cell periphery (Fig.1). Using 
radiolabeled COM it was demonstrated that, once attached to the surface 
of LLC-PK1 or MDCK-II, only few crystals are liberated by fixation 
methods such as dehydration or protein crosslinking (Table 1). Moreover, 
brief treatment with trypsin did not liberate many of the crystals attached 
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to these two cell types. Hence, COM crystals became firmly anchored to 
the surface of LLC-PK1 and MDCK-II cells. Electron microscopy images 
showed that crystals indeed became tightly embedded in the plasma 
membrane to ultimately end up inside these cells (Fig.2). These 
observations were confirmed by a [14C]COM uptake assay, showing that 
the internalization of crystals by LLC-PK1 and MDCK-II cells is 
temperature- and time-dependent (Fig.4). Previously, we identified the 
polysaccharide hyaluronan (HA) as an important crystal binding 
molecule at the surface of MDCK-I cells [9]. However, pretreatment of 
LLC-PK1 and MDCK-II cells with hyaluronidase did not affect the 
affinity of these cell types for crystals indicating that this form of binding 
does not depend on HA (Fig.1). Crystals became only loosely attached to 
MDCK-I cells. Fixation or short trypsin treatment liberated most of the 
crystals bound to these cells. The affinity of MDCK-I cells for COM 
crystals is significantly reduced after pretreatment with hyaluronidase 
[9]. The quantitative uptake assay confirmed that MDCK-I cells are 
unable to internalize COM crystals. The possibility that uptake is 
impeded by HA coats was canceled out by the observation that crystals 
also did not enter MDCK-I cells that were treated with hyaluronidase 
prior to the addition of crystals (not shown). COM crystals also were not 
taken up by RCCD1 cells. Although an occasional RCCD1 cell contained 
a crystal, the quantitative uptake assay clearly demonstrated that the 
COM crystal uptake by RCCD1 cells is negligible. Collectively, these 
data show that crystals are taken up by LLC-PK1 and MDCK-II, but not 
by MDCK-I and RCCD1. 
LLC-PK1 and MDCK-II cells, exhibit many characteristics of the renal 
proximal tubule. Confluent monolayers formed by these cells are leaky 
(<200 Ω.cm2), are endowed with a luxurious brush border packed with 
tall microvilli, and their membranes express high levels of alkaline 
phosphatase (AP) and  γ-glutamyltranspeptidase (γ-GT) activity [10]. In 
addition, LLC-PK1 cells actively transport essential nutrients and water 
across the epithelium [14]. MDCK-I and RCCD1 cells, on the other hand, 
resemble the renal collecting ducts in many respects. MDCK-I cells, 
isolated from the original MDCK cell line, develop a high trans-epithelial 
electrical resistance (>10,000 Ω . cm2), are covered with short and stubby 
microvilli and express low levels of AP and γ-GT [10]. MDCK-I exhibits 
significant carbonic anhydrase activity [15] and its inward current can be 
activated by vasoactive intestinal polypeptide [16]. RCCD1 cells are 
isolated from rat collecting ducts; this cell line is also characterized by 
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high transepithelial resistances (>3,000 Ω . cm2) and specific hormonal 
sensitivities. Their morphological appearance resembles that of intact 
cortical collecting duct (CCD) [12]. On the basis of these results it is 
speculated that the ability of renal tubular cells to internalize crystals 
depends on their segmental origin. 
Up until now, crystal uptake studies have been predominantly performed 
with cells resembling the renal proximal tubule. Lieske et al. [17], for 
example, observed that African green monkey BSC-1 or parental MDCK 
(ATCC) cells rapidly took up calcium oxalate crystals. However, little is 
known about the segmental origin of BSC-1, whereas the original MDCK 
cell line contains various cell types including proximal tubular cells [12]. 
Crystal uptake has further been studied in the proximal tubular opossum 
kidney cell line, OK-1 [18], and again by several investigators in the 
original MDCK cell line [19-21]. Thus, these results are in agreement 
with those obtained with LLC-PK1 and MDCK-II in the present study. 
In vivo, the uptake of crystals followed by their translocation to the renal 
interstitium is typical for animals fed a stone-inducing diet, or for 
primary human forms of chronic hyperoxaluria [6, 22, 23]. In rats, 
hyperoxaluria is commonly generated by the addition of oxalate 
precursors such as ethylene glycol to the drinking water. Stone-inducing 
or, rather, crystal-inducing diets usually aim at increasing the amount of 
oxalate that is filtered at the glomerulus, thereby resembling primary 
forms of hyperoxaluria rather than idiopathic forms of calcium oxalate 
nephrolithiasis. High oxalate in ultrafiltrate may already lead to the 
formation of crystals in the proximal tubule and thus inevitably to crystal 
binding and uptake. Following this train of thoughts, it is reasonable to 
assume that evolution provided those areas in the urinary tract in which 
the urine can be very concentrated with a crystal-repulsive epithelial 
lining. Previously, we found that an intact monolayer formed by late 
nephron MDCK-I cells indeed is nonadherent to COM crystals. These 
anti-adherence properties were temporary lost, however, during the 
healing of wounds made in confluent monolayers [24]. Evidence was 
provided that during tissue repair and remodeling crystals adhered to the 
HA-rich zones surrounding the wounded areas [9]. From these 
observations it was speculated that crystal binding in late segments of the 
nephron and remaining part of the urinary tract requires some form of 
tissue damage [25, 26]. 
During the concentration process in the kidney, oxalate gradually 
increases from, on average, 2 µmol/L in ultrafiltrate to approximately 
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300 µmol/L in the final urine. Oxalate is poorly soluble in the tubular 
fluid and calcium oxalate crystals are occasionally formed in anyone’s 
kidneys. Although it is difficult to exactly pinpoint the segment in the 
nephron where crystal formation takes place, it is assumed to occur 
somewhere beyond the thin limbs [27-29]. Hence, proximal tubular cells 
are not used to encounter crystals, which might explain why this 
epithelium is not provided with an anti-adherent surface. However, the 
concentration of oxalate can be 10 to 20 times higher in plasma of 
patients suffering from inborn errors of oxalate metabolism [30]. Because 
the upper limits of supersaturation in the primary urine depend on the 
amount of oxalate that is filtered at the glomerulus, it is plausible that 
crystals are formed earlier in the nephrons of these patients. This implies 
that in primary hyperoxalurias crystals are formed at sites in the nephron 
where the epithelium is not protected against their adherence. 
The essence of the present study is not the observation that crystals 
adhere to HA or to other cell surface constituents, but that certain cell 
types constitutively bind and take up crystals, whereas others do not. The 
possibility that crystal binding and uptake cannot be avoided in proximal 
tubules and that epithelial injury-induced binding in the collecting ducts 
does not involve crystal uptake may have consequences for the treatment 
of the various forms of renal stone disease. In patients suffering from 
primary forms of hyperoxaluria measures should be taken to avoid 
crystal adherence in the proximal tubule, whereas in idiopathic recurrent 
calcium oxalate renal stone disease the best approach could be the 
prevention of tissue damage in the distal tubule and/or collecting ducts. 
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ABSTRACT 
 
Background. The interaction between renal tubular cells and crystals 
generated in the tubular fluid could play an initiating role in the 
pathophysiology of calcium oxalate (CaOx) nephrolithiasis. Crystals are 
expected to form in the renal collecting ducts, but not in the proximal 
tubule. In the present investigation, we studied the damaging effect of 
CaOx crystals on renal proximal- and collecting tubule cells in culture. 
Methods. Studies were performed with the renal proximal tubular cell 
lines, LLC-PK1 and MDCK-II and the renal collecting duct cell lines, 
RCCD1 and MDCK-I. Confluent monolayers cultured on permeable 
growth substrates in a two-compartment culture system were apically 
exposed to calcium oxalate monohydrate (COM) crystals, after which 
several cellular responses were studied, including monolayer morphology 
(confocal microscopy), transepithelial electrical resistances (TER), 
prostaglandin E2 (PGE2) secretion, DNA synthesis ([3H]thymidine), total 
cell numbers, reactive oxygen species (H202) generation, apoptotic 
(annexin V, DNA fragmentation) and necrotic (propidiumiodide influx) 
cell death. 
Results Crystals were rapidly taken up by proximal tubular cells and 
induced a biphasic response. Within 24 hours approximately half of the 
cell-associated crystals were released back into the apical fluid (early 
response). Over the next two weeks half of the remaining internalized 
crystals were eliminated (late response). The early response was 
characterized by morphological disorder, increased synthesis of PGE2, 
H202 and DNA and the release of crystal-containing cells from the 
monolayers. These released cells appeared to be necrotic, but not 
apoptotic cells.  Scrape-injured monolayers generated even higher levels 
of H202 than those generated in response to crystals. During the late 
response, crystals were gradually removed from the monolayers without 
inflammation-mediated cell death. Crystals did not bind to, were not 
taken up by and did not cause marked responses in collecting tubule 
cells.  
Conclusions This study shows that CaOx crystals cause acute 
inflammation-mediated necrotic cell death in renal proximal tubular cells, 
but not in collecting tubule cells. The crystal-induced generation of 
reactive oxygen species by renal tubular cells is a general response to 
tissue damage and the increased levels of DNA synthesis seem to reflect 
regeneration rather than growth stimulation. As long as the renal 
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collecting ducts are not obstructed with crystals, these results do not 
support an important role for crystal-induced tissue injury in the 
pathophysiology of calcium oxalate nephrolithiasis.   
 
 
INTRODUCTION 
 
Kidney stones are composed of numerous microcrystals accumulated in 
the kidney. The human kidney produces concentrated urine commonly 
supersaturated with poorly soluble salts like calcium oxalate. The 
precipitation of these salts as crystals is common and harmless as long as 
these crystals are excreted with the urine. To ensure their efficient 
elimination, the renal epithelial lining should be nonadherent in nephron 
segments with high levels of supersaturation. Compared to persons not 
forming stones, the levels of stone salt supersaturation are usually higher 
in urine of recurrent stone formers, which is why these patients often 
excrete higher amounts of crystals. Crystal binding to renal tubular cells 
may be the underlying cause of nephrocalcinosis and nephrolithiasis. 
Perhaps there are pathological circumstances during which healthy cells 
are transformed in a crystal binding phenotype. 
The impression that the crystals themselves could be actively involved in 
this process came from studies performed in animals and in cell 
culture[1-4]. These studies suggested that calcium oxalate crystals 
generate free radicals that are damaging to the renal tubular cells. There 
are some questions, however, about the model systems used. In animals, 
CaOx crystalluria cannot exist without hyperoxaluria which makes it 
difficult to discriminate between effects caused by crystals or by oxalate. 
Another point of concern is that most calcium oxalate toxicity studies are 
performed with renal proximal tubular cells while crystal formation is 
extremely unlikely in this nephron segment.  
In the present investigation, we studied the possible toxic effect of 
calcium oxalate crystals to renal proximal and collecting tubule cells 
grown as confluent monolayers on permeable growth substrates in a two-
compartment culture system. In this model system, the apical 
compartment is representative for the tubular fluid whereas the basal 
compartment is representative for the interstitial space and blood supply. 
Crystals are added at the luminal side of the monolayers in serumfree 
growth medium, while serum-containing growth medium is added to the 
basal compartment. Thus, during their apical exposure to CaOx crystals, 
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the cells have free access to serum components from the basolateral 
membrane. The results show that under these conditions CaOx crystals 
are toxic to renal proximal tubular cells, but not to collecting duct cells.  
 
 
MATERIALS AND METHODS   
 
Cell culture 
MDCK-I and MDCK-II cells were kindly provided by Prof. G. van Meer 
(Laboratory for Cell Biology and Histology, Amsterdam Medical Center, 
The Netherlands)[5]. LLC-PK1 cells were obtained from the American 
Type Culture Collection (ATCC). RCCD1 (rat renal cortical collecting 
duct) cells [6] were kindly provided by Dr. M. Blot-Chabaud (INSERM 
U246, Faculté de Médecine Xavier Bichat, Paris, France). Routinely, 
cells were grown in Dulbecco’s modified Eagle's Medium (GIBCO, 
Grand Island, NY, USA) supplemented with 10% fetal calf serum (PAA 
Labs, Linz, Austria) and weekly replated. Cells are cultured at 
intermediate densities in polystyrene tissue culture treated 75 cm2 flasks 
(Falcon, BD Biosciences, Bedford, USA) and the culture medium 
refreshed twice a week. For experiments cells are trypsinized and seeded 
at a concentration of 1x106 cells/polycarbonate permeable support 
(Transwells, 24 mm diameter inserts, 4.7 cm2 surface area, 0.4 µm pore 
size, Corning Costar, Badhoevedorp, The Netherlands). Within 6-7 days 
the cells proliferate and migrate into confluent monolayers with, 
depending on the cell type, a cell density of 4-6 x 106 cells.  
To study crystal-cell interaction, confluent monolayers were washed after 
which serumfree DMEM (1.5 ml) was added to the apical compartment 
whereas the basal compartment received DMEM 10% FCS (2.6 ml) and 
100 µl (146 µg) COM crystal suspension was added at the apical side of 
the monolayers. 
Tight junction formation is assessed by transepithelial electrical 
resistance (TER) measurements. TER is measured in ohms (Ω) after 
placing the insert in an Endohm 24 connected to a Voltohm meter (World 
Precision Instruments, Sarasota, USA). Monolayers are considered 
confluent as soon as the highest TERs are reached. Routinely, PCR 
analyses were performed on DNA isolated from cell culture conditioned 
medium for the presence of mycoplasma. Cells used in this study were 
not contaminated with mycoplasma. 
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Crystal formation in cell culture medium. 
To reveal at which concentrations oxalate induces crystal formation in 
culture medium, increasing amounts of oxalate were added to DMEM 
containing 1.8 mM calcium. Sodium oxalate was dissolved in Milli-Q 
distilled water and added at the appropriate concentration in a small 
volume on the bottom of a tube. Subsequently 50 ml DMEM was added 
at room temperature and the tube immediately vigorously shaken. After 
centrifugation at low speed (1000 rpm), the pellet was inspected by 
phase-contrast microscopy. 
 
Morphological studies   
Several staining procedures were used to visualize aspects of crystal-
induced cell responses by confocal microscopy. To monitor cell-
associated crystals, light reflection was applied to visualize the 
localization of the crystals and fluorescein isothiocyanate (FITC)-
conjugated phalloidin to stain polymeric F actin in the cell cytoskeleton. 
At the various time points, filter inserts were washed three times with 
physiological saline (PBS) and fixed for 15 minutes in ethanol 70%. 
Previously, it was demonstrated that fixation with ethanol releases most 
of the crystals that are loosely associated with the cell surface[7]. 
Ethanol-fixed cells are subsequently incubated for 15 minutes with 5 
µg/ml phalloidin-FITC (Sigma Aldrich Chemie BV, Zwijndrecht, The 
Netherlands), washed 3 times and mounted in Vectashield (Vector 
Laboratories, Burlingame, USA).  To study the subcellular localization of 
crystals under the various conditions, XY-scans in a focal plane 
(horizontal) and cross-sectional XZ-scans (vertical) were made with a 
Zeiss LSM 510 Meta (Zeiss, Oberkochen, Germany)[8]. A 488-nm argon 
laser was used to excite the FITC-phalloidin. Crystals were detected by 
633-nm (red) Kr-laser light reflection. A 560-nm beam splitter separated 
the FITC emission signal and the 633-nm signal reflected by the crystals. 
The FITC signal was passed through a 510- to 540-nm band-pass filter to 
block the reflection from the 488-nm laser. No blocking filter was used 
for the light reflection signal. The mounted inserts were extensively 
inspected, images (magnification 63x) were made of at least 10 random 
fields per insert from which representative images were selected. 
Experiments were repeated at least three times.  
 
Chapter 5 
 76 
Calcium oxalate monohydrate (COM) crystal binding  
A solution of radiolabeled sodium oxalate was prepared by adding 10 µl 
37 MBq/ml [14C]oxalic acid (Amersham Int.plc, Buckinghamshire, UK) 
to 0.25 ml 200 mM sodium oxalate. A calcium chloride solution was 
prepared by adding 0.25 ml 200 mM CaCl2 to 9.5 ml distilled water. 
Mixing the two solutions at room temperature (final concentration of 5 
mM for both oxalate and calcium) immediately resulted in the nucleation 
of radiolabeled COM. After settling for three days, crystals were washed 
three times with and resuspended in CaOx-saturated H2O in a final 
volume of 5 ml (1.46 mg COM crystals/ml). In this study the cells were 
incubated with 100 µl crystal suspension (146 µg/insert or 32 µg/cm2). 
The same procedure but without [14C]oxalic acid was used for the 
generation of non-radiolabeled COM. The crystals prepared with this 
method consist entirely of calcium oxalate monohydrate (COM) with an 
average size of 1-2 µm[9]. 
To quantify the amount of COM crystals that remained associated with the 
monolayers in time, radiolabeled crystals were added at the luminal side of 
confluent monolayers in serumfree DMEM, while in the basal 
compartment the cells received DMEM 0.5% FCS. Cells were incubated 
for one hour, after which the inserts were rinsed to remove all non-
associated crystals, cut out and placed in a scintillation vial. To extract 
radioactivity, 1 ml 1M perchloric acid was added and the amount of 
radioactivity was counted in a liquid scintillation counter (Packard, UK). 
The amount of associated crystals was calculated from the dpm/filter. The 
remaining inserts were extensively washed after which the apical 
compartment received serumfree DMEM whereas DMEM 10% FCS was 
added to the basal compartment. The procedure to assess the amount of 
cell-associated radioactivity was subsequently repeated 1, 2, 7 and 15 days 
post-incubation.  
To study the ability of the cells to process internalized crystals the 
following study was conducted. Monolayers were incubated for one hour 
with [14C]COM according the method described above. Twenty-four 
hours post-incubation, released or loosely attached crystals were removed 
through extensive washing of the monolayers. During the days thereafter 
and starting two-days post-incubation, the fluid in the apical and basal 
compartments was collected and centrifuged. The amount of radioactivity 
was counted in 100 µl portions in the supernatants and in the pellets after 
dissolution in 1M PCA. The amount of [14C]COM that remained 
associated with the monolayers was counted in a scintillation counter.  
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Hydrogen peroxide (H2O2) 
The reactive oxygen intermediate hydrogen peroxide (H2O2) was 
measured in the apical fluid of cells exposed to various concentrations of 
oxalate using the Amplex Red Hydrogen/Peroxide assay kit (A-22188; 
Molecular Probes, Leiden, The Netherlands). Since phenol red in the 
culture medium interferes with the absorbance measurements the studies 
are performed with a buffer containing (in mM): 124 NaCl, 25 NaHCO3, 
2 NaH2PO4.2H2O, 5 KCl, 0.5 MgCl2.6H2O, 5 Na-acetate, pH 7.4, 310-320 
mosmol/kg H2O from now on called calcium-free buffer B, added to the 
apical fluid compartment, while the basal compartment receives DMEM 
10% FCS without phenolred and sodium pyruvate (Gibco). A standard 
curve is prepared at 10 µmol/l to 1.25 µmol/l. Samples, standards and 
blank are aliquoted to a 96-well plate. A working solution of 100 µmol/l 
Amplex red reagent and 0.2 U/ml Horseradish peroxidase (HRP) is 
prepared and added to all the samples, standards and blank. The plate 
was protected from light and incubated for 30 minutes at room 
temperature. The absorbance was read at 560 nm using a Bio-Rad 550 
microplate reader. 
 
Prostaglandin E2 (PGE2).  
PGE2 secreted into the luminal compartment is measured in a switch 
enzyme-linked immunoassay (EIA) Kit (Cayman). This assay is based on 
the competition between PGE2 and a PGE2-acetylcholinestrase (AchE) 
conjugate (as tracer) for a limited amount of PGE2 monoclonal antibody. 
Because the concentration of the PGE2 tracer is held constant while the 
concentration of PGE2 varies, the amount of PGE2 tracer that is able to 
bind to the PGE2 antibody is inversely proportional to the concentration 
of PGE2 in the well. PGE2 standard curves are prepared by diluting 10 
mg/mL PGE2 in EIA buffer to produce a concentration range of 0-1000 
µg PGE2/mL. Each plate or set of strips contains a blank-, a non-specific 
binding-, a maximum binding and a total activity control. Standard curve 
samples (50 µl), controls and experimental samples are added to the 
wells. Each well receives 50 µl tracer except the total activity and the 
blank wells. The wells subsequently receive 50 µl PGE2 monoclonal 
antibody except the total activity well, the non-specific binding well, and 
the blank well. The plate is covered with plastic film and incubated for 
18 hours at 4oC. The wells and rinsed extensively with wash buffer after 
which 200 µL Ellman’s Reagent is added to each well and 5 µl tracer to 
the total activity well. The plate is then covered with plastic film and 
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developed in the dark on an orbital shaker. When the blank absorbance is 
between 0.3-0.8 units, the plate is read in a Bio-Rad 550 microplate 
reader at 405-420 nm wavelengths. 
 
[3H]Thymidine incorporation 
To assess the effect of crystals on DNA synthesis, monolayers were 
incubated for 24h with 146 µg COM after which all non-associated 
crystals were removed by extensive washing and the monolayers received 
fresh DMEM 10% FCS containing 3.7 KBq/ml [methyl-3H]thymidine 
(Amersham). After a pulse labeling period of 3 h, the cultures were 
washed 3 times with PBS, the filters cut out and counted in a liquid-
scintillation counter. Results are expressed in dpm/filter insert.  
 
Crystal-induced apoptotic or necrotic cell death 
To assess the nature of crystal-induced cell death, annexin V (A.G. 
Scientific, Inc, USA) staining was applied to reveal the surface exposure 
of phosphatidylserine (apoptosis) and propidium iodide (Sigma Aldrich 
Chemie) to reveal the loss of plasma membrane integrity (necrosis). At 
the various time points, filter inserts were washed and unfixed cells were 
incubated for 15 minutes with FITC labeled annexin V (1:40), washed 3 
times and subsequently incubated for 15 minutes with 1 µg/ml propidium 
iodide, washed and mounted in Vectashield (Vector Laboratories). 
Another widely applied method to study apoptosis is DNA fragmentation 
staining with Hoechst 33258 (Sigma Aldrich Chemie). At the various 
time points, filter inserts were washed and incubated with 0.1 mg/ml 
Hoechst, washed and mounted in Vectashield. In some experiments 
propidium iodide influx or Hoechst in combination with light reflection 
(crystals) was applied to assess if crystal-cell interaction is accompanied 
with apoptotic or necrotic cell death. Incubation of the cells for 4 hours 
with 1.0 µM antimycin A (Sigma Aldrich) was used as positive control 
for apoptosis, while cell fixation with ethanol to permeabilize the 
membrane served as positive control for necrosis. Phase-contrast 
microscopy was applied to monitor the release of crystal-containing cells 
in the apical fluid compartment.  
 
Statistics.  
ANOVA or Student’s t-tests were performed using triplicate samples and 
repeated at least two times to assess the statistical significance between 
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data points. Differences were considered statistically significant at 
p<0.05.  
 
 
RESULTS 
 
Oxalate-induced crystal formation in culture medium 
One of the motives to study the cellular response to calcium oxalate 
crystals was that oxalate is often added to calcium-containing culture 
media without sufficiently taking into account the risk for crystal 
formation. Effects attributed to oxalate in these studies can be partially or 
entirely be caused by crystals. In Fig.1 we show the oxalate 
concentrations inducing calcium oxalate crystal formation in DMEM (1,8 
mM calcium). Calcium oxalate crystals were formed after the addition of 
≥0.5 mM sodium oxalate (Fig.1). 
 
Morphological studies. 
Confluent monolayers were incubated for various periods of time with 
COM crystals and studied by confocal microscopy (CLSM) to monitor 
crystal localization and to reveal possible crystal-induced alterations in 
cell shape or behavior compared to cells of the same age that did not 
receive crystals. XY-images of phalloidin-FITC stained cells in 
combination with light reflection demonstrated no particles in cells that 
did not receive crystals (Fig.2A) and crystals inside MDCK-II, 1 day 
(Fig. 2B) and 7 days (Fig. 2C) after a one-hour incubation with 146 µg 
COM, which was also observed in LLC-PK1 cells (not shown). As repor-
ted previously, crystals did not bind to and were not internalized by 
MDCK-I or RCCD1 cells [7]. After 24 hours, the morphological appea-
rance of crystal-containing cells was rather disorderly and images made 
perpendicular to the growth substrate (XZ-images) revealed the release of 
crystal-containing cells into the apical fluid (Fig. 2D). Exfoliation of cells 
with crystals was confirmed by phase-contrast microscopy showing 
birefringent crystals in and around released single cells (Fig. 2E). After 
this initial vigorous response, the cells in the monolayers seemed to 
accept internalized crystals. After 7 days the quiescent and functional 
monolayers still contained cells with internalized crystals (Fig. 2C).  
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Figure 1.  Calcium oxalate crystal formation after adding sodium oxalate to DMEM.  
Crystals are detected by phase-contrast microscopy at oxalate concentrations 0.5 mM 
added to 1.8 mM calcium-containing  growth medium. 
Figure 2. CLSM images of MDCK-II cells cultured on permeable supports in a two-
compartment culture system. Cells (green) are visualized with FITC-conjugated 
phalloidin abd crystals (red) using light reflection (A). Confluent MDCK-II cells 
incubated for one hour with 146 µg COM crystals. Internalized crystals are found 
inside cells after one (B) and seven days (C). An image made perpendicular to the 
growth substrate 24 hours post-incubation revealed that crystal-containing cells were 
exfoliated from the cultures (D), which was confirmed by the presence of crystal-
containing cells in the supernatant by phase-contrast microscopy (E).
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Calcium oxalate monohydrate (COM) crystal binding 
Since it is not possible from CLSM images to appreciate quantitative 
variations, this study was repeated with radiolabeled crystals. Confluent 
monolayers of MDCK-II cells were incubated for one hour with 146 µg 
[14C]COM. After extensive washing to remove crystals that were not 
bound to the cells, the amount of monolayer-associated radioactivity was 
quantified immediately (t=1h) and 1, 2, 7 and 15 days later (Fig. 3). After 
one hour (t=1) a relatively large amount of crystals were associated with 
the monolayers. After the first 24 hours, the amount of monolayer-
associated radioactivity was reduced by approximately 50% (Td~21h), to 
further decline at a much slower rate in the next 14 days (Td~312h). As 
mentioned above, crystals were eliminated during the initial response by 
the release of crystal-containing cells from the monolayers, but we do not 
exclude the possibility that part of the crystals were translocated back 
into the apical fluid or rapidly dissolved intracellularly.  
To study the cellular handling of endocytosed crystals during the late 
response, MDCK-II cells were incubated for one hour with [14C]COM 
crystals. After extensive washing at t=24 hour, the cells were monitored 
for an additional period of time. Two, 4 and 7 days later, the apical and 
basal fluid were collected, centrifuged, the filter inserts cut out and 
radioactivity counted in the pellets, supernatants and in the cells. Of the 
total amount of radioactivity eliminated by the monolayer in 5 days (~20 
x103 dpm), approximately 20% (4.3 x103 dpm) was recovered in the 
apical fluid as solid material, ~30% (6.2 x103 dpm) as ion in the apical 
fluid and ~50% (9.8 x103 dpm) as ion in the basal fluid. Since the volume 
ratio in the apical (1500 µl) and basal (2600 µl) compartment also is 
approximately 3:5, this suggests that the ion concentration on both sides 
of the monolayer equilibrated through passive paracellular diffusion. 
Although about 80% of the eliminated crystals are recovered as ions in 
the apical and basal fluid compartment this does not necessarily imply 
that the cells were able to dissolve them. Because the fluid in both 
compartments was not saturated with calcium and oxalate it is also 
possible that eliminated crystals dissolved in the growth medium.  
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Figure 3. The elimination of [14C]COM by MDCK-II cells showed a biphasic pattern. 
Within the first 24 hours approximately half of the amount of the crystals that initially 
became associated with the cells was removed (early response with Td=21h). The cells 
required another two weeks to eliminate again 50% (late response with Td=312 h). The early 
response may deal with crystals in the plasma membrane, while the late response may deal 
withinternalized crystals. 
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Prostaglandin E2 (PGE2). 
The secretion of prostaglandin E2 (PGE2) into the luminal compartment 
was measured as marker for crystal-induced inflammation. RCCD1 and 
LLC-PK1 appeared to be less suitable for these studies because they 
produced no or hardly detectable levels of PGE2. Arachidonic acid is 
converted to eicosanoids like PGE2 by cyclooxygenases (COX) and it is 
known that certain cell lines, including LLC-PK1, have defects in COX 
activity[10]. These studies were therefore primarily performed with the 
two MDCK strains. Earlier we found that MDCK cells indeed express 
COX-2 mRNA (unpublished results). After seeding cells at high 
densities, both cell types secreted relatively high levels of PGE2, which 
steeply decreased after the cultures became confluent (not shown). The 
exposure of confluent MDCK-II monolayers for 24h to COM induced 
levels of PGE2 secretion that were about 5 times higher than those 
secreted by control cultures. COM did not increase the secretion of PGE2 
by MDCK-I cells (Fig. 5).  
 
Hydrogen peroxide (H2O2) 
The production of reactive oxygen species has been proposed as one of 
the mechanisms by which oxalate and calcium oxalate crystals exert their 
damaging effect. The production of the reactive oxygen intermediate 
H2O2 was measured in the apical fluid of subconfluent cultures, confluent 
control cultures, confluent cultures exposed for 24 hours to 146 µg COM 
and mechanically damaged confluent monolayers. Compared to 
confluent cultures, H2O2 secretion was not higher in subconfluent 
cultures, indicating that the generation of reactive oxygen species is not a 
physiological event of growth-activated cells. Although the response was 
larger in MDCK-II, exposure to COM crystals resulted in increased 
levels of H2O2 production in both MDCK cell lines, as well as in scrape-
injured monolayers (Fig. 6).  
 
 
 
Figure 4. The elimination of internalized [14C]COM during the late response. The crystals 
are gradually removed from the cultures (●). Approximately 20% is was retrieved in the 
luminal compartment as insoluble (centrifugable) material (○). About 80% was recovered as 
ions that were equally distributed between both the apical ( ∆) and basal ( ∇) fluid 
compartment. Because the medium in both fluid compartments was not saturated with 
calcium oxalate, it is not entirely clear if crystals are dissolved inside cells or in the growth 
medium. 
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Figure 5     Figure 6 
 
 
Figure 5. Prostaglandin E2 secretion in response to COM. The addition of COM 
crystals to confluent monolayers increased PGE2 secretion in MDCK-II, but not in 
MDCK-I. 
 
 
Figure 6. Confluent monolayers are incubated with 146 µg COM crystals or scrape-
damaged with the tip of a sterile culture pipette. One day after the addition of crystals 
or after mechanical damage, H2O2 is measured in the apical fluid compartment. The 24 
hours conditioned medium of subconfluent and confluent cultures served as controls. 
 
 
[3H]thymidine incorporation 
To study the effect of crystals on DNA synthesis, cells with and without 
crystals were pulse-labeled (3 h) with [3H]thymidine, directly or one day 
after a 24 hour incubation with 146 µg COM. [3H]Thymidine 
incorporation was significantly higher 2 days after incubating MDCK-II 
with COM crystals, while COM did not affect MDCK-I proliferation 
(Table 1). Considering the release of MDCK-II cells from the monolayer 
(24h post-COM) and the time required for DNA synthesis to become 
significantly increased (48h post-COM), these results suggest that the  
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cells in the monolayer proliferated to replace released cells 
(regeneration).     
 
 
Table 1. [3H]thymidine incorporation in MDCK cells, 24 and 48 hours after 
incubation with 146 µg COM crystals. Results expressed as 103 dpm/filter insert, 
(n=3). The incorporation of thymidine was increased in MDCK-II, but not in MDCK-I 
cells. One day post-incubation the p-value of the unpaired Student’s t-test was not yet 
<0,05 (p=0.067), while 2 days post-incubation* the incorporation of [3H]thymidine in 
COM treated MDCK-II cells was significantly higher compared to untreated controls 
(p=0.041). 
 
 
Cell line  24h 48h 
MDCK-I Control 16.6 ± 0.96 9.06 ± 0.88 
 COM 15.7 ± 1.36 8.83 ± 2.62 
MDCK-II Control 5.13 ± 0.27 3.95 ± 0.23 
 COM 5.63 ± 0.21 4.97* ± 0.55 
 
 
 
%T[UVCNKPFWEGFCRQRVQVKEQTPGETQVKEEGNNFGCVJ
To assess if the released crystal-containing cells during the early 
response are viable or not, these cells were studied for various forms of 
cell death. Studies were performed in all cell lines. LLC-PK1 cells were 
not suitable because there were relatively many necrotic cells in 
untreated confluent monolayers. The results obtained with RCCD1 were 
comparable to those obtained with MDCK-I. Confluent monolayers of 
both MDCK strains were exposed for 24h to COM crystals and then 
incubated with propidium iodide (PI) to find out if crystals are capable to 
induce pathological cell death (necrosis). Earlier, we have demonstrated 
that crystals bind directly to the plasma membranes of MDCK-II and 
LLC-PK1 cells, while crystals did not bind to confluent MDCK-I and 
RCCD1 cells and some force prevented crystals from directly contacting 
the plasma membrane of proliferating MDCK-I cells. This force 
appeared to be the invisible pericellular matrix surrounding mobile 
cells[11]. Our present study shows few necrotic cells in WPVTGCVGF
EQPHNWGPV/&%-++ EWNVWTGU 
(KI#6JGCFFKVKQPQH%1/ET[UVCNU
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JQYGXGTYKVJKPJKPFWEGFOCUUKXGEGNNPGETQUKUCUKPFKECVGFD[VJG
CDKNKV[ QH 2+ VQ GPVGT PQPHKZGF EGNNU 
(KI$ 6JG ET[UVCNEQPVCKPKPI
GZHQNKCVGF EGNNU HTQO HKIWTG  CRRGCTGF VQ DG PGETQVKE EGNNU 
(KI%
(KIWTG  UJQYU VJCV RCVJQNQIKECN EGNN FGCVJ QPN[ QEEWTU KP/&%-++
EGNNUVJCVDKPFCPFKPVGTPCNK\GET[UVCNU
(KI(DWVPQVKPPQPCFJGTGPV
/&%-+ EGNNU 
(KI$ & +P CFFKVKQP VJKU HKIWTG UJQYU VJCV UGXGP
FC[U CHVGT %1/ CFFKVKQP ET[UVCNU CTG UVKNN RTGUGPV KP VJG /&%-++
EWNVWTGUDWVFQPQNQPIGTECWUGPGETQUKU
(KI*
To reveal if crystals can induce programmed cell death (apoptosis), cells 
were incubated for 24 hours with COM after which they were stained 
with Hoechst 33258 to visualize the DNA. Untreated controls had few 
apoptotic cells (Fig.9A). Whereas treatment with the apoptosis-inducer 
antimycin resulted in DNA fragmentation (Fig. 9C), COM crystals did 
not (Fig.9B). Apoptosis was also studied with annexin V that specifically 
binds to phophatidylserine at the surface of apoptotic cells. Annexin V 
bound only minimally to untreated confluent MDCK-I and MDCK-II 
monolayers (Fig. 10A and D). While treatment with antimycin A resulted 
in enhanced levels of annexin V binding (Fig.10C and G), 24 hours with 
COM did not increase annexin V binding in either cell type (Fig.10B and 
E). Crystals were clearly present in MDCK-II (reflection signals in red in 
Fig.10E) and absent in MDCK-I (no reflection signals in the laser light in 
Fig.10B), reinforcing the findings in figure 6 and in previously published 
results [7, 12] that, in contrast to confluent MDCK-II, confluent MDCK-I 
monolayers do not bind or take up crystals (Fig.10 E). 
 
 
DISCUSSION  
 
This study shows that calcium oxalate monohydrate (COM) crystals are 
toxic to renal proximal tubular cells, but not to renal collecting tubular 
cells. Crystals rapidly bind to and are taken up by renal proximal tubular 
cells, where they induce inflammation (PGE2), oxidative cell stress 
(H202), DNA synthesis ([3H]thymidine) and pathological cell death 
(necrosis). The response to crystals was less marked and without necrotic 
cell death in renal collecting tubule cells. Two weeks after their initial 
contact, significant amounts of crystals were still found inside proximal 
tubular cells, indicating that these cells do not easily remove crystals. 
Proximal tubular cells showed a biphasic response to crystals. Within 24 
hours, approximately half of the cell-associated crystals were released 
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back into the apical fluid compartment (early response), while another 
two weeks were required for the cells to remove again half of the 
internalized crystals (late response). In contrast to the late response, the 
early response was accompanied by inflammation-mediated cell death, 
suggesting that after surviving crystal internalization, the cells accepted 
the presence of crystals in their interior. Crystals induced increased levels 
of H202 in proximal tubular cells as well as in scrape-damaged 
monolayers, indicating that any form of tissue damage may lead to H202 
generation. Although crystals also slightly increased the production of 
H2O2 in MDCK-I, it should be noted that these cells were non-
physiologically covered for 24 hours with a relatively large amount of 
crystals that resulted in some cellular response. Finally, annexin V 
binding, DNA fragmentation and propidium iodide influx studies clearly 
demonstrated that crystals induce necrotic cell death without apoptosis. 
The concept that crystals induce tissue damage was initially reported in 
non-renal tissues such as joints[13], soft tissues[14], cysts of the oral 
cavity[15], synovial fibroblasts [16] and endothelial cells[17]. Since 
kidney stones are largely composed of crystals this concept was also 
introduced in urolithiasis research. 
Evidence came from rats fed a crystal-inducing diet and from studies 
performed in cell culture. In 1992 Lieske and Toback[18] reported that 
the internalization of calcium oxalate monohydrate crystals by BSC-1 
and MDCK cells stimulated DNA synthesis. Hackett and coworkers 
[19]subsequently found that crystal-containing MDCK and LLC-PK1 
cells were rapidly released from the cultures, which was confirmed in 
other studies [4, 18, 20-25]. Koul et al found that COM activates p38 
mitogen-activated protein kinase (MAPK) in LLC-PK1 [1, 26]. Crystals 
increased the mitochondrial production of reactive oxygen species in 
LLC-PK1 and MDCK cells with a subsequent depletion of the 
antioxidant status. The damaging effect of crystals to MDCK cells was 
inhibited by antioxidants[27]. The concept was born that not only 
oxalate, but also calcium oxalate crystals cause oxidative stress in renal 
tubular cells. Although these data collectively support the concept that 
crystal-cell interaction is damaging to renal tubular cells there is concern 
about the validity of this hypothesis.  Let’s look at the model systems 
used. Animals, usually rats, are made hyperoxaluric with ammonium 
oxalate, sodium oxalate, hydroxyproline or ethyleneglycol. Animals 
treated with these agents excrete higher levels of renal tubular enzymes 
and histological examination shows the deposition of crystals at sites 
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where the renal tubules are clearly damaged [28-33]. Recently, our group 
found that oxalate itself most likely is not nephrotoxic (paper submitted), 
suggesting that calcium oxalate crystals cause renal tissue damage in rats 
but the question is how? Based on the results in the present paper and on 
data in the literature it is conceivable that an oxalate overload 
immediately leads to the precipitation of crystals in ultrafiltrate, or that 
somewhere in the nephron tubules are obstructed by large crystal 
aggregates. It is less likely, however, that subtle crystal-cell interactions 
trigger inflammatory responses in late segments of the nephron. 
In cell culture, damaging effects of crystals were found in MDCK [19, 
27, 34-36], LLC-PK1 [20, 26, 27, 35, 37], OK-1 [24], BSC-1 [21, 38-40] 
and NRK52E cells [41-43]. MDCK was established in 1958 from the 
whole kidney of a dog. The heterogeneous nature of this cell line became 
clear by the isolation of various strains with completely different 
properties [5, 44-46]. The LLC-PK1 and OK-1 cells are widely used as 
model for the renal proximal tubule and BSC-1 and NRK52E cannot be 
assigned to a particular segment of the nephron. Thus, although crystal 
formation occurs in later parts of the nephron, such as the collecting 
ducts, crystal-cell interaction studies are performed with proximal tubular 
cells, mixed cell types, or undefined cell types, but not with collecting 
tubule cells. Data in the literature combined with the results presented in 
this paper suggest that crystals induce inflammation in cells that are not 
used to encounter crystals, such as fibroblast [16], endothelial cells [17] 
and renal proximal tubular cells (this study), but that they do not harm 
cell types that are frequently confronted with crystals in their 
environment, like renal collecting duct cells (this study) and most likely 
the urothelial cells in the remaining urinary tract. To avoid 
misunderstanding it should be emphasized that this does not include 
crystals-induced obstruction in the nephron or urinary tract. The 
limitations of this study are that we used cell lines derived from different 
species and it is questionable if they are representative for the human 
kidney. In addition, these cell types may have lost important functions in 
cell culture. We cannot exclude the possibility that crystals affect cells in 
nephron segments that are not included in our set of cell lines. Finally, it 
is possible that crystals trigger intracellular transduction pathways that 
were not monitored in our study.  
Taken together, our results show that calcium oxalate crystals induce an 
inflammatory reaction in proximal tubular cells, but not in collecting 
tubular cells. Crystals bind and enter proximal tubular cells provoking an 
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inflammatory response leading to the exfoliation of necrotic crystal-
containing cells that are replaced by new cells. This early reaction is 
followed by a much milder response during which non-necrotic crystal-
containing cells are gradually eliminated from the monolayer. Crystals 
did not induce inflammation or necrosis in collecting tubule cells and it is 
unlikely that they are damaging to the epithelium in the late nephron. 
Figure 7. Crystal-induced pathological cell death. Confluent monolayers of MDCK-II 
cells are incubated for 24 h with 146 µg COM after which the influx of propidium 
iodide (red) in living cells is studied by CLSM. Crystals are visualized by light 
reflection (white). There is no influx of propidium iodide in controls (A). One day after 
the addition of crystals, crystal-containing necrotic cells are seen all over the cultures 
(B). An image made perpendicular to the growth substrate revealed that most of the 
released crystal-containing cells are necrotic (C). 
Figure 8. Influx of propidium iodide (red) in MDCK cells in confluent monolayers, 1
and 7 days after COM (light reflection, white) addition. Influx only occasionally occurs 
in control MDCK-I cells (A, C) and is not increased by COM (B, D). Influx seldom 
occurs in control MDCK-II cells (E and G). One day after the addition of COM, 
crystals became associated with MDCK-II cells (F), causing necrosis (F). Seven days 
later COM was still present in MDCK-II, but did no longer cause cell necrosis (H).  
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Figure 9. Hoechst staining (blue) of confluent MDCK-II cell monolayers 24 hours after 
the addition of COM crystals (light reflection, red). DNA is not fragmented in untreated 
controls (A) or in cells that received COM crystals (B), while DNA fragmentation is 
clearly observed in MDCK-II cells treated with antimycin A (C). A CLSM XZ-image 
made perpendicular to the growth substrate showing that exfoliated crystal-containing 
cells are not apoptotic. 
Figure 10 
Crystal-induced cell death  
 
91 
Figure 10. Annexin V exhibits minimal binding to confluent monolayers of MDCK cells (A 
and D). The ability of annexin V to bind to MDCK-I and MDCK-II is increased after 
pretreatment with antimycin A C (and F). COM crystals do not increase annexin V binding 
to MDCK-I or MDCK-II cells (B and E). Propidium iodide influx occurs only in MDCK-II 
cells incubated with crystals (E). 
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ABSTRACT 
 
Background Oxalate-induced tissue damage may play an initiating role 
in the pathophysiology of calcium oxalate (CaOx) nephrolithiasis. The 
concentration of oxalate is higher in the renal collecting ducts (~0.1-0.5 
mM) than in the proximal tubule (~0.002- 0.1 mM). In the present 
investigation, we studied the damaging effect of oxalate to renal 
proximal-and collecting tubule cells in culture. 
Methods Studies were performed with the renal proximal tubular cell 
lines, LLC-PK1 and MDCK-II and the renal collecting duct cell lines, 
RCCD1 and MDCK-I. Confluent monolayers cultured on permeable 
growth substrates in a two-compartment culture system were apically 
exposed to relatively low (0.2, 0,5 and 1.0 mM) and high (5 and 10 mM) 
oxalate concentrations, after which several cellular responses were 
studied, including monolayer morphology (confocal microscopy), trans-
epithelial electrical resistances (TER), prostaglandin E2 (PGE2) secretion, 
lactate dehydrogenase (LDH) release, DNA synthesis ([3H]thymidin 
incorporation), total cell numbers, reactive oxygen species (H202) 
generation, apoptotic (annexin V, DNA fragmentation) and necrotic 
(propidium iodide influx) cell death. 
Results Visible morphological alterations were observed only at high 
oxalate concentrations. Most oxalate concentrations had little effect on 
TER; only 10 mM oxalate decreased TER irrevocably in collecting 
tubule monolayers. Elevated levels of PGE2, LDH and H202 were 
measured in both cell types after exposure to high, but not to low oxalate. 
Exposure to high oxalate resulted in elevated levels of DNA synthesis 
with decreasing total cell numbers. High, but not low oxalate, induced 
necrotic cell death without signs of programmed cell death. 
Conclusion This study shows that oxalate is toxic to renal tubular cells, 
but only at supraphysiological concentrations.     
 
 
INTRODUCTION 
 
Most kidney stones are predominantly composed of calcium oxalate 
(CaOx). Oxalate is a metabolic end product that is freely filtered at the 
glomerulus and excreted with the urine. Oxalate is a major risk factor in 
CaOx renal stone disease because of its poor solubility in the presence of 
calcium. In addition, it has been proposed that an increased oxalate 
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delivery to the kidney is nephrotoxic. Urinary oxalate excretion is low in 
healthy subjects (0.1-0.45 mmoles/24 h), somewhat higher in idiopathic 
CaOx renal stone disease (0.45-0.65 mmoles/24h) and considerably 
higher in primary hyperoxaluria (1-3.5 mmoles/24h) [1, 2]. The concept 
that oxalate is toxic to the kidney came from studies performed in 
animals [3-6] and cell culture [7-9]. These studies suggested that oxalate 
generates free radicals that are damaging to the renal tubular cells. There 
are some questions, however, about the model systems used to reach this 
conclusion. In animals, hyperoxaluria cannot exist without crystalluria 
that makes it difficult to discriminate between effects caused by either 
oxalate or calcium oxalate. Since oxalate rapidly forms crystals in 
calcium-containing growth media, the same problem may also apply to 
studies performed in cell culture. Another point of concern is that renal 
tubular cells are grown on plastic dishes receiving culture media 
containing 1-2 mM calcium and oxalate in the same compartment. 
Especially in the high oxalate range (≥1 mM oxalate) this leads to 
calcium depletion.  Finally, most oxalate toxicity studies in cell culture 
are performed with renal proximal tubular cells while high oxalate occurs 
at the end of the nephron. 
In the present investigation we studied the possible toxic effect of oxalate 
to renal proximal and collecting tubule cells grown as confluent 
monolayers on permeable growth substrates in a two-compartment 
culture system. Oxalate is added to the apical compartment in a simple 
buffer without calcium or serum, while growth medium containing 
calcium and serum is added to the basal compartment. Thus, during their 
apical exposure to oxalate, the cells have free access to nutrients and 
calcium from the basolateral membrane. The results show that under 
these conditions oxalate is toxic only at supraphysiological concen-
trations.     
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MATERIALS AND METHODS 
 
Cell culture 
MDCK-I and MDCK-II cells were kindly provided by Prof. G. van Meer 
(Laboratory for Cell Biology and Histology, Amsterdam Medical Center, 
The Netherlands). LLC-PK1 cells were obtained from the American Type 
Culture Collection (ATCC). RCCD1 (rat renal cortical collecting duct) 
cells [10] were kindly provided by Dr. M. Blot-Chabaud (INSERM 
U246, Faculté de Médecine Xavier Bichat, Paris, France). Routinely, 
cells were grown in Dulbecco’s modified Eagle's Medium (GIBCO, 
Grand Island, NY, USA) supplemented with 10% fetal calf serum (PAA 
Labs, Linz, Austria) and weekly replated. For experiments, cells are 
grown on permeable supports in a two-compartment culture system 
(Transwells, 24 mm diameter inserts, 4.7 cm2 surface area, 0.4 µm pore 
size, Corning Costar, Badhoevedorp, The Netherlands). In this culture 
system, growth medium containing 10% serum is added to the basal fluid 
compartment, while the apical compartment receives either growth 
medium or  calcium and serum-free buffer B containing (in mM): 124 
NaCl, 25 NaHCO3, 2 NaH2PO4.2H2O, 5 KCl, 0.5 MgCl2.6H2O, 5 Na-
acetate, pH 7.4, 310-320 mosmol/kg H2O. Cells are trypsinized and 
seeded at a concentration of 1x106 cells/polycarbonate permeable support 
(Corning Costar). Within 6-7 days the cells proliferate and migrate into 
confluent monolayers with a cell density of on average 4-6 x 106 cells. 
Routinely, PCR analyses were performed on DNA isolated from cell 
culture conditioned medium for the presence of mycoplasma. Cells used 
in this study were not contaminated with mycoplasma. 
 
Coulter counter  
To reveal at which concentrations oxalate induces crystal formation in 
culture medium, increasing amounts of oxalate were added to DMEM 
containing 1.8 mM calcium. Sodium oxalate was dissolved in Milli-Q 
distilled water and pipetted in the appropriate concentration in a small 
volume at the bottom of a tube. Subsequently 50 ml DMEM was added at 
room temperature and the tube vigorously shaken. After centrifugation at 
low speed (1000 rpm), the pellet was taken up in a smaller volume and 
measured in a Coulter Multisizer (Coulter Electronic Ltd, Luton, UK). 
The number of particles was determined in 500 µl sample volumes using 
a 70 µm orifice tube.  
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Transepithelial electrical resistances (TERs)   
Tight junction formation is assessed by transepithelial electrical 
resistance (TER) measurements. TER is measured in ohms (Ω) after 
placing the insert in an Endohm 24 connected to a Voltohm meter (World 
Precision Instruments, Sarasota, USA). Monolayers are considered 
confluent as soon as the highest TERs are reached. Cells were incubated 
for 6 hours with increasing oxalate concentrations after which TERs were 
measured. The monolayers were subsequently washed and fresh serum 
and calcium-containing culture medium was added to both compartments 
to monitor if monolayers with decreased TERS are capable to re-
establish the electrical resistance.  
 
Morphological studies   
Fluorescein isothiocyanate (FITC)-conjugated phalloidin was applied to 
stain polymeric F actin in the cell cytoskeleton. At the various time 
points, filter inserts were washed three times with physiological saline 
(PBS), fixed for 15 minutes in ethanol 70% and incubated for 15 minutes 
with 5 µg/ml phalloidin-FITC (Sigma Aldrich Chemie BV, Zwijndrecht, 
The Netherlands), washed 3 times and mounted in Vectashield (Vector 
Laboratories, Burlingame, USA).   A 488-nm Ar laser was used to excite 
the FITC-phalloidin. Mounted inserts were extensively inspected, images 
(magnification 63x) were made of at least 10 random fields per insert 
with a Zeiss LSM 410 laser scanning confocal microscope (Zeiss, 
Oberkochen, Germany) from which representative images were selected. 
Experiments were repeated at least three times.  
 
Lactate dehydrogenase (LDH) release 
LDH (EC 1.1.1.27) was measured in the luminal compartment with 
pyruvate as substrate using a standard autoanalyzer.   
  
Prostaglandin E2 (PGE2).  
PGE2 secretion into the luminal compartment was measured in a switch 
enzyme-linked immunoassay (EIA) Kit (Cayman). This assay is based on 
the competition between PGE2 and a PGE2-acetylcholinestrase (AchE) 
conjugate (as tracer) for a limited amount of PGE2 monoclonal antibody. 
Because the concentration of the PGE2 tracer is held constant while the 
concentration of PGE2 varies, the amount of PGE2 tracer that is able to 
bind to the PGE2 antibody is inversely proportional to the concentration 
of PGE2 in the well. PGE2 standard curves are prepared by diluting 10 
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mg/mL PGE2 in EIA buffer to produce a concentration range of 0-1000 
µg PGE2/mL. Each plate or set of strips contains a blank-, a non-specific 
binding-, a maximum binding and a total activity control. Standard curve 
samples (50 µl), controls and experimental samples are added to the 
wells. Each well receives 50 µl tracer except the total activity and the 
blank wells. The wells subsequently receive 50 µl PGE2 monoclonal 
antibody except the total activity well, the non-specific binding well, and 
the blank well. The plate is covered with plastic film and incubated for 
18 hours at 4oC. The wells and rinsed extensively with wash buffer after 
which 200 µL Ellman’s Reagent is added to each well and 5 µl tracer to 
the total activity well. The plate is then covered with plastic film and 
developed in the dark on an orbital shaker. When the blank absorbance is 
between 0.3-0.8 units, the plate is read at 405-420 nm wavelengths in a 
Bio-Rad 550 microplate reader. 
 
H2O2 determination 
The reactive oxygen intermediate hydrogen peroxide (H2O2) was 
measured in the apical fluid of cells exposed to various concentrations of 
oxalate using the Amplex Red Hydrogen/Peroxide assay kit (A-22188; 
Molecular Probes, Leiden, The Netherlands). Since phenol red in the 
culture medium interferes with the absorbance measurements the studies 
are performed with buffer B, added to the apical fluid compartment, while 
the basal compartment receives DMEM 10% FCS without phenolred and 
sodium pyruvate (Gibco). A standard curve is prepared at 10 µmol/l to 
1.25 µmol/l. Samples, standards and blank are added to a 96-well plate. 
A working solution of 100 µmol/l Amplex red reagent and 0.2 U/ml 
Horseradish peroxidase (HRP) is prepared and added to all the samples, 
standards and blank. The plate was protected from light and incubated for 
30 minutes at room temperature. The absorbance was read at 560 nm 
using a Bio-Rad 550 microplate reader. 
 
[3H]Thymidine incorporation 
To assess the effect of oxalate on DNA synthesis, confluent monolayers 
are incubated for 24h with various oxalate concentrations added to the 
apical compartment in calcium-free buffer B, while DMEM 10% FCS was 
added to the basal compartment. The next day (24 h) or one day later (48 
h) the inserts are extensively washed and the fluid in both compartments 
replaced with fresh DMEM 10% FCS containing 3.7 KBq/ml [methyl-
3H]thymidine (Amersham). The cells are pulse-labeled for 3h, washed 3 
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times with PBS; the filters are cut out and counted in a liquid-scintillation 
counter. Results expressed in dpm/filter insert.  
 
Apoptosis and necrosis 
To assess the nature of crystal-induced cell death, annexin V (A.G. 
Scientific, Inc, USA) staining was applied to reveal the surface exposure 
of phosphatidylserine (apoptosis) and propidium iodide (Sigma Aldrich 
Chemie) to reveal the loss of plasma membrane integrity (necrosis). At 
the various time points, filter inserts were washed and unfixed cells 
incubated for 15 minutes with FITC labeled annexin V (1:40), washed 3 
times and subsequently incubated for 15 minutes with 1 µg/ml propidium 
iodide, washed and mounted in Vectashield (Vector Laboratories, 
Burlingame, USA). Another widely applied method to study apoptosis is 
DNA fragmentation staining with Hoechst 33258 (Sigma Aldrich 
Chemie). At the various time points, filter inserts were washed and 
incubated with 0.1 mg/ml Hoechst, washed and mounted in Vectashield. 
In some experiments Hoechst dye (DNA fragmentation) and light 
reflection (crystals) were simultaneously applied to assess if crystal-cell 
interaction was accompanied with physiological cell death (apoptosis), 
while propidium iodide (membrane permeabilization) in combination 
with light reflection (crystals) were simultaneously applied to reveal if 
crystal-cell interaction led to pathological cell death (necrosis). 
Incubation of the cells for 4 hours with 1.0 µM antimycin A was used as 
positive control for apoptosis, while cell fixation with ethanol to 
permeabilize the membrane served as positive control for necrosis. 
Phase-contrast microscopy was applied to monitor the release of crystal-
containing cells in the apical fluid compartment.  
 
Statistical analysis 
All experiments were performed at least three times. The results are 
presented as means ± SD 0f three independent inserts. Statistical analysis 
was performed with 0ne-way analysis of variance (ANOVA). 
Differences were considered significant at p< 0.05.  
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RESULTS 
 
Coulter counter. 
The pH of DMEM was approximately 7.3 and was not influenced by 
oxalate. The measurements showed that in order to study the effect of 
oxalate alone the experiments should be performed in a calcium-free 
buffer because crystals are rapidly formed in culture medium (Fig.1).  
 
Figure 1. Crystals are formed in culture medium (DMEM) at oxalate concentrations 
above 400 µM. 
 
 
Morphological studies. 
Because other investigators found that the exposure of renal tubular cells 
in culture to oxalate leads to the spontaneous release of cells from the 
growth substrate [7], we started our studies by monitoring the 
morphological behavior of the cells in response to oxalate. Confluent 
monolayers were apically exposed for 24h with 0, 0.2, 0.5, 1, 5 and 10 
mM oxalate after which the cell cytoskeleton was stained with 
phalloidin-FITC and inspected by confocal microscopy. The scans made 
perpendicular to the growth substrate (xz-scans) clearly show that cells 
are not released from the monolayer at any of the concentrations used 
(Fig.2). In MDCK-I cells, the first morphological alterations are observed 
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not sooner than at 10 mM oxalate and in MDCK-II cells at 5 mM oxalate 
(Fig.2). At these concentrations the cells lose their normal cubical shape, 
they begin to round up. Although cellular stress responses do not 
necessarily lead to alterations in cell shape, soluble oxalate certainly does 
not easily release renal tubular cells from their growth substrates. 
Comparable results were obtained with LLC-PK1 and RCCD1 cells (not 
shown).
Figure 2. Morphological alterations in renal tubular cells exposed for 24 hours to 
increasing oxalate concentrations. The cells are cultured as confluent monolayers on 
porous supports in a two-compartment culture system in which oxalate is added to the 
apical fluid compartment in a calcium and serum-free buffer, while DMEM with 
calcium and serum is added to the basal fluid compartment. The first visible effect of 
oxalate is observed in MDCK-I cells at 10 mM oxalate and in MDCK-II cells at 5 mM 
oxalate. Note that even at these extremely high oxalate concentrations the cells are not 
released from the growth substrate.    
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Transepithelial electrical resistances (TERs)   
To study oxalate-induced effects on functional properties such as 
monolayer epithelial barrier integrity, TER was measured across 
confluent monolayers exposed for 6h to increasing concentrations of 
oxalate (0, 1, 5 and 10 mM) in a calcium-free buffer. Collecting duct cell 
monolayers are much more tight (~5000 Ω.cm2) than proximal tubular 
cell monolayers (~ 100-200 Ω.cm2). In MDCK-II and LLC-PK1, TER 
was not influenced by 1 and 5 mM oxalate, but a significant reduction 
was seen at 10 mM. Surprisingly, both cell lines were capable to re-
establish their TERs within one to two days (Fig.3). Although TER 
dropped across MDCK-I and RCCD1 monolayers directly after oxalate 
exposure, this was also observed in untreated controls, indicating that 
manipulation of the cells or the change of the apical fluid was responsible 
for the decrease in TER at this point in time. The effect of oxalate on 
TER across MDCK-I seemed to be concentration-dependent. Re-
establishment of the electrical resistance was seen with 0, 1 and 5 mM 
oxalate, but not with 10 mM. TER across RCCD1 had difficulty to regain 
its starting value but there were only small differences between untreated 
controls and monolayers treated with 1 and 5 mM oxalate. TER hardly 
re-established from 10 mM oxalate.  
 
Lactate dehydrogenase (LDH) release. 
The release of LDH was measured as marker for plasma membrane 
damage. It should be noted that the absolute amounts of LDH secreted or 
released by these cells varied depending on the developmental stage of 
the monolayers. Comparisons could be made, however, when matching 
untreated controls of the same age were included. Confluent monolayers 
of MDCK-I and MDCK-II cells were exposed for 24h to increasing 
oxalate concentrations ranging from 0.2 to 10 mM. Up to 1 mM, the 
amount of LDH in the apical compartment was not different from 
untreated controls. Increased levels of LDH were measured in response 
to 5 and 10 mM oxalate in MDCK-II and MDCK-I (Fig.4).  
 
Prostaglandin E2 (PGE2). 
To reveal a possible inflammatory response to oxalate we measured the 
secretion of PGE2 in the apical fluid compartment after 24h exposure to 
oxalate concentrations ranging from 0.2-10 mM. The secretion of PGE2 
by untreated controls of MDCK-I and MDCK-II was not higher after 24 
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hours ≤1mM oxalate. However, increased levels of PGE2 were measured 
in response to 5 and 10 mM oxalate (Fig. 5). 
  
 
Figure 3. Transepithelial electrical resistance measurements across confluent 
monolayers of various renal tubular cell types in response to a six hour exposure to 
increasing concentrations of oxalate (•Control, 1 mM,  5 mM, S10 mM). Oxalate 
is added in a calcium and serum-free buffer to the apical fluid compartment while 
DMEM containing calcium and serum is added at the basolateral side. After oxalate 
treatment the cells received DMEM with calcium 10% serum in both fluid 
compartments to monitor their ability to recover from potential oxalate-induced injury. 
Note that TERs across the two proximal tubular cell types LLC-PK1 and MDCK-II are 
much lower than those across the two collecting duct cell types, MDCK-I and RCCD1.  
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Figure 4               Figure 5 
 
 
Figure 4. Release of LDH in the apical fluid of confluent renal tubular cell monolayers 
cultured on permeable supports in a two-compartment culture system and treated for 24 
hours with increasing concentrations of oxalate. Oxalate is added in a calcium and 
serum-free buffer to the apical fluid compartment while DMEM containing calcium and 
serum is added at the basolateral side. Means ± SD of a representative experiment are 
shown. Statistical analysis was performed using ANOVA (p< 0.05, n=3). * Significantly 
different compared to 0 mM oxalate. 
 
 
Figure 5. PGE2 secretion in the apical fluid of confluent renal tubular cell monolayers 
cultured on permeable supports in a two-compartment culture system and treated for 24 
hours with increasing concentrations of oxalate. Oxalate is added in a calcium and 
serum-free buffer to the apical fluid compartment while DMEM containing calcium and 
serum is added at the basolateral side. Oxalate-induced inflammation occurs in both 
cell types at oxalate concentrations ≥5 mM. Means ±  SD of a representative experiment 
are shown. Statistical analysis was performed using ANOVA (p< 0.05, n=3).  
* Significantly different compared to 0 mM oxalate. 
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H2O2 determination 
To study the ability of oxalate to generate reactive oxygen species the 
concentration of H2O2 was measured in the luminal fluid of confluent 
monolayers formed by MDCK-I and MDCK-II cells in response to a 24h 
exposure to increasing concentrations of oxalate (0, 0.2, 0.5, 1, 5 and 10 
mM). Although in MDCK-II cells there seemed to be a relatively small 
increase in untreated controls and in monolayers exposed to the lowest 
dose of oxalate 0.2 mM, this probably reflects the vulnerability of this 
assay rather than a true effect on the cells. Compared with untreated 
controls, a significant increase in H2O2 production by MDCK-II was seen 
only at the highest oxalate concentration used (10 mM). Also the 
production of H2O2 by MDCK-I cells was increased with 10 mM oxalate 
(Fig.6). To study if there are also other conditions during which the 
production of H2O2 is increased we measured H2O2 in the apical fluid of 
scrape-damaged monolayers and during subconfluency. Whereas the 
production of H2O2 was relatively low in subconfluent and confluent 
cultures (not shown), relatively high levels of H2O2 were measured in the 
luminal fluid of scrape-damaged confluent monolayers, indicating that 
H2O2 production is not an exclusive cellular response to oxalate (Fig.6). 
 
 
[3H]Thymidine incorporation and total cell numbers. 
Previously, oxalate was found to induce DNA synthesis [8, 11], which 
prompted us to study the incorporation of [3H]thymidine in response to 
oxalate. Whereas a 24h exposure to 1.0 mM oxalate did not affect DNA 
synthesis in both MDCK strains, thymidine incorporation was increased in 
MDCK-II cells treated for 24h with 5 and 10 mM oxalate (Fig. 7). 
Although the incorporation of thymidine was not yet increased in MDCK-I 
cells at this point in time, these levels were increased one day later (not 
shown). Thus, although at much higher oxalate concentrations, we hereby 
confirm the ability of oxalate to stimulate DNA synthesis.  
Now there are two possibilities: 1) oxalate has a mitogenic effect on renal 
tubular cells, or 2) the increase in DNA synthesis reflects damage-induced 
regeneration. To answer this question we decided to count the cells in a 
hemocytometer following oxalate exposure. The results show that 
relatively low oxalate concentration (≤ 1mM) had no effect on the total cell 
numbers and that high oxalate (≥ 5mM) decreased total cell numbers 
(Fig.8).  
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Figure 6                 Figure 7 
 
 
Figure 6. H2O2 in the apical fluid of confluent renal tubular cell monolayers cultured 
on permeable supports in a two-compartment culture system and treated for 24 hours 
with increasing concentrations of oxalate or scrape-damaged with the tip of a 10 ml 
culture pipette. Oxalate is added in a calcium and serum-free buffer to the apical fluid 
compartment, while DMEM containing calcium and serum is added at the basolateral 
side. Oxalate-induced H2O2 generation occurs in both cell types at oxalate concen-
trations ≥ 5 mM. Means ± SD of a representative experiment are shown. Statistical 
analysis was performed using ANOVA (p< 0.05, n=3). * Significantly different 
compared to 0 mM oxalate. 
 
 
Figure 7. Incorporation of [3H]thymidine measured in 3 hours pulse labeling studies in 
renal tubular cells pre-exposed for 24 hours to increasing oxalate concentrations. Cells 
are cultured as confluent monolayers on permeable supports in a two-compartment 
culture system. Oxalate is added in a calcium and serum-free buffer to the apical fluid 
compartment while DMEM containing calcium and serum is added at the basolateral 
side.  Exposure for 24 hours to ≥5 mM oxalate leads to elevated levels of thymidine 
incorporation in MDCK-II. Increased levels of thymidin incorporation were also seen in 
MDCK-I exposed to 5 and 10 mM oxalate but this occurred 2 days (48h) post-injury 
(not shown). Means ± SD of a representative experiment are shown. Statistical analysis 
was performed using ANOVA (p< 0.05, n=3). * Significantly different compared to 0 
mM oxalate. 
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Figure 8.  Total cell numbers counted with a hemocytometer in confluent renal tubular 
cell monolayers cultured on permeable supports in a two-compartment culture system 
and treated for 24 hours with increasing oxalate concentrations. Oxalate is added in a 
calcium and serum-free buffer to the apical fluid compartment while DMEM containing 
calcium and serum is added at the basolateral side. This figure shows that the oxalate-
induced increase in DNA synthesis with ≥5 mM oxalate (Fig.7) is accompanied by 
decreased total cell numbers. Means ± SD of a representative experiment are shown. 
Statistical analysis was performed using ANOVA (p< 0.05, n=3). * Significantly 
different compared to 0 mM oxalate 
 
 
Apoptosis and necrosis 
The observation that the total cell numbers decreased after incubation with 
high oxalate concentrations indicated that oxalate can be lethal to renal 
tubular cells. Since the existing literature is contradictory on the mode of 
oxalate-induced cell death [12-15] we decided to study physiological 
(apoptosis) and pathological (necrosis) cell death in response to oxalate. 
Confluent monolayers were exposed to oxalate concentrations ranging 
from 0.2-10mM. Hoechst staining studies showed that although oxalate 
concentration-dependently reduced the total amount of cells in MDCK-I as  
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well as in MDCK-II, there were no signs of DNA fragmentation and 
therefore no indication for the involvement of apoptosis in this process. 
Treatment with the apoptosis inducer antimycin A, on the other hand, 
clearly resulted in DNA fragmentation in both cell types (Figure 9).  
We selected a second method to assess oxalate-induced apoptotic or 
necrotic cell death namely a combination of the binding of annexin V to 
surface exposed phosphatidylserine (PS), which occurs during program-
med cell death or apoptosis and the ability of propidiumiodide (PI) to enter 
the cell interior that occurs during unprogrammed cell death or necrosis. 
Again antimycin A was used as marker for apoptotic cell death.  These 
studies showed that in contrast to antimycin, oxalate exposure to both cell 
types did not lead to increased annexin V binding, thereby confirming the 
observation that high oxalate does not induce apoptosis. On the other hand, 
PI entered MDCK-II cells after a 24h exposure to 5mM oxalate, while 
10mM was required to cause the same effect in MDCK-I (Fig.10). The 
oxalate-induced reduction in total cell numbers therefore was caused by 
necrotic cell death. 
 
 
DISCUSSION 
 
This study shows that oxalate is not very toxic to renal tubular cells in 
culture. Inflammation (PGE2), membrane damage (LDH), oxidative cell 
stress (H202), DNA synthesis ([3H]thymidine) and pathological cell death 
(necrosis) are observed only at extremely high oxalate concentrations (≥5 
mM). There is not much difference between renal proximal and 
collecting tubule cells in their response to oxalate. In time, high oxalate 
increased DNA synthesis without higher total cell numbers indicating 
that this reflects repair from oxalate-induced tissue damage rather than 
growth stimulation. Although high oxalate induced increased levels of 
H202 this was also achieved by scrape injury, indicating that any form of 
tissue damage may lead to H202 generation. The production of limited 
amounts of free radicals most likely has a functional role in the cellular 
response to tissue injury, rather than that oxalate-induced free radical 
production is responsible for the observed tissue damage. Finally, 
annexin V binding, DNA fragmentation and propidium iodide influx 
studies clearly demonstrated that high oxalate leads to necrotic cell death 
but not to apoptosis.   
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Figure 9. Confluent monolayers cultured on a porous support in a two-compartment 
culture system exposed for 24 hours to increasing oxalate concentrations are stained 
with Hoechst to detect apoptosis. Oxalate is added in a calcium and serum-free buffer 
to the apical fluid compartment while DMEM containing calcium and serum is added at 
the basolateral side. This image shows that oxalate does not induce DNA fragmentation 
at any of the concentrations used. As positive control the cells are treated with 
antimycin A. Note that the cell density decreases at 10 mM oxalate. 
Figure 10. Confluent monolayers cultured on a porous support in a two-compartment 
culture system exposed for 24 hours to increasing oxalate concentrations are stained 
with annexin V and propidium iodide to detect apoptosis and necrosis.  Oxalate is 
added in a calcium and serum-free buffer to the apical fluid compartment while DMEM 
containing calcium and serum is added at the basolateral side. This image shows that 
oxalate does not lead to increased annexin V binding at any of the concentrations used. 
As positive control the cells are treated with antimycin A. Oxalate leads to the influx of 
propidiumiodide at 5 mM in MDCK-II and 10 mM in MDCK-I. 
MDCK-II
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The concept that oxalate toxicity may play an important role in the 
pathophysiology of renal stone disease initially was derived from studies 
in hyperoxaluric rats [3, 16]. The accumulation of hydroxyl radicals and 
decreased free radical scavengers were found in organs of hyperoxaluric 
rats [4]. The idea that hyperoxaluria causes free radical-mediated 
inflammation was supported by the beneficial effects of free radical 
scavengers like vitamin E, glutathione, mannitol and allopurinol [17, 18] 
and anti-inflammatory drugs such as calcium agonists, ACE inhibitors 
and fish oil [19-21]. The results obtained in animal studies inspired 
several investigators to study the effect of oxalate on renal tubular cells 
in culture [7, 8, 12, 22]. Studies performed with various cell lines 
demonstrated that oxalate provoked several cellular responses varying 
from activation of DNA synthesis to apoptotic and necrotic cell death.  
Oxalate-induced cell injury appeared to result from free radical-induced 
stress-activated protein kinase-mediated inflammation [8, 11, 13-15, 22-
29]. Despite the overwhelming number of publications in this area, there 
is concern about the validity of this hypothesis.    
Let’s first look at the animal studies. Animals are treated with oxalate or 
oxalate precursors [5, 30, 31]. These methods successfully increase 
oxalate in blood and ultrafiltrate. In the primary urine, oxalate rapidly 
precipitates as calcium oxalate crystals [32]. Renal tissue damage in 
hyperoxaluric rats cannot be exclusively attributed to oxalate because 
crystals could also cause it. The choice to study the damaging effect of 
oxalate in cell culture therefore seems logical. Unfortunately, also this 
approach has it pitfalls. In most oxalate toxicity studies, renal tubular 
cells are cultured on tissue culture plastic [7-9, 22, 23, 25]. The 
disadvantage of this method is that confluent monolayers can be 
maintained only for a relatively short period of time. At confluence the 
cells assemble tight junctions and begin to transport salt and water from 
the apical to the basolateral side of the monolayer leading to the 
formation of fluid-filled domes between cells and growth substrate. In 
addition, these cells rapidly suffer from the lack of nutrients since they 
normally feed from the basal membrane [33, 34]. As a result of these 
conditions confluent monolayers rapidly begin to detach from their 
growth support. Another problem is the addition of oxalate to calcium-
containing growth medium. Belliveau et al. [35] recently investigated the 
equilibrium parameters for calcium oxalate solubility in culture media. It 
was found that the addition of 1 mM oxalate to culture medium leads to 
>50% precipitation resulting in equilibrium oxalate concentrations of ≤60 
Oxalate toxicity 
 
113 
µM. Microscopy and Coulter Counter measurements confirmed the 
formation of particles at oxalate concentrations ≥0.4 mM added to 
Dulbecco’s essential modified medium (Fig.1). Another problem is 
oxalate-induced depletion of calcium from the growth medium. Calcium 
is an essential ingredient of growth media. Without sufficient amounts of 
calcium, the tight junctions will disassemble leading to cell rounding and 
release. Thus, also in cell culture it is difficult to differentiate between 
damaging effects caused by oxalate, calcium oxalate crystals or the lack 
of calcium.  
In the present study we tried to circumvent many of these problems by 
culturing the cells on permeable growth substrates in a two-compartment 
culture system, a method that enables us to add oxalate to the apical 
compartment, while calcium and serum are added to the basal 
compartment. The results show that oxalate is toxic to renal tubular cells, 
but only at very high concentration (≥5 mM). The literature is contro-
versial on the mode of oxalate-induced cell death. Some investigators 
found that oxalate induces apoptosis as well as necrosis [13, 14], while 
others found that oxalate leads to necrotic cell death [12]. Our study 
clearly shows that high oxalate causes necrosis but no apoptosis.  
The experiments in this investigation were designed to study the 
damaging effect of luminal oxalate on renal tubular cells in culture. 
Limitations of this study are: 1) In contrast to most previous oxalate 
toxicity studies [7, 25, 29], our cells were cultured on permeable growth 
substrates and did not receive calcium and serum in the apical compart-
ment. From the present study it is not entirely clear which of these 
variables is responsible for the relative insensitivity of the cells to 
oxalate. 2) The addition of oxalate to the apical compartment leads to 
apical-to-basal oxalate leakage resulting in gradual decreased luminal 
oxalate concentrations. The addition of oxalate to both fluid 
compartments is unusable because of the presence of calcium in the basal 
compartment. [14C]oxalate flux studies demonstrated that the apical-to-
basal paracellular flux of oxalate is much higher across proximal tubular 
cells than collecting duct cells [36]. In the proximal tubular cell types, 
estimated oxalate equilibrium in both fluid compartments is reached in 
approximately 12 hours, while numerous days are required to reach this 
point in collecting tubular cells. During a 24 hours incubation period the 
apical-to basal leakage across intact collecting tubular monolayers is 
neglectible, while in proximal tubular cells the luminal concentration of 
oxalate gradually decreases in time. Starting, for example, with 10 mM in 
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the apical compartment, oxalate leaks into the basal compartment until its 
concentration in both fluid compartments is ~3.7 mM. Despite the 
gradual reduction in luminal oxalate we do not believe that this alters the 
conclusion that oxalate is not very toxic to renal tubular cells in culture. 
3) We used cell lines derived from different species and it is questionable 
if they are representative for the human kidney. 4) Cell lines may have 
lost important functions in cell culture. 5) Perhaps oxalate affects renal 
tubular cell types that were no part of our set of cell lines. 6) Oxalate may 
trigger intracellular transduction pathways that were not measured in our 
study.  
Collectively the data of this study show that oxalate causes 
inflammation-mediated necrotic cell death in renal tubular cells at supra-
physiological concentrations (≥5 mM), but not at oxalate concentrations 
that are within the physiological range (≤1 mM).  
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7 .1 INFLUENCE OF URINE ON CRYSTAL-CELL INTERACTION 
 
The development of a renal stone largely depends upon the structural 
composition of the surface epithelium lining the renal tubules. CaOx 
crystals occur in the distal tubules and in the collecting ducts. It is crucial 
that the tubular epithelium in this region does not retain crystals, so that 
they can be excreted with the urine. Cell surface protection against 
crystal adherence is of less importance to the proximal tubular epi-
thelium, as crystallization is not to be expected there. Crystallization in 
the early parts of the nephron is exceptional and can only occur in 
patients with late stages of primary hyperoxaluria or after ethylene glycol 
poisoning. As discussed in Chapter 1, individual parts of the nephron 
contain specialized epithelial cells. Although the prime function of these 
cells is not to bind or repel crystals, they have to be able to cope with 
them if needed. 
 
Previous studies by our group and others have shown that cell lines 
derived from renal collecting tubular epithelium lose their affinity for 
calcium oxalate monohydrate (COM) crystals at confluence [1, 2]. Injury 
inflicted to the epithelium by scraping cells from the monolayer, triggers 
cells at the edge of the wound to migrate and proliferate. During this 
process, they regain their crystal binding capacity. It is possible that in 
vivo, urinary proteins can influence the binding of crystals to the 
epithelium by interacting with the surface of the crystals and/or the cells. 
Theoretically, while in non-stone forming individuals the quality and 
quantity of these urinary inhibitors is sufficient to prevent the stone-
forming process, in stone-formers the urine might be less able to prevent 
crystallization, aggregation and crystal retention.  
 
Several studies have been undertaken to identify markers for stone 
formation in urine of stone forming patients. Considering the amount of 
proteins present in urine, detecting small differences between healthy 
subjects and stone-formers is a difficult process. Not only are there 
variations in urine composition within groups, even in one person there 
can be day-to-day variations. Comparing whole urines, e.g. using 2D-gel 
electrophoresis, looking for differences in the complete protein pattern is 
like looking for a needle in a hay stack. Given that there are indeed 
different expression patterns found, one has to be sure that those are 
derived from stone formation in the kidney. The final urine contains a 
General Discussion 
 119 
mixture of components secreted along the entire urinary tract and filtered 
blood proteins, making it virtually impossible to backtrack them to a 
specific part of the kidney, or even one specific nephron segment.  Even 
when specific markers are produced along the renal tubules, the 
possibility exists that these are transported to the basal side of the 
epithelium instead of into the tubular fluid. If this happens, one cannot 
detect those in the urine but in the blood. Therefore, it might be a better 
strategy to initially narrow down the search to known crystallization 
inhibitors like osteopontin (OPN), prothrombin (PT) and inter-α-inhibitor 
(IαI). These proteins are known to be present in the organic crystal 
matrix [3] and are also involved in injury repair or inflammation [4, 5]. 
The presence of these substances in the urine might provide a clue for the 
presence of an activated, crystal-binding epithelium lining the renal 
tubules. 
 
A comparison between urines of clinically active stone formers (SFs) and 
healthy individuals using sodium dodecyl sulphate- polyacrylamide 
electrophoresis (SDS-PAGE) did not bring to light differences in relative 
densities of CaOx crystallization inhibitors osteopontin and prothrombin, 
but inter-α-inhibitor trimer was about twofold increased. The hypothesis 
that the incidence of CaOx nephrolithiasis is higher in men because of a 
generalized decrease in CaOx crystallization inhibitors compared to 
women was not supported by the results of this and other studies [6, 7]. 
 
Another approach is to study substances that can be found in the stone 
matrix. In this manner, only molecules with affinity for crystals or for 
other substances in the crystal matrix are collected, concentrating the 
pool of potential markers. Crystallization can be induced in urine samples 
through the addition of oxalate, after which the crystal matrix is 
investigated [8-12]. After dissolving the crystals with EDTA, the 
remaining molecules can be separated by gel electrophoresis to be 
subsequently identified. The group of Khan induced CaOx as well as CaP 
crystals in urine of normal subjects and stone formers and subsequently 
identified protein components that became entrapped in the crystal 
matrices. There were no differences between stone formers and normal 
subjects observed in either the amount of crystals formed or the organic 
crystal matrix. Albumin, inter-α-inhibitor related proteins, α-1-micro-
globulin, osteopontin (OPN), Tamm-Horsfall protein (THP) and pro-
thrombin (PT)-related proteins were detected. The main constituents 
Chapter 7 
 120
were albumin, PT-related proteins and OPN. CaP crystals, which 
contained more proteins than CaOx crystals, also contained a large 
amount of THP [12].  
 
Incubation of CaOx crystals in physiological urine (pH 5.5) led to less 
aggregation of CaOx crystal seeds compared to controls. Alkaline urine 
(pH 8.0) on the other hand did not affect the crystal morphology [13]. 
Urinary macromolecules can influence the CaOx crystal structure, as 
shown by Wesson et al. In an in vitro system at pH 7.5, in the presence of 
urinary inhibitors of crystallization like OPN and PT, the favoured form 
of crystals shifted from CaOx monohydrate (COM) to CaOx dihydrate 
(COD). In cell culture, COM have greater affinity for the cell surface 
than COD [14]. Instead of using animal models or cell culture for 
mimicking the development of renal stones, some investigators have 
developed in vitro model systems to grow stones out of small calcium 
oxalate fragments by incubating them in flowing (artificial) urine. In 
these “stone-farms” the impact of specific urinary components on stone 
growth composition can be investigated [15-17].  
 
In Chapter 2 of this thesis, we studied the effects of urine from normal 
healthy males on COM crystal binding to LLC-PK1 cells and to MDCK-I 
cells during wound healing. During incubation of CaOx crystals in urine, 
crystallization inhibitors with affinity for the crystals form a coat around 
them, altering their surface characteristics. This might affect the binding 
of CaOx to the renal tubular epithelial cells.  If urine should indeed 
prevent crystal retention, then COM crystal binding to injured cells 
would be similar to that of undamaged MDCK-I monolayers that lost 
their affinity for crystals. The results of our study showed that COM 
crystals that were coated with urinary proteins bound to the epithelium 
almost to the same extent as uncoated crystals. In a parallel series of 
experiments, we compared the binding of treated and untreated crystals 
to LLC-PK1 cells that constitutively bind crystals during all stages of 
development. The results were comparable to those obtained with 
MDCK-I. Thus, the cell surface properties of the epithelium appeared to 
be of more importance for crystal retention than the presence of urinary 
inhibitors. In other words, if the epithelium has become susceptible to 
CaOx crystal binding, the crystals will bind regardless of the presence of 
inhibitors in the urine. 
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In another study, Kumar et al. found that coating of CaOx crystal with 
whole urine decreased crystal binding to MDCK-I cells cultured on 
impermeable substrates, while urine from which  molecules bigger than 
10 kDa were filtered out did not. Apparently, these macromolecules were 
responsible for the inhibiting effects. Urine exerted its effect on the 
crystals, and not on the cell surface, as pre-treatment of the cells did not 
affect crystal binding [18]. These authors incubated their crystals in a 
larger volume of urine than we did, which might in part explain the 
differences between the results of the studies. It is indeed possible that 
alterations in the urinary protein-to-crystal ratio result in differences in 
the type or amount of proteins in the coat of the crystals, affecting their 
affinity for the epithelium. The effect of urine pH on CaOx crystal 
binding to both healthy (polarized) and injured (nonpolarized) primary 
IMCD cells was investigated by the group of Mandel. Below pH 6 the 
negative charge on the crystal surface decreases and the attachment to 
injured cells enhanced. At lower pH, more proteins adhered to the crystal 
surface and the tertiary structure of the adsorbed protein was altered. 
Coating of crystals with urine macromolecules at pH 5, 6 or 7 greatly 
reduced their binding to normal as well as injured epithelia. At all pH 
values, THP was the most abundant protein in the crystal coating. 
Removal of one crystallization inhibitor from the total pool of urinary 
proteins is unlikely to enhance crystal binding to the epithelium, since 
other inhibitors will fill in the gap. Therefore it seems more useful to 
study the effect of whole urine instead of that of isolated urinary proteins. 
As shown in this study, alterations in the urine pH have more effect on 
the type and structure of proteins attached to the crystals. [19].  
 
From these studies, it can be concluded that urinary components can 
indeed influence the interaction between CaOx crystals and the renal 
tubular epithelium. However, effects are depending on the cell surface 
composition of the epithelium as well as on the urine composition, 
especially the pH. Although I do not dispute the finding that urinary 
macromolecules can inhibit the binding of crystals to a certain extent, 
most likely the cell surface properties of the epithelium are far more 
important. At times when the tubular lining becomes adherent to crystals, 
the protective effects of urinary inhibitors are limited, since they cannot 
completely block the binding of crystals 
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7.2 HYALURONAN AND PERICELLULAR MATRIX FORMATION 
 
A few years ago, the polysaccharide hyaluronan (HA) was identified as a 
key crystal binding molecule at the cell surface of proliferating and 
migrating MDCK-I cells. More detailed investigations have shown that 
HA is not just a simple cell surface molecule. 
 
Hyaluronan is produced by hyaluronan synthases (HAS), that are located 
inside the cell membrane. HA synthesis takes place on the cytoplasmic 
side of the plasma membrane, after which the product is extruded across 
the plasma membrane into the extracellular space. There are three types 
of synthases (HAS-1, -2 and -3) that have specific enzymatic properties, 
synthesizing hyaluronan of varying molecular weights. HAS-1 is the 
least active of the three HAS proteins and drives the synthesis of high 
molecular weight HA (> 106 Da). HAS-2 is more active than HAS-1, is 
widely expressed throughout embryonic development and also produces 
high molecular weight HA. HAS-3, the most active of the three HAS-
proteins, drives the synthesis of short HA chains (< 2 x 105 Da) [20-22]. 
Hyaluronan sugar chains are connected to the cell surface via hyaluronan 
synthases (HAS-1, -2 or -3) and/or via receptors like CD44 [23, 24]. The 
hyaluronan molecules can get as large as 10 million Da and are 
intertwined and stabilized via large proteoglycans and hyaluronan-
binding proteins (HABP), forming a relatively thick water-attracting 
layer. This cell coat is often called a pericellular matrix (PCM) [25-27]. 
PCMs are formed by many cell types, like fibroblasts, chondrocytes and 
vascular smooth muscle cells. During proliferation and wound repair, 
they are creating a path for migrating cells. Cell coats are also protecting 
the cell surface against invasions of e.g. bacteria [28-31]. In cell culture, 
metastatic prostate adenocarcinoma cells assembled PCMs to enable 
adhesion to bone marrow endothelial cells [32].  
 
In the kidney, HA is normally present only in the medullary interstitium, 
where it is involved in water homeostasis. It is not expressed at the 
luminal surface of the tubular epithelium in healthy kidneys [33-35]. 
Hyaluronan can be upregulated in the kidney during renal inflammatory 
diseases like interstitial nephritis[36], acute ischemic injury [37, 38], 
autoimmune renal injury [39] and acutely rejecting human kidney grafts 
[40].  
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The production of hyaluronan can be induced by pro-inflammatory 
stimuli [41]. Eicosanoids are important local mediators of inflammation. 
Arachidonic acid (AA) is metabolized by cyclooxygenase (COX) into 
eicosanoids including leukotriens, thromboxane, prostacyclin and prosta-
glandins [42, 43]. During inflammation activated cytosolic phospholipase 
A2 (cPLA2) cleaves AA from membrane phospholipids as rate limiting 
step in the production of eicosanoids. There are two different COX 
isoenzymes, COX-1 and COX-2. COX-1 is constitutive in many organs 
and cells and catalyzes the prostaglandin (PG) synthesis believed to 
support physiologic functions. The COX-2 isoform is also constitutive in 
some tissues, but unlike COX-1, this isoenzyme is markedly induced by 
cytokines and growth factors and catalyzes the synthesis of pro-
inflammatory prostaglandins [44]. There is a relationship between the 
production of eicosanoids and hyaluronan. Prostaglandin E2 (PGE2 ) 
stimulates the production of HA in cultured rabbit pericardial mesothelial 
cells and in fibroblasts[45, 46]. Hyaluronan increases glomerular COX-2 
protein expression in a p38 MAP-kinase-dependent process [47] and in 
renal tubular cells hyaluronan-induced COX-2 promoted the production 
of eicosanoids[48]. The production of HA in the glomerulus depends on 
prostaglandins [49, 50]. Interaction of HA with cell surface receptors 
triggers the production of pro-inflammatory cytokines, chemokines and 
adhesion molecules [51]. In renal tubular cells, low molecular weight HA 
stimulates COX-2, but not COX-1. The expression of monocyte 
chemoatractant protein (MCP-1) is induced by low molecular weight, but 
not high molecular weight HA [47, 48, 52]. 
 
Using our cell culture models, we found that the majority of MDCK-I 
cells form hyaluronan-rich PCMs during migration, while only few 
MDCK-II cells are able to do so (Chapter 3).  In order to form cell coats, 
sufficient high MW HA has to be produced. Furthermore, the presence of 
cell surface receptors like CD44 is required to connect the HA chains to 
the cell surface and hyaluronan binding proteins (HABPs), e.g. large 
proteoglycans,  are necessary to stabilize the cell coat [25, 26]. During 
proliferation, MDCK-I cells produced about six fold more cell-surface 
associated HA than MDCK-II cells, while LLC-PK1 cells did not synthe-
size cell-associated HA. We determined the amount of high molecular 
weight HA ( > 106 Da) that was secreted into the apical fluid of 
subconfluent cells and found that MDCK-I cells produced significant 
amounts of high MW HA, while MDCK-II cells synthesized only small 
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amounts of high MW HA. In addition, MDCK-I cells assembled large 
amounts of high MW proteoglycans, necessary for stabilizing the peri-
cellular matrix. Results from this study provide evidence for the concept 
that PCM formation is necessary for crystal retention in the renal distal 
tubule-collecting duct. As a rule, these cells are normally protected form 
crystal binding. Proximal tubular cells appear to be constitutively 
covered with molecules with affinity for CaOx crystals. [53].  
 
Primary cultures of tubular epithelial cells derived from human kidneys 
behaved similar to the MDCK cell lines. At subconfluence, proximal as 
well as distal tubular cells were susceptible to COM crystal binding. 
Distal tubular cultures lost this affinity for crystals when they achieved 
confluence. As with the cell lines, HA was expressed at the cell surface 
of proliferating subconfluent cells where it formed a PCM, but was 
absent from the confluent cultures. To strengthen those observations, it 
was found that in damaged rat kidneys hyaluronan was expressed at the 
luminal side of the tubules, while HA  was not found in the lumen of 
intact tubules [5].  
 
Recent data from a study with rats given ethylene glycol in drinking 
water to induce crystal formation and -retention have provided more 
evidence for the concept that HA might be involved in stone disease. In 
the renal cortex as well as outer stripe of outer medulla (OSOM, HA is 
virtually undetectable in control rats. EG-treated rats display  HA in the 
cortex and the OSOM at days 4 and 8 after beginning of treatment. 
Injured/regenerating tubule epithelial cells express HA on their apical 
surface, and at these sites calcium oxalate crystals are found attached to 
the tubule wall. Interestingly, the presence of HA at the apical surface 
was accompanied by that of osteopontin (OPN) and CD44.  In healthy 
kidneys, CD44 and OPN are not expressed at the luminal side of the 
renal tubules [54]. OPN and HA are both ligands for the cell surface 
receptor CD44. OPN is known as urinary inhibitor of crystallization [55]. 
At the apical cell surface, it can act as crystal binding molecule [5, 54].  
 
Hyaluronan has been shown to be an important crystal binding molecule 
in cell culture as well as in animal models for nephrolithiasis. Production 
of HA is stimulated during proliferation and injury repair. Hyaluronan 
was found inside the organic renal stone matrix [56, 57]. Detection of 
HA in human stone forming kidneys would provide evidence for its role 
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in crystal-cell interaction in vivo. It is however virtually impossible to 
pinpoint the exact sites where stone formation is initiated. Nevertheless, 
studies will be undertaken to investigate the presence of HA in biopsy 
material obtained at the site of Randall’s plaques, where stones have been 
attached. In theory, crystalline material that has been in contact with 
activated hyaluronan-covered tubular epithelial cells before continuing its 
way through the nephron might have affinity for the surface of Randall’s 
plaques. Crystals that are not retained by the tubular epithelium and 
therefore not coated with HA, on the other hand, are less likely to bind to 
Randall’s plaques. 
 
 
7.3  FATE OF CELL-BOUND CRYSTALS 
 
Cells derived from different parts of the nephron interact with crystals in 
specific ways that appear to vary from segment to segment. Normal 
confluent distal tubule-like cells do not have affinity for CaOx crystals, 
while proximal tubule-like cells bind crystals at all stages of development 
[1].  To study the fate of crystals that have been bound to the cell surface 
in distal as well as proximal tubule-like cells, we therefore used 
proliferating cells. As discussed in Chapter 4, renal tubular cell lines 
exposed to CaOx crystals during subconfluence initially retain them at 
the apical surface. When the time of exposure is extended, proximal- and 
distal tubule-like cells respond differently. While the first ones inter-
nalize the crystals, the latter ones keep the crystals on the outside of the 
cells. This is probably due to the fact that proximal tubular cells in vivo 
normally do not encounter CaOx crystals and therefore do not display 
defence mechanisms against their retention. Crystallization in the early 
parts of the nephron is exceptional and can only occur in patients with  
late stages of primary hyperoxaluria or after ethylene glycol poisoning. 
Otherwise, plasma oxalate values are not high enough to cause nucleation 
calcium oxalate nucleation [58]. 
 
Lieske et al. have discussed a patient with type 1 primary hyperoxaluria, 
requiring a combined liver-kidney transplantation. A biopsy two weeks 
after the operation displayed calcium oxalate crystals inside the renal 
tubular cells. These crystals appeared to stimulate cell proliferation. 
Crystals seemed to be moved from the tubular lumen through the 
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basement membrane into the interstitium. One month after transplan-
tation, calcium oxalate deposits were no longer observed [59].  
 
The presence of intracellular crystals was also shown in rats kept on a so-
called crystal inducing diet of ethylene glycol (EG) alone or in combi-
nation with ammonium chloride (AC). Most crystals were observed 
within the tubular lumen in the renal medulla, where they were firmly 
attached to the cell surface and covered by neighbouring epithelial cells. 
A smaller number of crystals was present in the intercellular spaces and 
inside the epithelial cells and the interstitium. Intracellular oedema and 
blebbing of the microvilli occurred in the crystal-containing tubules[60]. 
Some investigators believe that these intracellular crystals can travel 
through the basement membrane into the interstitium[61]. When crystals 
are anchored to the basement membrane of the peripheral collecting duct, 
they can aggregate and move towards the papillary surface to form a 
stone nidus[60].  
 
Ebisuno et al. studied kidney tissues from rats and humans, looking for 
adhesion and/or endocytosis of CaOx crystals. Sprague-Dawley rats that 
were peritoneally injected with sodium oxalate had formed CaOx crystals 
inside their kidneys. These crystals were located inside the tubular lumen 
or internalized into the membrane in the cortical region, whereas in the 
papilla crystal aggregates were located freely inside the degenerated 
tubular lumen, together with cell debris. In human kidney tissue obtained 
from renal stone formers without underlying disorders like primary 
hyperoxaluria, before the era of ESWL, crystals were observed inside the 
tubular lumen or attached to the tubular epithelium in about half of the 
specimens. Some crystals were seen inside the cells [62].   
 
It is believed that CaOx crystals that are taken up by renal tubular 
epithelial cells act as stressor, leading to cell activation or injury. The 
internalization of CaOx crystals has been observed in different types of 
renal tubular epithelial cells in culture, like, LLC-PK1 , BSC-1 , OK-1, 
MDCK and NRK-52E [60, 62-72]. The crystals come in contact with 
microvilli on the apical cell surface, after which they protrude through 
the membrane into the cell. Lieske et al. reported already in 1992 that 
CaOx crystals are avidly internalized by monkey kidney BSC-1 and 
canine kidney MDCK cells, where they initiate DNA synthesis and 
induce cell proliferation [67]. Large amounts of CaOx crystals might be 
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toxic to MDCK cells, as shown by Hackett et al. Addition of 500 µg/ml 
CaOx crystals led to some degree of cell detachment and release of 
enzymes (LDH, NAG, LAP, γ-GT). Similar effects were observed of 200 
µg/ml oxalate ions [66, 73]. By contrast, our group did not observe toxic 
effects of  CaOx crystals on MDCK cells at 100 µg/ml (or 32 µg/cm2) 
[74]. 
 
In Chapter 5 of this thesis, we investigated whether CaOx crystals can 
actually induce damage to renal tubule epithelial cells. The responses of 
confluent proximal and distal tubular cells to increasing amounts of 
CaOx were described. While collecting tubule cells (MDCK-I) do not 
bind, take up or respond to CaOx crystals, renal proximal tubular 
epithelial cells have to cope with CaOx crystals that are bound and 
internalized. In MDCK-II cells an early and a late response could be 
distinguished.  After their association with the plasma membrane COM 
crystals were rapidly taken up by both proximal tubule cells to remain 
lodged inside the cells for weeks. Within the first 24 hours, about 50% of 
the cell-associated COM were released back into the apical fluid. The 
other half of the crystals were gradually eliminated by the release of 
crystals and/or crystal-containing cells during the following fortnight. 
The early proximal tubular response was characterized by an increased 
secretion of PGE2 and incorporation of [3H]thymidine accompanied by 
the release of crystal-associated necrotic cells without signs of apoptosis. 
PGE2 secretion declined to control levels after the immediate response, 
while crystal-containing cells remained incorporated in the otherwise 
functional monolayers. This study shows that COM triggers acute 
inflammation and necrosis in proximal tubular cells. It is however 
unlikely for these cells to encounter crystals in vivo. Collecting duct cells 
did not bind and internalize crystals. We did not observe crystal-induced 
activation, injury or cell death. As long as the renal collecting ducts are 
not obstructed with crystals, these results do not support an important 
role for crystal-induced tissue injury in the pathophysiology of calcium 
oxalate nephrolithiasis.  
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7.4 OXALATE TOXICITY 
 
During the past decade, many research groups have focussed on studying 
the role of oxalate toxicity in the development of nephrolithiasis. Oxalate 
toxicity was extensively studied using animal models, but also in cell 
culture.  
 
Animal models 
Studies performed with laboratory animals have indicated that injury to 
the epithelium is required for crystal retention. A commonly used model 
for renal stone formation in rats is the addition of ethylene glycol to the 
drinking water, which leads to chronic hyperoxaluria and CaOx crystal 
formation Administration of EG not only leads to increased excretion of 
urinary oxalate, but also decreases urinary pH and citrate excretion. 
Persistent crystalluria can be observed within the first week of this diet 
and nephrolithiasis is induced within 2-3 weeks [75-77]. Ethylene glycol 
(EG) is metabolized into a range of  intermediates, such as glyco-
aldehyde, glycolate, glyoxylate and oxalate. Less than one percent of EG 
is ultimately  turned into oxalate. In a study by Huang et al., increased 
urine lipid peroxides and enzymuria (GAL, NAG) were found in rats that 
were on  a diet supplemented with 0.75% EG in drinking water for 7 
days. In addition to this, renal tubular dilatation and infiltration of 
macrophages/monocytes in the interstitium were found. In the early 
phase of chronic hyperoxaluria, increased production of free radicals 
occurred. Acute oxalate infusion increases the production of free radicals 
in the kidney in a dose-dependent manner [78-80]. In rabbits, addition of 
0.75% EG to drinking water led to crystal deposition in tissues. 
Apoptotic changes occurred prominently in distal tubular and collecting 
duct cells, but less in proximal tubular cells. [81] Recent results from our 
group have demonstrated that in rats fed a diet supplemented with 0.5% 
or 0.75 % ethylene glycol (EG) in drinking water tubular injury was 
induced without loss of renal function. In these rats, crystals were formed 
from day 1 but at that moment those were not retained inside the tubules. 
Injury to the tubules could not be detected, and CD44, HA and OPN were 
absent form the luminal surface of the epithelium. At day 4, tubular 
injury could be detected in EG-treated rats, but not in control rats. CaOx 
crystals were especially detected at sites were injured/regenerating cells 
were present. At these sites, HA and OPN were present at the cell 
surface, where they could serve as crystal binding molecules [54].  
General Discussion 
 129 
It is generally believed that high oxalate concentrations and/or crystals 
caused by an EG-supplemented diet provide the noxious stimulus for 
tubular injury. However, in studies with experimental animals, effects are 
seen of ethylene glycol and oxalate together with all their intermediate 
metabolites. To rule out the possibility that observed effects are not 
caused by CaOx crystals or by oxalate itself, but by other products of 
metabolism, cell culture studies are required.  
 
Cell culture models 
For over a decade, investigators have been studying the effects of oxalate 
and CaOx crystals on renal tubular epithelial cells in culture.  Most of 
these studies were performed using cells from proximal tubular origin, 
like LLC-PK1. From early studies the idea arose that oxalate was harmful 
to the cells, since time- and concentration dependent changes in cell 
morphology were observed, together with increased membrane per-
meability, DNA fragmentation and even cell death. These effects were 
observed upon exposure to 1 to 4 mM oxalate, added in calcium-
containing DMEM or buffer [82]. Although the authors denied the 
formation of CaOx crystals under these circumstances, based on esti-
mations made using the EQUIL program, this appears to be inaccurate. In 
a more recent study, Belliveau et al. performed measurements on the 
solubility of oxalate in calcium-containing cell culture media and found 
that addition of 1.0 mM oxalate to normal DMEM medium, containing 
1.8 mM CaCl2, causes precipitation of 94.3 % of the available oxalate. 
Instead of the calculated 0.35 mM free oxalate, there is actually only 60 
µM free oxalate left under these circumstances [83]. When cells grown 
on plastic wells are exposed to high oxalate concentrations, precipitation 
of calcium from the tissue culture medium with oxalate leads to calcium 
depletion and subsequent cell detachment 
 
When we started to investigate oxalate toxicity in the two-compartment 
cell culture model, we expected to find damaging effects to renal tubular 
epithelial cells. Surprisingly, even LLC-PK1 and MDCK-II cells, with 
properties of the proximal tubules, could withstand oxalate concen-
trations up to 1 mM without undergoing massive injury. These findings 
contradicted those obtained by Scheid et al., who published a large 
number of studies on oxalate toxicity in LLC-PK1 cells [82, 84-92]. This 
discrepancy might be contributed to cell culture techniques, since in most 
studies cells were cultured on impermeable tissue culture plastic rather 
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than on permeable supports in a two-compartment model. Cells cultured 
on plastic surfaces are less well-developed than those cultured on 
permeable supports. Since cells normally feed from their basal side, 
plastic-cultured cells are more likely to suffer from lack of nutrients upon 
reaching confluence. This might make them more susceptible to dama-
ging stimuli. Indeed, we found that incubating the cells with high oxalate 
in calcium-containing medium, such that all calcium was complexed with 
oxalate, caused rounding and detachment of the cells from the substrate, 
an effect that was similar to that of incubation in calcium free medium. 
LLC-PK1 cells that were cultured to confluence in plastic wells sponta-
neously detached from the substrate when the maximal amount of cells 
per well was reached. (unpublished results). As described in Chapter 6, in 
our cell culture model only extremely high oxalate concentrations (5 and 
10 mM) triggered an inflammatory response and necrotic cell death. 
Apparently, the availability of nutrients and calcium in the basal com-
partment provides the proximal tubular cells with a protective mechanism 
against oxalate-induced injury.  
 
In contrast to proximal tubular cells, distal tubule/collecting duct  cells in 
vivo are used to encounter higher oxalate concentrations (up to 0.3-1 
mM). Therefore, it seems more physiologically relevant to study the 
effects of oxalate on cells derived from the late part of the nephron. We 
examined MDCK-I and RCCD1 cells after exposure to increasing 
concentrations of oxalate and found little or no effects of up to 5 mM 
oxalate. Only at the extreme supraphysiological concentration of 10 mM 
oxalate, morphological changes, inflammatory responses and cell death 
occurred. The results from our studies suggest that oxalate in the kidney 
is not as damaging to the tubular epithelium as has been believed during 
the past years. Oxalate appears not to be the stressor leading to activation 
of renal tubular epithelium, turning it into a crystal-binding instead of a 
crystal-repelling phenotype. 
 
General Discussion 
 131 
7.5  CONCLUSIONS 
 
Crystallization in the renal tubules is  a common occurrence that is 
normally harmless. Intact epithelium in the distal parts of the nephron is 
not susceptible to crystal binding. When renal tubular epithelial cells are 
exposed to a stressor and are activated or injured, this might turn the 
epithelium into a crystal-binding state. This thesis was conducted to 
obtain more insight in the response of renal tubular cells to oxalate and 
calcium oxalate and to clarify some of the contradictions in nephrolithia-
sis research literature. 
 
Our results show that particular cellular responses such as crystal uptake 
and crystal-induced inflammation and necrosis are characteristic for cells 
derived from nephron segments such as the proximal tubule where 
crystallization does not take place. In the distal tubules and collecting 
ducts, where crystallization is common, the epithelium is not susceptible 
to crystal binding, unless it is activated/injured. In other words, the 
reported crystal-induced cell death most likely is not physiologically 
relevant. 
We also found that the adherence of crystals to a crystal binding 
collecting tubule phenotype is not prevented by pre-coating crystals with 
urinary proteins. This undermines the theory that crystal binding requires 
structurally abnormal or insufficient proteins. On the other hand, this 
finding reinforces the concept that crystal binding depends on the 
structural composition of the cell surface in certain areas of the nephron. 
Finally, our studies disproved the idea that high urinary excretion of 
oxalate could injure the renal tubular epithelium thereby setting the stage 
for crystal attachment and stone development. Studies performed in our 
model in which the cells are cultured on permeable supports in a two 
compartment culture system revealed that oxalate is not very toxic at all 
and that most of the damaging effects reported by other most likely were 
caused by crystals that were formed in calcium-rich culture medium. 
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SUMMARY 
 
Nephrolithiasis (renal stone disease) is a common disorder in 
industrialized countries. About 10% of the population will develop 
kidney stones during lifetime. Approximately 50% of the patients that 
formed a renal stone for the first time will do that again within a period 
of 10 years. Although renal stone disease generally is not life threatening, 
stones can be very painful and invasive clinical interventions are required 
for their removal. Since nephrolithiasis is such a widespread disease, 
clinical procedures and the allied absence from work have a substantial 
economical impact. For that reason, it is important to disclose the 
abnormalities underlying stone disease. With this knowledge we might 
be able to develop strategies to prevent stone recurrence. 
Risk factors for stone formation are a positive family history of stones, 
nutrition, nutritional deficiencies, life style and associated diseases. 
Excessive intakes of salt, animal protein and oxalate, as well as 
insufficient intake of fluid, vegetable fibres and calcium increase the risk 
of stone formation. Specific dietary advice and/or pharmacological 
interventions can lower the risk of recurrence for some patients. 
In the kidneys, concentrated urine is produced. Each day, 180 litres of 
fluid are filtered at the glomerulus. During this process, essential 
nutrients and salts are reabsorbed together with most of the water  and 
waste products are excreted. The concentration of  components that are 
not or less extensively reabsorbed rises towards the end of the nephron. 
When super saturation occurs, i.e. when the concentration of salts gets 
too high to be kept in solution, crystals can spontaneously be formed 
(nucleation). Urine normally contains compounds that interfere with the 
nucleation, growth, agglomeration or retention of crystals. Renal stones 
can be formed when crystals are not eliminated with the urine, but are 
retained in the kidney. Different theories exist about the retention of 
crystals in the kidney. According to the “fixed particle” theory, crystals 
grow and aggregate until they become too large to pass through the 
tubular lumen and become e trapped. In contrast, according to the “free 
particle” theory, crystal retention could be dependent on the interaction 
between the renal tubular epithelium and the crystals, even when those 
are small.  The epithelium has to become susceptible to crystal binding, 
which might occur under pathological conditions. Urinary constituents 
can influence the interaction between crystals and between crystals and 
the epithelium. In Chapter 2, we investigated the inhibitory effect of 
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urinary components  on  CaOx crystal binding to a susceptible 
epithelium. Crystal binding was studied using renal tubular epithelial cell 
lines with characteristics from different parts of the nephron. Since 
hyaluronan (HA) was earlier identified as major crystal binding 
molecules in MDCK-I cells during migration and proliferation, the role 
of HA in crystal binding was more extensively investigated in different 
cell lines (Chapter 3).  The fate of crystals that have been bound to the 
renal tubular epithelium varies depending on the origin of the epithelium. 
Proximal tubular epithelium usually does not encounter crystals and do 
not display defence mechanisms against their retention. Crystals that are 
retained by this cell type are subsequently internalized. In contrast, distal 
tubule/collecting duct cells often come in contact with crystals and are 
normally protected against crystal binding. The epithelium from this part 
of the nephron can be  turned into a crystal-binding phenotype during 
pathological conditions. Even then, crystals are not internalized by this 
cell type ( Chapter 4). 
It is believed that CaOx crystals that are taken up by renal tubular 
epithelial cells act as stressor, leading to cell activation or injury. For this 
reason, we investigated the effects of long-term exposure of confluent 
renal tubular epithelial cells grown on permeable supports to a high dose 
of CaOx crystals (32 µg/cm2). Our studies showed that collecting tubule 
cells (MDCK-I), that were protected against crystal binding, did not bind  
take up or respond to crystals. Proximal tubular cells, by contract, bound 
and internalized CaOx crystals, after which an early and a late response 
could be distinguished. The early response was characterized by an 
increased secretion of prostaglandin E2 (PGE2) and a proliferative 
response. At the same time, crystal-containing necrotic cells were 
released. After this immediate response, PGE2  levels declined to control 
levels and crystal-containing cells remained incorporated in the normal 
functioning monolayer. COM triggers acute inflammation and necrosis in 
proximal tubular cells, but do not induce tissue injury in collecting duct 
cells (Chapter 5). 
Calcium oxalate (CaOx) is the most common component of renal stones. 
The soluble amount of CaOx is about fourfold higher in  normal urine 
than in water. Oxalate has a bigger influence on the soluble amount than 
calcium. Urinary oxalate is increased in many idiopathic stone formers. 
This might be ascribed to increased intestinal calcium absorption, 
increased bone resorption and decreased renal tubular calcium 
reabsorption. Oxalate is believed to be toxic to renal tubular epithelial 
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cells. We investigated oxalate toxicity using our two-compartment cell 
culture model, comparing proximal tubular cells and collecting tubule 
cells. Contrary to our expectations, physiological oxalate concentrations 
did not exert damage to either cell type. At extreme supraphysiological 
concentrations, oxalate did induce morphological alterations, inflam-
matory responses and cell death (Chapter 6).  
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SAMENVATTING 
 
Nephrolithiasis (niersteenvorming) is een algemeen voorkomende ziekte 
in geïndustrialiseerde landen. Ongeveer één op de tien mensen zal tijdens 
zijn leven nierstenen ontwikkelen. Van de patiënten die voor de eerste 
keer een steen gevormd hebben zal ongeveer de helft  dat binnen tien jaar 
nog een keer doen. Hoewel niersteenziekte niet levensbedreigend is 
kunnen stenen veel pijn veroorzaken en zijn de klinische procedures om 
ze te verwijderen erg ingrijpend. Niersteenvorming is een wijdverbreide 
ziekte, daarom hebben de klinische procedures en het daarmee samen-
hangende werkverzuim een grote economische impact. Om die reden is 
het belangrijk de onderliggende afwijkingen van steenziekte bloot te 
leggen.  Met deze kennis kunnen we mogelijk strategieën ontwikkelen 
om het terugkeren van een steen te voorkomen. 
Risicofactoren voor steenvorming zijn het voorkomen van stenen in de 
familie, voeding, voedingstekorten, levensstijl en onderliggende ziekten. 
Overmatige inname van zout, dierlijk eiwit en oxalaat verhogen de kans 
op steenvorming, net zoals onvoldoende inname van vocht, vezels en 
calcium. Specifieke dieetadviezen en/of farmacologisch ingrijpen kan 
voor sommige patiënten de kans op recidive voorkomen. 
In de nieren wordt geconcentreerde urine geproduceerd. Iedere dag wordt 
180 liter vloeistof gefiltreerd aan de glomerulus. Tijdens dit proces 
worden essentiële voedingsstoffen en zouten teruggeresorbeerd met het 
grootste deel van het water en worden afvalstoffen uitgescheiden. De 
concentratie van stoffen die niet of slecht geresorbeerd worden neemt toe 
naar het einde van het nephron. Wanneer supersaturatie optreedt, d.w.z. 
wanneer de concentratie van zouten te hoog wordt om in oplossing 
gehouden te kunnen worden, kunnen zich spontaan kristallen vormen 
(nucleatie). Urine bevat normaliter bestanddelen die de nucleatie, groei, 
agglomeratie of retentie van kristallen beïnvloeden. Nierstenen kunnen 
gevormd worden wanneer kristallen niet met de urine uitgescheiden 
worden, maar achterblijven in de nier. Er bestaan verschillende theorieën 
over de retentie van kristallen in de nier. Volgens de “fixed particle” 
theorie blijven kristallen groeien en samenklonteren tot ze te groot 
worden om door het lumen van de tubulus te passeren en blijven steken. 
Volgens de “free particle”theorie, daarentegen, zou het achterblijven van 
kristallen afhankelijk kunnen zijn van de interactie tussen het epitheel 
van het niertubuli en  de kristallen, zelfs als deze klein zijn. Het epitheel 
is ontvankelijk geworden voor kristalbinding, wat onder pathologische 
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omstandigheden kan gebeuren. Urine bestanddelen kunnen invloed 
uitoefenen op de interactie tussen kristallen onderling en tussen kristallen 
en het epitheel. In hoofdstuk 2 hebben wij het remmende effect van 
urinebestanddelen op de binding van CaOx kristallen aan een ontvan-
kelijk epitheel onderzocht. Hyaluronzuur (HA) was al eerder geïdenti-
ficeerd als belangrijk kristalbindend molecuul in MDCK-I cellen tijdens 
migratie en proliferatie. Om die reden  hebben we de rol van HA uitge-
breider bestudeerd in  meerdere cellijnen (hoofdstuk 3). Het lot van 
kristallen die aan het epitheel van de niertubuli gebonden zijn is 
afhankelijk van de oorsprong van dat epitheel. In de proximale tubuli 
komt het epitheel normaalgesproken niet in contact met kristallen en 
heeft daarom geen mechanisme ontwikkeld om achterblijven van 
kristallen te voorkomen. Kristallen die plakken aan dit celtype worden 
vervolgens in de cel opgenomen. Cellen uit de distale tubuli en verzamel-
buizen komen daarentegen veelvuldig in contact met kristallen en zijn 
onder normale omstandigheden beschermd tegen kristalbinding. Het 
epitheel uit dit gedeelte van het nephron kan onder pathologische 
omstandigheden een kristalbindend fenotype tentoonspreiden. Zelfs 
onder die condities worden kristallen door deze cellen niet opgenomen ( 
hoofdstuk 4).  
Men gelooft dat CaOx kristallen die door cellen opgenomen worden 
fungeren als stressor en leiden tot activering of beschadiging van cellen. 
Wij hebben daarom de effecten onderzocht van blootstelling van 
confluente, op permeabele filters gekweekte, cellen aan een hoge dosis 
calcium oxalaat kristallen. De resultaten van onze studie wezen uit dat 
verzamelbuiscellen (MDCK-I), die beschermd zijn tegen kristalbinding, 
kristallen binden noch opnemen, noch een reactie op de kristallen 
vertonen. Cellen afkomstig uit de proximale tubulus (MDCK-II), binden 
CaOx kristallen en nemen deze op in de cellen, waarna een vroege en een 
late reactie onderscheiden kunnen worden. De vroege respons kenmerkt 
zich door een toegenomen uitscheiding van prostaglandine E2 (PGE2) en 
een groei reactie. Tegelijkertijd worden necrotische, kristallen bevat-
tende, cellen losgelaten. Na deze onmiddellijke respons keert de PGE2  
uitscheiding terug naar het oorspronkelijke niveau en blijven de cellen 
die kristallen bevatten in de normaal functionerende monolaag. De COM 
kristallen brengen  acute ontsteking en necrose in proximale tubulus 
cellen teweeg, maar veroorzaken geen weefselschade in verzamel-
buiscellen (hoofdstuk 5). 
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Calcium oxalaat (CaOx) is het meest voorkomende bestanddeel van 
nierstenen. De oplosbare hoeveelheid CaOx in urine is ongeveer viermaal 
zo hoog als in water. De invloed van oxaalzuur op de oplosbare hoeveel-
heid is groter dan die van calcium. Oxaalzuur in de urine is verhoogd bij 
veel idiopathische steenvormers. Dit kan toegeschreven worden aan 
toegenomen intestinale calcium absorptie, verhoogde botresorptie en 
verlaagde calcium reabsorptie in de niertubuli. Oxaalzuur wordt veron-
dersteld toxisch te zijn voor het tubulaire nierepitheel. Wij hebben de 
toxiciteit van oxaalzuur onderzocht in ons tweecompartimenten 
celkweekmodel, warbij we proximale tubuluscellen en verzamelbuis-
cellen vergeleken hebben. Tegen onze verwachting in brachten 
fysiologische oxaalzuurconcentraties geen schade toe aan elk van deze 
celtypen. Slechts wanneer extreem hoge concentraties oxaalzuur toege-
diend werden, veroorzaakten deze morfologische veranderingen, ontste-
kingsreacties en celdood (hoofdstuk 6).  
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